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SUMMARY 
Ralstonia eutropha H16 (also known as Cupriavidus necator H16) is a non-pathogenic 
chemolithoautotrophic soil bacterium. It has increasingly gained biotechnological interest 
for its use as a microbial cell factory for the production of several valuable bio-based 
chemicals. However the absence of a large repertoire of molecular tools to engineer this 
organism remains a critical limiting factor to exploiting its full biotechnological potential. 
Also, adopting established molecular tools applicable to the more notable microbial hosts 
such as E. coli and Saccharomyces cerevesiae is severely hampered by chassis-
incompatibility and functional variability of essential biological parts. The work detailed in 
this thesis focuses on the development of key molecular tools crucial to improving the 
biosynthesis of malonyl-CoA - a precursor metabolite required for the biosynthesis of fatty 
acids and potentially several valuable bio-products in Ralstonia eutropha H16.  
 
All molecular tools developed were based on the broad host range (BHR) plasmid vector 
backbone of pBBR1MCS1 – a R. eutropha H16-compatible vector.  Firstly, to facilitate 
heterologous pathway optimization, a combination of pre-existing and novel methods of 
genetic modifications were applied to engineer a collection of 42 promoters. Promoter 
strengths were characterized using a fluorescence-based assay and benchmarked to the 
dose-dependent activity of an L-arabinose-inducible PBAD promoter. Next, to detect 
intracellular accumulation of malonyl-CoA, transcriptional factor-based malonyl-CoA-
sensing genetic circuits were developed via careful selection from the promoter collection. 
Thirdly, BHR L-arabinose-inducible -Red plasmid vectors were developed for mediating 
-Red-based genome editing. These were first tested in E. coli BW25113 to confirm their 
functionality and then subsequently tested in R. eutropha H16. 
 
Overall, the collection of engineered promoters yielded a 137-fold range of promoter 
activity and the malonyl-CoA biosensors responded to changing malonyl-CoA 
concentrations. The BHR -Red plasmids showed high recombination efficiency in E. coli 
BW25113. The molecular tools developed from this work will further facilitate rapid 
control and regulation of gene expression in R. eutropha, particularly for malonyl-CoA 
engineering. 
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genetically-encoded malonyl-CoA biosensors for metabolic engineering of microbial cell 
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1.10 Scope of research  
Rapid advancement in the development of state-of-the-art metabolic engineering tools, and 
the synergistic application of these tools promises to improve the use of R. eutropha H16 as 
an industrial work strain for chemical production. Overall, regulation of gene expression is 
a forefront strategy in improving the accumulation of pre-defined chemicals and/or their 
precursor metabolites. To this end, the research study in this thesis aims to expand the 
collection of molecular tools available to alter/modify/control/regulate gene expression in R. 
eutropha H16 by focusing on (1) engineering promoters for static and/or dynamic control 
of gene expression, (2) engineering metabolite-responsive genetic circuits for reporting the 
accumulation of vital metabolites and for achieving programmable and orthogonal 
regulation of the biosynthesis of such metabolites, (3) developing a facile genome editing 
molecular tool to alter gene expression at the genomic level. In particular, the goal is to 
develop these molecular tools to potentially facilitate metabolic engineering efforts to 
improve biosynthesis of malonyl-CoA in R. eutropha H16. All of these tools will rely on 
the use of expression vectors that are compatible with the transformation, replication and 
transcriptional machineries of R. eutropha H16. 
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1.11 Why Malonyl-CoA?  
In practically every living system, a portion of the acetyl-CoA flux from the central 
metabolic pathway is carboxylated into malonyl-CoA, with the aid of acetyl-CoA 
carboxylase (ACC). This suggests the vital roles that malonyl-CoA plays in cell 
metabolism and structure. Specifically, malonyl-CoA is a rate limiting substrate for fatty 
acid synthesis, which in turn, is pivotal for maintaining cell membrane integrity and energy 
conservation (Schujman et al., 2008, Schujman et al., 2006, Schujman et al., 2003). In 
mammals, it has been identified as a crucial fatty acid oxidation regulator which inhibits the 
mitochondrial carnitine palmitoyltransferase (CPT) − an enzyme involved in fatty acid 
uptake in the heart and skeletal muscle (Folmes and Lopaschuk, 2007, Foster, 2012). This 
makes it a target molecule for treating diseases caused by poor or excessive fatty acid 
uptake. This has also attracted medical interest in drug development to control malonyl-
CoA metabolism at the enzymatic level (Folmes and Lopaschuk, 2007). More relevant to 
this review, malonyl-CoA is also the modulatory effector molecule for regulating fatty acid 
synthesis in many Gram-positive bacteria (Dirusso et al., 1993, James and Cronan, 2003, 
Magnuson et al., 1993, Marrakchi et al., 2001, Nunn et al., 1977, Schujman et al., 2003, 
Schujman et al., 2006, Schujman et al., 2008, Yao et al., 2012).  
 
The role of malonyl-CoA as a precursor metabolite for fatty acid biosynthesis has 
particularly attracted vast industrial biotechnology interest in harnessing intracellular 
malonyl-CoA flux for the synthesis of both value-added fatty acid based end chemicals, and 
a wide range of non-fatty acid based end chemicals in notable microbial cell factories, such 
as Escherichia coli and Saccharomyces cerevesiae, (James and Cronan, 2003, Schujman et 
al., 2003, Schujman et al., 2006) (Figure 1.11). These end chemicals are potentially useful 
as pharmaceutical intermediates, biofuels or other potentially useful chemical products vital 
to a sustainable bio-economy (Liu et al., 2015b, Xu et al., 2014a, Xu et al., 2014b). 
However, perpetually low intracellular concentrations of malonyl-CoA in microbial hosts 
(4 – 90 M or 0.01 – 0.23 nmol/mg dry weight in E. coli) necessitate the use of metabolic 
engineering approaches to realize its commercial-scale applications (Miyahisa et al., 2005, 
Takamura et al., 1985, Takamura and Nomura, 1988).  
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1.12 Strategies for malonyl-CoA engineering in model microbial factories 
Early metabolic engineering strategies employed static manipulation of relevant pathway 
enzymes that are directly or indirectly involved in malonyl-CoA metabolism in conjunction 
with metabolic pathways to channel the ensuing increase in malonyl-CoA amounts to the 
synthesis of pre-defined end chemicals. Some of these approaches include increasing 
expression level and/or enzymatic activity of ACC – the enzyme that converts acetyl-CoA 
to malonyl-CoA, increasing intracellular availability of acetyl-CoA – a malonyl-CoA 
precursor, and down-regulating malonyl-CoA sink pathways (Figure 1.12 and Table 1.4). 
As such, early attempts at malonyl-CoA engineering relied on conventional bio-analytical 
techniques such as HPLC and LC to quantify increased concentrations of malonyl-CoA and 
the ensuing end chemicals, and to validate the effectiveness of various strategies.  
 
In addition, the outcomes of static manipulation of relevant pathways have been used in 
building and validating predictive computational models as a metabolic engineering tool 
(Fowler et al., 2009, Xu et al., 2011). By studying the entire metabolic network of a 
biological host, such models nominate target genes for knock out and/or over-expression to 
improve malonyl-CoA amounts. Besides nominating genes directly related to malonyl-CoA 
metabolism, computational tools have been applied in highlighting potential impact of 
targeted genes on cell growth. Further, they have been used to explore the potential roles of 
genes that are indirectly related to malonyl-CoA metabolism with the aim of improving 
intracellular malonyl-CoA accumulation. Overall, computational tools have been 
successfully applied for finding the most promising combination of approaches to achieve 
an improved malonyl-CoA yield. As an example, Xu et al. applied a genome-scale 
metabolic network model to achieve a balanced carbon flux to the citric acid cycle for cell 
viability and to the synthesis of naringenin, a flavonoid compound, in E. coli (Xu et al., 
2011). The model predicted over-expression of ACC, phosphoglycerate kinase (PGK) and 
pyruvate dehydrogenase (PDH), in addition to double knockout of genes for the citric acid 
cycle enzymes: succinyl-CoA synthetase (sucC) and fumarase (fumC). The combination of 
these metabolic adjustments resulted in a 3.7-fold increase in malony-CoA amount and a 
5.6-fold increase in naringenin production at 474 mg/L, compared to the wild-type cells. 
Similarly, Fowler et al. demonstrated the use of a computational model known as Cipher of 
Evolutionary Design (CiED) (Fowler et al., 2009). The tool nominated knockout of citric 
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acid cycle genes (sdhCDAB and citE), amino acid transporter (brnQ) and pyruvate 
consumer (alcohol dehydrogenase adhE) in engineering an efficient malonyl-CoA 
producing E. coli strain. This deletion strain was subsequently used to overexpress ACC, 
acetyl-CoA synthetase, biotin ligase and pantothenate kinase to achieve 660% and 420% 
increase in naringenin and eriotictyol production, respectively.  
 
Beside the use of genetically orchestrated metabolic engineering strategies, fatty acid 
synthesis inhibiting-chemicals such as cerulenin and triclosan have been shown to induce 
relatively large increase in intracellular malonyl-CoA amounts (Davis et al., 2000). 
Cerulenin up-regulates intracellular malonyl-CoA amounts by inhibiting -ketoacyl-acyl 
carrier protein synthase enzymes (FabB and FabF), which condense malonyl-ACP with 
acyl-ACP to extend the fatty acid chain by two carbon atoms (Schujman et al., 2006, 
Schujman et al., 2008). However, the blockade in fatty acid synthesis under high cerulenin 
concentrations negatively impacts on cell viability. This and the high cost of cerulenin 
greatly limit its use for commercial-scale malonyl-CoA production (Davis et al., 2000). 
Despite its limited commercial application, experimentation with cerulenin concentrations 
to incite increasing malonyl-CoA concentrations was crucial in establishing malonyl-CoA 
as the modulatory effector molecule for regulating fatty acid synthesis in Gram- positive 
bacterial species (Schujman et al., 2006, Schujman et al., 2003). 
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Figure 1.11: Compounds derived from malonyl-CoA. Malonyl-CoA, a direct product of 
acetyl-CoA, can be used as a precursor for the synthesis of fatty acids, flavonoids, bio-
polymers, biofuels, and polyketides. 
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Figure 1.12: A summary of metabolic engineering strategies to increase intracellular 
malonyl-CoA concentration.  
Increasing the pool of acetyl-CoA, decreasing the flux of acetyl-CoA towards non-malonyl-
CoA producing acetyl-CoA sink pathways, increasing the expression and/or activity of 
acetyl-CoA carboxylase and decreasing the flux of malonyl-CoA towards fatty acid 
synthesis, are direct ways of improving intracellular malonyl-CoA accumulation. 
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Table 1.4: Notable examples of conventional metabolic engineering strategies to increase intracellular malonyl-CoA amount and end 
chemicals 
Strategy Mechanism Microbial host Malonyl CoA End chemical Reference 
Increased expression of 
acetyl-CoA carboxylase 
(ACC) 
Overexpressing the four 
subunits of E. coli acetyl-CoA 
carboxylase (ACC) in a low 
copy number plasmid under the 
control of T7 promoter. 
E. coli  100-fold increase 
relative to WT 
6-fold increase in free 
fatty acid synthesis  
Davis et al. (2000) 
Overexpression of the two 
subunits of Corynebacterium 
glutamicum acetyl-CoA 
carboxylase (ACC) in a high 
copy number plasmid under the 
control of T7 promoter. 
E. coli  Not quantified 60 mg/L yield in 
flavanones 
Miyahisa et al. 
(2005) 
Changing the promoter of ACC1 
to a strong constitutive promoter 
TEF1. 
S. cerevisiae Not quantified 60% increase in 6-
methyl acetyl–
salicylic acid 
Wattanachaisaereek
ul et al. (2008) 
Increased activity and 
expression of native 
acetyl-CoA carboxylase 
(ACC) 
Site-directed mutagenesis of 
S659 and A1157 to reduce 
SNF1-mediated phosphorylation 
of Acc1; overexpression of 
Acc1 WT and mutants. 
S. cerevisiae Not quantified 65% increase in total 
fatty acid content, 3-
fold increase in fatty 
acid ethyl esters 
(FAEE), and 3.5-fold 
increase in 3-
hydroxypropionic acid 
(3-HP) 
Shi et al. (2014) 
 
Table continues below 
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Strategy Mechanism Microbial host Malonyl CoA End chemical Reference 
Increased acetyl-CoA 
flux towards malonyl-
CoA accumulation 
T7 promoter-controlled 
overexpression of acetyl-CoA 
carboxylase (ACC), 
overexpression of acetyl-CoA 
synthetase, which recycles 
acetate to acetyl CoA; double 
knock-out of genes encoding 
phosphotransacetylase (Pta) and 
acetate kinase (AckA), which 
are genes responsible for acetate 
biosynthesis from acetyl-CoA; 
deletion of alcohol/aldehyde 
dehydrogenase (adhE). 
E. coli  15-fold increase 
relative to WT 
4-fold increase in 
phloroglucinol 
production 
Zha et al. (2009) 
Overexpression of the four 
subunits of Photorhabdus 
luminescens acetyl-CoA 
carboxylase (ACC) in a low 
copy number plasmid and 
overexpression of Photorhabdus 
luminescens biotin ligase (BirA) 
in a high copy number episomal 
vector. Biotin ligase catalyzes 
the biotinylation of the biotin-
dependent BCCP subunit of 
ACC. 
E. coli  Not quantified 1166% increase in 
flavonone synthesis 
Leonard et al. (2007) 
 
Table continues below 
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Strategy Mechanism Microbial host Malonyl CoA End chemical Reference 
Decreased expression of 
malonyl-CoA-
consuming enzymes 
Use of anti-sense RNA to 
silence the expression of 
malonyl-CoA transacylase 
(FabD) – a fatty acid synthesis 
enzyme. 
E. coli 4.5-fold increase 
relative to WT 
2.53-, 1.70-, 1.53-fold 
increase in the 
production of 4-
hydroxycoumarin, 
resveratrol, and 
naringenin, 
respectively 
Yang et al. (2015) 
Expression of other 
malonyl-CoA source 
pathway 
Overexpressing the malonate 
carrier protein (matC), which 
transports malonate into the cell 
and malonyl-CoA synthetase 
(matB), which converts 
malonate to malonyl-CoA. 
E. coli Not quantified 100.64 mg/L of (2S)-
naringenin 
Wu et al. (2014) 
Use predictive 
computational models to 
select a combination of 
metabolic engineering 
approaches for strain 
optimization 
Overexpression of acetyl-CoA 
carboxylase (ACC), 
phosphoglycerate kinase (PGK) 
and pyruvate dehydrogenase 
(PDH), coupled with double 
knock-out of fumarase (fumC) 
and succinyl-CoA synthetase 
(sucC) genes. 
E. coli  3.7-fold increase 
relative to WT 
474 mg/L naringenin 
production 
Xu et al. (2013) 
Overexpression of acetyl-CoA 
carboxylase (ACC), biotin 
ligase (BirA), pantothenate 
kinase in a citric acid cycle 
genes (sdhCDAB and citE), 
amino acid transporter gene 
(brnQ), alcohol dehydrogenase 
gene (adhE) deletion strain. 
E. coli 2.7-fold increase in 
relative to WT 
660 % fold increase in 
naringenin synthesis 
and 420 % fold 
increase in eriodictyol 
synthesis 
Fowler et al. (2009) 
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1.13 Development of chassis-compatible expression vectors 
Recombinant strain engineering via plasmid-borne expression/overexpression of specific 
gene(s) has enormous capabilities for genetic manipulation towards desired metabolic 
phenotypes. By leveraging polished synthetic biology crafts using standardized biological 
parts; recombinant plasmid vectors have evolved into highly modular expression systems in 
microbial cell factories. Hence aside heterogeneous over-expression/expression of 
metabolic genes, recombinant plasmids have also been applied in the design of plasmid 
modules for (1) mediating genome editing; (2) engineering genetic sensors and circuits for 
tunable/dynamic protein expression and metabolite biosynthesis. However, beyond 
function-driven design of plasmid constructs, it is required that the cellular physiology and 
native machineries of replication and transcription of chosen microbial cell factories is 
properly understood in order to ensure chassis-compatibility of vectors with the microbial 
cell factory.  
 
Unlike conventional microbial cell factories like E. coli and Saccharomyces cerevisiae, the 
replication and transcriptional machineries for gene expression and regulation in Ralstonia 
eutropha is not totally understood, despite availability of its genetic information (Pohlmann 
et al., 2006, Cramm, 2009, Schwartz et al., 2003). Expanding the synthetic biology toolbox 
for efficient genetic manipulation hence begins with the construction of plasmid systems 
that are compatible with its native replication and transcriptional machineries. Typically, 
only broad-host range plasmids requiring strand displacement replication mechanism are 
able to replicate in Ralstonia eutropha, for reasons yet to be fully elucidated (Jain and 
Srivastava, 2013). Narrow range plasmids are transferable into Ralstonia eutropha only if 
they possess a mob site from a broad host range plasmid which functions as an origin of 
transfer. However, the rather cumbersome conjugative transfer is required for bacterial 
transformation of such plasmids. Additionally, when transformed, these narrow host range 
plasmids are still unable to replicate, and thus remain as suicide vectors without potential 
use as expression systems. These constraints immediately limit the choice of plasmid 
vectors for altering cellular phenotypes to broad host range plasmid and/or recombinant 
plasmid with broad host range plasmid origin of replication. Electroporation method of 
bacterial transformation is leveraged on for efficient cellular transfer of these plasmids in 
order to aid their functions as expression vectors of predefined genes. 
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Previous studies have focused on leveraging broad host range plasmid for expanding the 
synthetic biology toolbox for Ralstonia eutropha. For example, the broad-host range 
pBBR1-based vectors are plasmids for have been employed for heterologous gene 
expression in Ralstonia eutropha (Dennis et al., 1998, Kovach et al., 1994, Kovach et al., 
1995). Other broad host range plasmids derivatives such as pKT230 (Park et al., 1995), 
pBHR1 (Solaiman et al., 2010), pCM62 (Bi et al., 2013), have also been employed as 
expression vectors. Beyond BHR origins, other biological components and properties of 
suitable plasmid constructs, also inform their suitability for gene expression in Ralstonia 
eutropha. These include vital biological parts for plasmid stability, plasmid mobilization, 
and host-compatible promoter systems.  
 
1.14 Promoter engineering  
Maximal product yield and titre are key requirements in biomanufacturing. To this end, 
metabolic pathway optimization is vital in eliminating metabolic bottlenecks that 
compromise cellular productivity and metabolic phenotypes that are detrimental to cell 
viability (Johnson et al., 2018, Johnson et al., 2017). Proven strategies of tuning gene 
expression of a metabolic pathway include varying plasmid copy number, gene dosage and 
promoter strength, among others (Johnson et al., 2018). Inducible promoters are applicable 
where tunable control of gene expression is required. The L-arabinose inducible PBAD 
promoter is particularly a choice promoter for controllable gene expression owing to its fast 
induction rate, its repressibilty, high expression level and tight modulation (Guzman et al., 
1995). It has hence been widely utilized as a promoter system in plasmid vectors for 
inducible expression in Ralstonia eutropha (Fukui et al., 2011, Bi et al., 2013). Leveraging 
on promoter strength of constitutive promoters for pathway optimization however requires 
proper characterization, standardization of promoters for universal comparison of promoter 
activity (Johnson et al., 2018). It also requires promoter engineering strategies to tune 
promoter activity at both transcriptional and translational levels (Johnson et al., 2018). 
 
1.15 Metabolite sensing genetic circuits 
The field of metabolic engineering has witnessed rapid advancements, further consolidating 
it as an enabling technology for engineering biological cell factories for producing value-
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added chemicals and bio-products. A key advancement is the application of synthetic 
biology to construct orthogonal genetic circuits or biosensors for in vivo detection of 
metabolites (Liao and Oh, 1999, Mainguet and Liao, 2010, van der Meer and Belkin, 2010). 
Such synthetic biosensors are archetypal of naturally evolved biosensors that propagate 
changing environmental signal or cellular status into a biological actuation or cellular 
phenotype that promotes either cell viability, survival or metabolic economics (Harrison 
and Dunlop, 2012, Liu et al., 2015b, Liu et al., 2015a). These biosensors are often made up 
of two components: metabolite-responsive transcriptional regulator and fluorescence-
coupled or fitness-related read-out module (Harrison and Dunlop, 2012, Rogers et al., 
2015).  This enables metabolic engineers to efficiently quantify varying concentration of 
cellular metabolites in contrast to the more time consuming and lower throughput bio-
analytical methods such as HPLC and LC-MS (Dietrich et al., 2013, Liu et al., 2015b, Liu 
et al., 2015a). Metabolite-sensing genetic circuits have been reported for sensing various 
metabolites including macrolides (Mohrle et al., 2007), acetyl phosphate (Farmer and Liao, 
2000), farnesyl pyrophosphate (Dahl et al., 2013), 3-hydroxypropanoic acid (Rogers and 
Church, 2016, Rogers et al., 2015), 1-butanol (Dietrich et al., 2013), and more recently, 
malonyl-CoA (Ellis and Wolfgang, 2012). 
 
The use of biosensors for in vivo detection and/or quantification of metabolite essentially 
creates an input-output communication platform within biological cells. This platform has 
predominantly been exploited for real-time monitoring of metabolite or product 
accumulation, i.e., product formation kinetics, allowing metabolic engineers to study 
product formation dynamics over a cultivation period. In turn, this enables detection of 
metabolic pathway bottlenecks and other factors that potentially limit end product titers. 
That said, biosensors have also found front-end applications as dynamic metabolic pathway 
regulators and back-end applications as screening devices. When applied for dynamic 
metabolic pathway regulation, biosensors allow the cell to respond to environmental 
perturbations or potentially detrimental metabolic phenotypes by adjusting pathway 
expression towards more effective carbon flux for the desired end products (Xu et al., 
2014a). When applied as screening devices, they are used to screen for and select high 
producer genetic variants, and in some cases, for identifying optimized process conditions 
for high product titers (Dietrich et al., 2010, Dietrich et al., 2013, Williams et al., 2016). All 
of these applications potentially help to fast track design-build-test cycles in engineering 
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synthetic metabolic pathways by facilitating genotype manipulation-phenotype evaluation 
processes (Rogers et al., 2015, Rogers and Church, 2016). Over all, these applications 
require that such sensors are well crafted and programmed with the right level of specificity, 
sensitivity and dynamic range needed for their functionality.  
1.15.1 Malonyl-CoA biosensors 
Malonyl-CoA biosensors are a synthetic mimicry of the native fatty acid biosynthesis 
transcriptional regulatory circuits, found naturally in many Gram-positive bacteria such as 
Bacillus subtilis, Staphylococcus aureus, Bacillus anthracis, Listeria monocytogenes and 
Streptococcus pneumonia (Fujita et al., 2007, James and Cronan, 2003, Li et al., 2015, Liu 
et al., 2015b, Xu et al., 2014a). This regulation is modulated by the interaction between 
transcription factor FapR (Fatty acid and phospholipid Regulator) and its operator fapO. 
FapR represses the fatty acid operon through binding to the 17-bp cis-regulatory fapO 
operator localized within or in proximity to the operon’s promoter. Malonyl-CoA acts as an 
inducer of the FapR regulon by impairing the FapR-fapO interaction. Through replacing the 
fatty acid operon with a gene encoding a reporter protein, for instance a fluorescence 
protein, a biosensor that is transcriptionally regulated by malonyl-CoA is created, where the 
reporter protein activity reflects the intracellular malonyl-CoA concentration. 
1.15.2 Mechanism of malonyl-CoA sensing 
The naturally occurring fatty acid biosynthesis regulon consists of an autogenously 
regulated FapR transcriptional repressor module localized adjacent to a fatty acid synthesis 
operon whose expression is driven by a hybrid promoter possessing a 17-bp cis-regulatory 
fapO-operator (James and Cronan, 2003). FapR mediates the repression of fatty acid 
synthesis genes via DNA-protein interaction with the fapO-operator sequence using its N-
terminal regulatory domain (KD = 0.12 M) (Xu et al., 2014a). This interaction cascades 
into a FapR-fapO complex that sterically hinders RNA polymerase from inducing 
transcription of the downstream fatty acid synthesis genes. Intracellular accumulation of 
malonyl-CoA gradually relieves this FapR-mediated repression through metabolite-protein 
interaction of malonyl-CoA with the C-terminal ligand-binding domain of FapR (KD = 2.4 
M) (Ellis and Wolfgang, 2012, Xu et al., 2014a, Schujman et al., 2003, Schujman et al., 
2006). This interaction triggers a conformational change at the N-terminal of FapR, which 
destabilizes the FapR-fapO complex and relieves FapR from interacting with fapO-operator, 
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thereby permitting interaction of RNA polymerase with the promoter, and thus transcription 
(Figure 1.13).  
 
 
 
Figure 1.13: Mechanism of malonyl-CoA sensing.  
Binding of malonyl-CoA to the C-terminus of FapR cascades into a conformation change at 
its N-terminus, which destabilizes FapR-fapO interaction. This enables the formation of an 
RNA polymerase-promoter complex, thus inducing transcription of the downstream fatty 
acid synthesis gene (FASII). 
 
 
 
1.15.3 The architecture of a malonyl-CoA biosensor 
The design of a typical malonyl-CoA-sensor (Figure 1.14) requires prototyping its modular 
architecture after the naturally occurring fatty acid biosynthesis regulon discussed above 
(Figure 1.13). A repressor module is located on one end of the circuitry, comprising a fapR 
gene and a suitable promoter driving the FapR expression. In the reporter module on the 
other end, there is a reporter gene typically encoding a fluorescence protein (e.g., eGFP, rfp, 
mCherry and tdTomato); the expression of which is driven by a fapO-hybrid promoter with 
the cis-regulatory fapO-operator sequence co-located within or adjacent to the reporter 
promoter. Identical to the naturally occurring regulons, the reporter module translates the 
increase in intracellular malonyl-CoA concentration (i.e., input) into the expression level of 
the reporter protein (i.e., output), at a rate that is commensurate with the degree of de-
repression of the reporter promoter. Hence, by inciting precise and measurable increase in 
intracellular concentration of malonyl-CoA (e.g., through the use of cerulenin), the 
resulting increase in fluorescence signal generates a malonyl-CoA concentration-dependent 
calibration curve. This, in turn, serves as an input-output model for using such malonyl-
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CoA sensors to quantify unknown malonyl-CoA concentrations derived from malonyl-CoA 
source pathways. 
 
 
 
Figure 1.14: Schematic diagram of the architecture of a malonyl-CoA sensor showing its 
modularity with a repressor module (P1 and FapR gene) and a reporter module (P2, fapO 
and RFP gene). P1 – repressor promoter, P2 – reporter promoter, O – fapO operator, T1, T2 
– transcriptional terminators. 
 
 
1.15.4 The design criteria of an effective malonyl-CoA biosensor  
Crafting a functionally effective malonyl-CoA sensing genetic circuit for a biological host 
requires a number of design considerations. Firstly, the biological chassis in question (i.e., 
the host itself) potentially predetermines the ease of transformation/transfection of the 
genetic circuit as well as its replication and maintenance within the chassis. This must be 
duly factored into the structural design of the circuit. In other words, the sensor must have a 
plasmid backbone with an origin of replication that is compatible with the replication 
machinery of the host (Li et al., 2015). Moreover, a dual plasmid circuit system with 
separate vectors for the repressor and reporter modules may be required for some 
organisms, where a large plasmid may prove difficult to be transformed or transfected. This 
latter case also requires due consideration of plasmid incompatibility and the choice of 
selection marker. A fitting example of how these considerations are crucial is seen in the 
malonyl-CoA biosensors that were developed to investigate fatty acid metabolism in 
mammalian cells, where carefully selected biological parts facilitated sensor functionality, 
such as transfection, replication and expression etc, in the mammalian host (Ellis and 
Wolfgang, 2012).  
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Secondly, a functionally effective sensor requires a fine-tuned balance in expression from 
both the repressor and reporter modules (Figure 1.16). This is a pre-requisite for a high 
detection limit and a broad dynamic range of response. The upper detection limit of the 
sensor is, however, also physically constrained by the maximum possible concentration of 
malonyl-CoA that does not negatively impact on cellular viability. Additionally, fine-
tuning is necessary to achieve optimal sensitivity (i.e., responsive to small changes in 
intracellular malonyl-CoA concentration), responsivity (i.e., yielding a measurable read-out 
value), and a high signal-to-noise ratio in response to malonyl-CoA. This intricate balance 
requires intracellular FapR repressor concentration to be optimal:  high enough to achieve 
high detection limit, but not too high so as to avoid poor sensitivity. Likewise, the 
expression of the reporter module should be high enough to achieve detectable read-out 
response, but not too high so as to avoid sub-optimal repression of the reporter module 
(Figure 1.16). 
 
Despite the importance of a fine-tuned repressor to operator ratio, there is no algorithm to 
design a well-balanced malonyl-CoA sensor, at least not to our knowledge. In practice, 
most sensors are achieved by extensive experimentation and trial-and-error. Common 
strategies are summarized in Figure 1.17, one of which is experimenting with plasmid copy 
number (low, medium, and high) of the genetic circuit to modulate the expression of both 
repressor and reporter modules. This parameter is more profound in cases where the 
repressor and reporter modules of the sensor circuit are expressed from separate plasmids. 
Alternatively, a wide range of promoters (constitutive or inducible) can be leveraged to 
tune for the right cellular transcription of the fapR gene. The promoter strength can be 
utilized in conjunction with cis-regulatory biological parts such as ribosome binding site 
(RBS) (Peretti and Bailey, 1987), upstream activation sequence (UAS) (Aiyar et al., 1998) 
and mRNA stem-loop (Paulus et al., 2004) to attain a desired level of FapR repressor 
(Figure 1.17). The copy number and location of the fapO-operator within the fapO-hybrid 
reporter promoter could significantly influence the degree of FapR-fapO interaction (Xu et 
al., 2014a), thus potentially affecting response to increasing malonyl-CoA amounts. In 
some cases, the copy number and the precise location of the fapO-operator could also 
influence the response through altering the resultant activity of the fapO-hybrid reporter 
promoter.  
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Lastly, unlike in naturally occurring regulons where the fapR promoter is autogenously 
regulated, the sensor promoters (both the fapR promoter and the reporter promoter 
excluding cis-regulatory fapO-operator sequence) in a malonyl-CoA biosensor must show 
minimal, ideally no, regulatory response to the FapR protein. Also, to ensure sensor 
orthogonality, the activities of the chosen promoters must not be naturally modulated by 
acyl-CoAs and/or any other intracellular metabolites. These are particularly crucial 
requirements to ensure that the sensor’s response to increasing malonyl-CoA amounts is 
exclusively an actuation of malonyl-CoA-FapR-fapO interactions. Making due design 
considerations for these requirements eliminates noise interferences in sensor response and 
invariably validates the correlation between fluorescence read-out responses and 
intracellular malonyl-CoA amounts. Examples of how the aforementioned design 
considerations have been successfully applied are detailed in Table 1.5. 
 
 
Figure 1.16:  A schematic of the key design considerations for crafting an efficient 
malonyl-CoA biosensor. 
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Figure 1.17: Key biological parts for crafting versatile malonyl-CoA sensors.  
(a) Choosing a promoter with the right transcriptional activity, (b) Tuning for the right 
promoter activity with cis-regulatory elements such as ribosome binding site (RBS), 
upstream activation sequence (UAS) or mRNA stem loop, (c) Varying the copy number of 
plasmid expressing the reporter and/or repressor module, (d) Varying the copy number 
and/or location of the fapO-operator sequence, and (e) Tuning the expression using varying 
inducer concentration, when an inducible promoter is adopted.  
 …
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Table 1.5: A summary of reported malonyl-CoA sensors 
Microbial 
Host 
Repressor Module Reporter Module 
Regulatory 
mechanism 
Dynamic 
detection 
range 
Ref. 
Promoter Repressor Promoter Operating Site Reporter 
E. coli IPTG-
inducible T7 
FapR IPTG-
inducible T7 
fapO inserted 
after the 
transcriptional 
start of T7 
promoter 
eGFP Binding of 
FapR to the 
fapO/ lacO/ 
fapO.lacO 
operator of the 
T7 eGFP 
promoter thus 
repressing the 
expression of 
eGFP 
0.1–1.1 
nmol/mgD
W  
(Xu et 
al., 
2014b) 
E. coli L-arabinose 
inducible PBAD 
FapR PFR1 fapO inserted into 
the flanking 
regions of -10 
region of phage 
PA1 promoter 
resulting in PFR1 
rfp Binding of 
FapR to the 
fapO of PFR1 
thus repressing 
the expression 
of rfp 
0.14–24.4 
M 
Feher et 
al. 
(2015), 
Liu et al. 
(2015b) 
         
 
Table continues below 
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Microbial 
Host 
Repressor Module Reporter Module 
Regulatory 
mechanism 
Dynamic 
detection 
range 
Ref. 
Promoter Promoter Promoter 
Operating 
Site 
Reporter 
E. coli pGAP, 
transcribed by 
E. coli RNA 
polymerase 
FapR pGAP fapO inserted 
after the 
transcriptional 
start of pGAP. 
eGFP Binding of 
FapR to the 
UAS of 
pGAP thus 
activating 
the 
expression 
of eGFP 
0.1–1.1 
nmol/mgD
W 
Xu et al. 
(2014a) 
Constitutive 
T7 promoter 
FapR Constitutive 
T7 promoter 
fapO inserted 
after the 
transcriptional 
start of T7 
promoter 
mCherry Binding of 
FapR to the 
fapO of 
pGAP thus 
repressing 
the 
expression 
of mCherry 
0.1–1.1 
nmol/mgDW 
S. 
cerevisiae 
TEF1 FapR GPM1 Inserted before 
the TATA box of 
the GPM1 
promoter 
tdTomato Binding of 
FapR to the 
fapO of 
GPM1 thus 
repressing 
the 
expression 
of tdTomato 
Malonyl-CoA 
amount 
equivalent to 
1- 12 mg/L 
cerulenin 
Li et al. 
(2015) 
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1.15.5 Applications of malonyl-CoA biosensors 
Dynamic quantification of malonyl-CoA has been widely demonstrated in mammalian cells 
(Ellis and Wolfgang, 2012) and model microbial cell factories (e.g., E. coli and S. 
cerevisiae) (Li et al., 2015, Xu et al., 2014b) using chemical agents such as cerulenin and 
triclosan, known to block the fatty acid biosynthesis thereby inducing intracellular 
accumulation of malonyl-CoA (Johnson et al., 2017, Zhang et al., 2006). Increased 
malonyl-CoA concentration resulting from heterologously expressed source pathways has 
also been quantified (Johnson et al., 2017). Examples include acetyl-CoA carboxylase 
(ACC), which converts acetyl-CoA into malonyl-CoA, and malonyl-CoA synthetase 
(MatB), which converts malonate, channeled into the cell via malonate carrier protein 
(MatC), into malonyl-CoA. Using malonyl-CoA biosensors, malonyl-CoA levels ranging 
from 0.1–1.1 nmol/mg DW can be detected in the aforementioned hosts.  
 
Other than the detection and quantification of intracellular malonyl-CoA accumulation, 
malonyl-CoA biosensors have also been modified into more complex genetic circuits, 
primarily to enhance cellular malonyl-CoA production or to facilitate the selection of high 
malonyl-CoA-producing strains. This of course requires more complex structural and 
system design considerations in crafting such circuits with relevant modular functionalities 
specific to the intended application(s). In this section, we review the design of such circuits 
and how they were applied for improved cellular production of malonyl-CoA and its end 
chemicals. 
1.15.5.1 Sensor-actuator 
The application of malonyl-CoA sensors for in vivo detection of malonyl-CoA relies 
heavily on the linearity between varying malonyl-CoA concentrations and fluorescence 
read-out responses as well as the orthogonality of the genetic circuit (i.e., elimination of 
regulatory protein and nonspecific DNA cross-communication). Hence, profiling how 
cellular fluorescence varies with intracellular malonyl-CoA level (and with time of 
cultivation in some cases) is a standard procedure in characterizing the biosensor 
constructed.  
 
To illustrate this, Xu et al. reported the construction of two promoter-regulator variants in E. 
coli (Xu et al., 2014a). They exhibited different kinetic response to increasing malonyl-
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CoA concentrations induced by increasing cerulenin concentrations. The first circuit 
(Figure 1.18a) consisted of an IPTG-inducible T7 promoter driving the FapR expression, 
and an IPTG-inducible lacO.fapO-hybrid T7 promoter driving the expression of a 
downstream eGFP reporter gene. The second circuit (Figure 1.18b) had the same circuitry 
as the former, except that the eGFP T7 promoter lacked the fapO-operator but had the 
lacO-operator. It was observed that the FapR repressor exhibited cross-communication with 
the lacO-operator, in both the first and second circuits. In other words, eGFP T7 promoter 
could be repressed via either FapR-fapO interaction or FapR-lacO interaction or both 
interactions simultaneously. IPTG induction of the T7 promoters in the above two circuits 
at low malonyl-CoA concentrations (<0.63 nmol/mgDW, induced by addition of <25 M 
cerulenin) resulted in a biphasic kinetic response – exhibiting increasing EGFP 
fluorescence signal in the first phase (t < 300 minutes), and subsequently decreasing EGFP 
fluorescence in the second phase (t > 300 minutes). The first phase was characterized by 
constitutive expression of lacI repressor, and IPTG-induced derepression of lacI-mediated 
repression of the eGFP T7 promoter at the lacO-operator. The second phase, however, was 
characterized by IPTG-induced FapR expression and FapR-mediated repression of the 
eGFP T7 promoter (at both lacO and fapO sites in the first circuit and the lacO site in the 
second circuit). This biphasic response was however gradually abolished at high malonyl-
CoA concentration (>0.63 nmol/mgDW, induced by addition of >25 M cerulenin), as 
more FapR repressor molecules were antagonized by malonyl-CoA, thus actuating 
continued increase in fluorescence response beyond 300 minutes of cultivation. The 
inconsistent response profile at low and high malonyl-CoA concentration meant that the 
promoter-regulatory systems could not actuate fluorescence signals over time consistent 
with malonyl-CoA concentration, and as such was unusable for real time monitoring of 
intracellular malonyl-CoA accumulation or consumption. To solve this problem, the lacO 
site in the eGFP T7 promoter in the first circuit was removed yielding a third circuit 
(Figure 1.18c). This abolished the lacI-mediated repression of eGFP T7 promoter at the 
lacO-operator and cross-communication of FapR repressor at the lacO-operator, thus 
correcting the biphasic response due to lacO-operator. The modification effectively 
improved the circuit’s linear response to increasing malonyl-CoA concentrations up to 1 
nmol/mgDW. 
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Figure 1.18: Promoter-regulatory circuits for actuation of malonyl-CoA in E. coli.  
(a) A circuit with a fapO.lacO-hybrid T7 reporter promoter, (b) A circuit with a lacO-
hybrid T7 promoter, and (c) A circuit with a fapO-hybrid T7 promoter. 
 
 
1.15.5.2 Sensor-inverter 
Liu et al. described the development of a sensor-invertor for negative feedback regulation 
of fatty acid synthesis in E. coli by modifying a malonyl-CoA-based sensor-actuator circuit 
(Liu et al., 2015b). The original sensor-actuator circuit (Figure 1.19a) had a L-arabinose-
inducible PBAD promoter driving the expression of FapR repressor, and this repressor 
module was grafted onto low copy number plasmid. Inserting the fapO-operator sequence 
into two DNA regions flanking the -10 region of a PA1 phage promoter resulted in the 
FapR-repressed fapO-hybrid reporter promoter PFR1, which drove the expression of an rfp 
reporter gene from a second plasmid. Varied intracellular malonyl-CoA concentrations 
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were achieved via IPTG-inducible expression of the acetyl-CoA carboxylase gene (acc)-
based malonyl-CoA source pathway, placed under the control of the LacI-repressed T7 
promoter from a third plasmid. At an optimal expression of FapR repressor [with 0.01% 
(w/v) L-arabinose], a 4-fold increase in the fluorescence signal from the reporter module 
was achieved, when cellular malonyl-CoA amount was varied by induction with 0 mM to 1 
mM IPTG. This increase in fluorescence signal correlated with the measured increase in 
malonyl-CoA concentration, resulting in fluorescence versus malonyl-CoA concentration 
calibration curve for rapid fluorescence-based quantification of cellular malonyl-CoA 
concentrations (Liu et al., 2015b). Subsequently, this sensor-actuator was modified into a 
sensor-invertor (Figure 1.19b) to alleviate acc-overexpression-mediated cellular toxicity 
and for dynamic regulation of malonyl-CoA source and sink pathways towards increased 
fatty acid production. By replacing the rfp reporter gene with a lacI gene, increasing 
malonyl-CoA concentrations (achieved with 0–40 M IPTG) was actuated into increasing 
expression of LacI repressor. This, in turn, would repress the expression of acc at 
unfavorably high malonyl-CoA concentrations, thus gradually decreasing malonyl-CoA 
synthesis. Additionally, when a cytosolic thioesterase (tesA)-based fatty acid synthesis 
pathway under the control of an aTc-inducible PTet promoter was co-transformed with the 
sensor-invertor (Figure 1.19b), 34% and 33% increases in fatty acid titre and productivity, 
respectively, were achieved, relative to when it was co-transformed with just the sensor-
actuator. 
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Figure 1.19: Schematic representation of a malonyl-CoA sensor-actuator and a negative 
feedback regulatory circuit.  
(a) The malonyl-CoA sensor-actuator comprises the PBAD-driven FapR repressor module, 
the PFR1-driven reporter module and the PT7-driven malonyl-CoA source pathway 
(accABCD). (b). The circuit comprises PTet-driven cytoplasmic thioesterasse gene (tesA), 
the LacI-repressed, PT7-driven malonyl-CoA source pathway (accABCD), the FapR-
repressed, PFR1 –driven lacI gene and the PBAD-driven FapR. The biosensor turns on lacI 
expression at excessively high malonyl-CoA amount thereby down-regulating acc 
expression and alleviating its cellular toxicity.  
 
1.15.5.3 Metabolic switch for autonomous metabolism control 
Xu et al. described a metabolic switch that reported the malonyl-CoA metabolic state of the 
cell by distinct on/off fluorescence signals (Xu et al., 2014a). In this sensor (Figure 1.20a), 
an E. coli 70-based pGAP promoter was used to drive the expression of eGFP reporter 
protein. However, FapR repressor expression resulted in a 7-fold increase in the pGAP-
driven eGFP expression. This clearly suggested that FapR exhibited promoter activity-
influencing protein-protein interaction with RNAP-pGAP complex, rendering it a 
transcriptional activator instead of a repressor on the pGAP promoter. Also, at malonyl-
CoA concentrations above 1 nmol/mgDW, eGFP fluorescence signals were comparable to 
the control construct lacking the sensor presumably because malonyl-CoA-FapR interaction 
annulled the activating FapR-RNAP-pGAP interaction. Further investigation with Surface 
Plasmon Resonance (SPR) analysis confirmed that the activating effect of FapR on the 
pGAP promoter was exerted on an upstream activating sequence (UAS), but not on the 
fapO-operator. A sensor variant without the fapO-operator reported higher fluorescence 
signal than the sensor with one fapO-operator placed after the transcriptional start of the 
pGAP promoter. Also, on creating a second sensor variant by replacing the pGAP promoter 
with a FapR-repressed fapO-hybrid T7 promoter and replacing eGFP reporter with 
 64 
mCherry reporter, and co-transforming this sensor variant with the FapR-activated pGAP-
based malonyl-CoA sensor, they achieved a malonyl-CoA metabolic switch that responded 
to both high and low intracellular malonyl-CoA concentrations (Figure 1.20a). At low 
malonyl-CoA concentrations, the pGAP-based malonyl-CoA sensor was turned on – 
actuating a green fluorescence signal while the T7-fapO-based sensor was turned off. 
Conversely, at high malonyl-CoA concentration, the FapR-repressed T7-fapO hybrid 
promoter was turned on – actuating a red fluorescence while the FapR-activated pGAP-
based malonyl-CoA sensor was turned off. This metabolic switch thus reported the 
malonyl-CoA metabolic state of the cell by actuating distinct flip-flop states of green and 
red fluorescence signals. Additionally, as increasing the copy number of fapO-units in the 
FapR-activated pGAP-based malonyl-CoA sensor gradually decreased the promoter 
activity of the pGAP promoter, a series of finely tuned sensors with varying response range 
to increasing malonyl-CoA-concentrations were derived. Varying the number of fapO-units 
in the metabolic switch was also leveraged to regulate the on-off flip-flop frequency of the 
metabolic switch.  
 
The authors then replaced the eGFP and mCherry reporter genes with acetyl-CoA 
carboxylase (accADBC) malonyl-CoA-source pathway and the fatty acid synthetase 
(fabADGI and tesA’) malonyl-CoA-sink pathway, respectively (Figure 1.20b). The 
oscillatory pattern of the metabolic switch was used to regulate expression in both 
pathways to achieve 15.7- and 2.1-fold improvement in fatty acid titer compared to the wild 
type strain and the strain expressing both pathways without the metabolic switch, 
respectively. In this metabolic switch, when malonyl-CoA amounts from the source-
pathway increased above a threshold range, derepressive malonyl-CoA-FapR interaction 
turned on the sink pathway to convert the malonyl-CoA into fatty acid products. 
Conversely, when the malonyl-CoA amount reached a critically low value, FapR-RNAP-
pGAP interaction up-regulated malonyl-CoA amounts from the source-pathway (Figure 
1.20b and 1.20c). Interestingly, it was shown that variants with only one fapO-unit in the 
FapR-activated pGAP promoter showed a more favorable oscillatory pattern in the on state 
of both sink and source pathways compared to the switch variants with no fapO unit or with 
three fapO units. This optimal oscillatory pattern, characterized by a sink-source oscillation 
faster than the oscillation in the zero fapO-unit variant but slower than the oscillation in the 
three fapO-unit variant, resulted in the highest titer of fatty acid (Xu et al., 2014a)
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Figure 1.20: Malonyl-CoA metabolic sensor and switch 
(a) Schematic representation of malonyl-CoA metabolic sensor. The sensor comprises the 
FapR-activated, pGAP-driven eGFP gene, and the FapR-repressed, T7-driven mCherry 
gene. Both promoters possess a fapO operator site after their transcriptional start. The 
sensor gives green fluorescence signal at excess cellular malonyl-CoA amount, and 
mCherry fluorescence signal at low cellular malonyl-CoA amount. (b) Schematic 
representation of a malonyl-CoA metabolic switch. The metabolic switch is archetypal of 
the sensor with the eGFP and mCherry genes replaced with a malonyl-CoA source pathway 
(ACC) and a malonyl-CoA sink pathway (FAS), respectively. (c) The metabolic switch 
turns on the expression of the malonyl-CoA source pathway (ACC) and turns off the sink 
pathway (FAS) at low cellular malonyl-CoA amount. At high cellular malonyl-CoA 
amount, the switch turns on the sink pathway and turns off the source pathway. 
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1.15.5.4 Malonyl-CoA producer screening tool 
S. cerevisiae, a widely utilized biological cell factory, is known to require biological parts 
and expression systems uniquely different from other eukaryotic systems and yet more 
complex than prokaryotic hosts, owing to its rather complex transcriptional and regulatory 
networks (Li et al., 2015). This, in turn, has limited the development of genetically encoded 
circuits for metabolite sensing and allied applications. However, by optimizing the 
functionality of carefully selected biological parts to bolster their compatibility with the 
host’s regulatory requirements, Li et al. reported the development of the first ever malonyl-
CoA biosensor for S. cerevisiae (Li et al., 2015). In this dual plasmid sensor system, a 
strong constitutive TEF1 promoter drove the transcription of a codon-optimized fapR gene, 
which had a strong SV40 nuclear localization sequence at its C-terminus to enhance nuclear 
import and an ADH1 terminator to terminate transcription. The tdTomato reporter protein 
was expressed from a separate plasmid under the control of an engineered GPM1 promoter, 
which had the fapO-operator inserted immediately upstream of the TATA box. To tune for 
a broad dynamic range of sensor responsiveness and optimal sensitivity, the authors varied 
the sensor FapR-fapO ratios. Single copy plasmid and multi-copy plasmids were used to 
adjust the FapR repressor expression, while the reporter expression was varied by using 
either a single fapO-unit or a double fapO-unit operator. By varying the intracellular 
concentration of malonyl-CoA through media supplementation with varying cerulenin 
concentrations ranging from 0–12 mg/L, malonyl-CoA-dependent response curves were 
derived for all sensor variants. Eventually, the sensor design comprising multi-copy 
plasmid expressing FapR and a reporter module with a single fapO-unit resulted in the 
broadest dynamic range of response to increasing cellular malonyl-CoA concentrations 
induced by cerulenin concentrations ranging from 0–8 mg/L. Other sensor variants had 
detection limits of less than 8 mg/L owing either to poor FapR repressor expression (as in 
the single copy plasmid) or low FapR-fapO ratio (as in the sensor variant with a double 
fapO-unit).  
 
The malonyl-CoA sensor with the broadest dynamic response range was subsequently used 
to screen for high malonyl-CoA producers from a yeast library, co-transformed with the 
sensor and plasmid carrying genome-wide overexpression cassette. By identifying 
transformant colonies with the highest fluorescence intensity using three rounds of FACS, 
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genes enhancing malonyl-CoA synthesis were identified from 11 different clones, which 
elicited 2-fold higher fluorescence signals. The genes PMP1 and TP1, encoding the plasma 
membrane proteolipid protein and triose-phosphate isomerase, respectively, were identified 
as genes which individually or collectively unregulated malonyl-CoA synthesis in yeast 
strain CEN.PK2 (Figure 1.21) (Li et al., 2015). The genes were subsequently individually 
expressed in yeast and the ensuing improved malonyl-CoA synthesis was subsequently 
leveraged on to achieve 120% increase in the titre of 3-hydroxypropanoic acid – a value-
added compound and important basic chemical derived from malonyl-CoA. While the 
attachment of SV40 nuclear localization signal on C-terminal ligand-binding domain 
facilitated the import of FapR inside the nucleus, this, however, may negatively interfere 
with the malonyl-CoA-FapR interaction and change the transcriptional activity of the FapR 
protein. 
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Figure 1.21: Malonyl-CoA sensor in yeast  
(a) The sensor comprises the TEF1 promoter-driven fapR gene possessing a strong SV40 
nuclear localization sequence at its C-terminus, an ADH1 terminator and the FapR-
repressed GPM1 promoter-driven tdTomato reporter gene. The GPM1 promoter has an 
upstream activation to prevent native transcriptional regulation and a fapO-operator 
sequence located before the TATA sequence. (b) Schematic representation of the 
application of the sensor for screening malonyl-CoA producers. Fluorescence actuation 
from the sensor was used to detect improved cellular synthesis of malonyl-CoA due to the 
plasma membrane proteolipid (PMP1) and the triose-phosphate isomerase gene (TPI1). 
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1.15.6 Future perspectives 
Malonyl-CoA genetic sensors allow real-time monitoring of the intracellular malonyl-CoA 
concentration, hence complementing analytical techniques like HPLC and LC-MS. Despite 
being able to conduct direct metabolite quantification, these analytical techniques are 
generally more time consuming and of relatively lower throughput, often entailing 
laborious pre-treatment requirements. Analytical technique, however, remains a sine qua 
non for generating malonyl-CoA concentration-response calibration curve from which 
malonyl-CoA amounts may be deduced. Yet the diverse applications of malonyl-CoA 
biosensors, as discussed in this review, form a compelling rationale to justify their design 
and subsequent use in the metabolic engineering of microbial hosts for malony-CoA 
production. Some of these applications include regulating malonyl-CoA sink/source 
pathways, screening for high malonyl-CoA producing strains and identifying high malonyl-
CoA-producing process conditions.  
 
Thus far, E. coli and S. cerevisiae are the two main microbial hosts that have been 
extensively engineered for improved cellular synthesis of malonyl-CoA and chemicals 
derived from it. This is largely owing to the ample availability of chassis-specific molecular 
biology and synthetic biology toolbox, robustness and our more comprehensive 
understanding of these two production hosts. As more biological hosts are successfully 
engineered for improved malonyl-CoA production, we envisage that the current design of 
malonyl-CoA biosensor will be adapted for use in such hosts. These may well include 
notable Gram-negative microbial hosts, such as Pseudomonas spp. and Ralstonia eutropha 
H16, and eukaryotic hosts such as Pichia pastoris, which are potentially promising for 
industrial-scale biomanufacturing.  
 
The success of expanding the range of hosts in which malonyl-CoA biosensors are 
applicable would depend on whether the engineered malonyl-CoA sensing circuits are 
compatible with chassis-specific biological parts. This could be primarily ascribed to 
intrinsic biological differences in the replication, transcription, translation, post-
translational modification and nuclear transport architectural network of different hosts. All 
these factors should be considered to design and engineer an effective malonyl-CoA sensor. 
Additionally, there is a need to ensure that the design of malonyl-CoA biosensors in such 
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hosts is robust and efficient, with optimal sensitivity, broad dynamic range of response and 
high detection limit. This is potentially achievable by leveraging the successes in 
engineering effective malonyl-CoA biosensors in model microbial hosts as a vantage point 
for achieving similar design successes in other potential microbial hosts, as summarized in 
this review. Moreover, we see the possibility of mathematically modeling existing 
experimental data to further polish the design and behavior of malonyl-CoA sensors and 
regulatory networks for more advanced applications (Liu et al., 2015b). 
 
1.16 Genome editing – a robust molecular tool for metabolic engineering in R. 
eutropha H16 
Cellular phenotypes requiring non-expression of certain genes require manipulation at the 
genomic level. Genome engineering techniques allow us not only to delete undesired genes 
from the genome, but also to insert desired genes into the genome, or replace undesired 
genes with desired genes, amongst many other options. More so, mutants created via 
genome engineering have permanent cellular phenotypes as against cellular phenotypes 
created via plasmid-borne recombinant strain engineering, which only last as long the 
stability of the plasmid vector in question. Several considerations have to be made in 
judging what genome engineering techniques are efficient for specific microbial cell 
factories. Amongst several other qualities, efficient techniques must be fast, robust, non-
complicated, and above all, should allow for relatively easy screening for successful 
mutants. Also, such a technique should have limited drawbacks in comparison to other 
promising techniques, and must show prospects for process improvements and 
optimizations, in terms of its capabilities.  
 
The diversity of genome engineering techniques and strategies has been critically reviewed 
by Song et al. (2015), Nakashima and Miyazaki (2014), Esvelt and Wang (2013). Some 
popular methods of genome editing, including those that have been demonstrated in 
Ralstonia eutropha, and those that potentially could also be used but have not been reported 
are summarized in Table 1.6. Allelic exchange (Lindenkamp et al., 2012, Brigham et al., 
2010), transposon mutagenesis (Braemer and Steinbuechel, 2001), using suicide vectors 
such as pJQ200 (Quandt and Hynes, 1993) have all been adopted for genome engineering 
in Ralstonia eutropha. Till date, the only expression system-based genome engineering 
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method reported for Ralstonia eutropha is the Group II introns retrohoming method (Zhong 
et al., 2003) using the pBBR1MCS2 broad host range plasmid as an expression vector for 
Group II introns (Park et al., 2010). An obvious major reason is the rather limited synthetic 
biology toolbox for efficient expression systems in Ralstonia eutropha, as described earlier. 
Expanding the options of techniques for genome engineering in Ralstonia eutropha will 
thus rely heavily on the development of robust expression systems that are both compatible 
with its transcriptional machinery, and also function efficiently for intracellular delivery of 
genome engineering modules/elements. Recombineering is a classical example of a 
promising genome editing technique that has continued to witness optimizations, making it 
a genome editing technique for rapid manipulation of metabolic/cellular phenotypes. 
However, till date, there has been no report of this technique being used for genome-level 
genetic manipulation in Ralstonia eutropha. 
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Table 1.6: Notable singleplex genome editing techniques potentially applicable in Ralstonia eutropha 
Genome Editing 
Tool 
Advantages Plasmid vector requirement 
Editing-effector 
Module 
Sequence 
specificity 
Module 
Allelic Exchange Scarless genome editing Suicide plasmids (pJQ200, pCVD441, 
pDS132, pKOK4, pKAS32, pCVD442), 
temperature-sensitive plasmids (pKO3, 
pSC101) with homology arms of target 
genes for knock-out/replacement/ knock-in  
Endogenous 
RecA/Rad51 
Target gene 
homology arms 
(>500 bp) 
Retrohoming with 
Group II Introns 
Offer efficiencies of 0.1 to 
25 % 
Expression vector for retargeted group II 
intron 
Llt lariat Intron 
Encoded Protein 
(IEP) 
Retargeted 
introns 
Transposition 
Mutagenesis 
 Expression vector for Transposase, Suicide 
vector for Transposon 
Transposase   
TALENa 
technology 
Programmable, scarless and 
efficient genome editing 
Expression vectors for repair construct and 
TALEN 
Heterodimeric FokI 
restriction 
endonuclease 
TALE DNA-
binding 
domains 
ZFNsb technology Programmable, scarless and 
efficient genome editing 
genome editing 
Expression vectors for repair construct and 
ZFN 
Heterodimeric FokI 
restriction 
endonuclease 
Zinc finger 
motifs 
CRISPR-Casc Offer 65-100% efficiencies. 
Programmable genome 
editing 
Expression vectors for sgRNA, Cas9 
nuclease, and repair construct 
Cas9 endonuclease Single guide 
RNA 
 
Table continues below 
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Genome Editing 
Tool 
Advantages Plasmid vector requirement 
Editing-effector 
Module 
Sequence 
specificity 
Module 
GETRd  Does not require selection 
markers. Offers 100% 
efficiencies. Allows for gene 
deletion, insertion, inversion, 
and tranversions of larger 
genomic/genetic fragments 
Expression vector retargeted group II intron 
with lox sites  
Delivery plasmid for gene insert with lox 
sites  
Expression vector for Cre/lox-recombinase 
Cre recombinase Retargeted 
introns (Ll.Ltrb 
and EcoI5 
introns) with 
lox sites 
containing 
retargeted 
introns. lox 
sites on gene 
insert 
λ-Beta 
Recombineering  
Relatively easier 
transformation of ssDNA 
compared to dsDNA and 
plasmids allows for 
multiplex genome editing 
with higher chances genomic 
integration 
Expression vector for beta protein λ-Beta recombinase Optimally 
matching 
ssDNA (~70-
nt) 
λ-Red 
Recombineering  
 Expression vector for λ-Red proteins 
Helper vectors for flippase protein.  
λ-Red recombinase Selection 
marker with 
flanking >35 
bps homology 
arms  
a – Transcription Activator-Like Effectors Nucleases (TALENs) 
b – Zinc Finger Nucleases (ZFN) 
c – Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
d – Genome Editing with Targetrons and Recombinases (GETR) 
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1.16.1 -Red Recombineering 
-Red Recombineering or recombination-mediated genetic engineering employs 
homologous recombination between a linear dsDNA cassette and targeted genome to 
orchestrate modification of chromosomal genes. It is required that the dsDNA cassette 
possesses 30-70 flanking nucleotide sequences (homology arms) homologous to sequences 
flanking, the targeted genomic region (Yu et al., 2000). In addition, site-specific 
recombinase proteins such as the RecET rac prophage or -Red prophage proteins are 
required to mediate recombination event. Use of the RecE/T proteins from the rac 
prophage for recombineering in the E. coli chromosome was first reported by Zhang et al. 
(1998). Similarly, recombineering with -Red proteins was demonstrated in E. coli for 
inactivation of chromosomal genes using a defective -prophage, and later with the use of 
specially designed plasmid systems for expressing the -Red proteins (Datsenko and 
Wanner, 2000, Murphy, 1998). 
 
1.16.2 Mechanism  
-Red recombinase proteins are Exo, Beta and Gam. Exo is an exonuclease which just like 
RecE in the RecET prophage systems, degrades linear dsDNA in the 5’-3’ direction into a 
ssDNA intermediate (Carter and Radding, 1971, Cassuto et al., 1971a). Beta, aided by Exo 
binds to the ssDNA intermediate thus stabilizing it from further degradation by endogenous 
exonucleases (Cassuto et al., 1971b). RecT is known to serve the same function as Beta in 
the Rec E/T system. Gam inhibits RecBCD and SbcCD endogenous exonucleases from 
degrading the dsDNA (Cassuto et al., 1971a, Murphy, 1991, Poteete, 2001). The 
recombination activities of the recombinase proteins in both systems, however occurs 
independently of the endogenous RecA-mediated homologous recombination responsible 
for natural recombinogenicity in some microbial systems (Yu et al., 2000, Poteete, 2001). 
It has been proposed that recombinase-mediated homologous recombination occurs through 
a strand annealing mechanism, wherein the ssDNA intermediate anneals as an Okazaki 
fragment at the replication fork preferentially to the lagging strand of the host genome (Lim 
et al., 2008, Mosberg et al., 2010, Li et al., 1998, Karakousis et al., 1998). 
This mechanism invariably culminates in the integration of the ssDNA intermediate into 
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targeted genomic region (Mosberg et al., 2010, Boyle et al., 2013), (Figure 1.22).  
 
Figure 1.22: Molecular mechanism of -Red recombineering. 
Gam inhibits endogenous RecBCB and SbcCB from degrading the dsDNA cassette, Exo 
degrades it in the 5’-3’ direction into a ssDNA intermediate, while Bet aided by Exo binds 
tightly to the ssDNA and mediates preferential strand annealing at the replication fork to 
the lagging strands, thus displacing an endogenous Okazaki fragment. Replication of the 
annealed ssDNA leads to integration to targeted region or either plasmid or chromosome. 
 
1.16.3 Application of -Red recombineering in microbial systems 
Beyond its application in E. coli by Datsenko and Warner, -Red recombineering has been 
adopted for genome editing in a number of microbial systems (Song et al., 2015). This is 
largely owing to its ease, efficiency and versatility allowing for genomic modifications to 
suit specific microbial systems. Examples of such microbial systems include Pseudomonas 
aeruginosa (Lesic and Rahme, 2008), Salmonella enterica (Datta et al., 2006, Blank et al., 
2011), Yersinia enterocolitica (Derbise et al., 2003), Aspergillus nigulans (Chaveroche et 
al., 2000). In addition to inactivation of chromosomal genes, -Red recombineering 
employed for making gene replacement, chromosomal insertion of large genomic 
fragments, and point mutations. 
1.16.3.1 -Red recombinase plasmids 
-Red recombinase plasmids are designed with inducible promoter systems for regulated 
expression of the -Red proteins to control the onset of homologous recombination Table 
Bet 
Exo 
Homology arm Homology arm 5’ 
5’ 
5’ 
5’ 
Okazaki 
fragment 
Annealed oligo 
Replication 
fork Parent 
chromosome or 
plasmid 
Mutated 
chromosome or 
plasmid 
dsDNA cassette 
Exo 
5’ 
3’ 
5’ 3’ 
Gam 
RecBCB, 
SbcCD 
   76 
1.7. pKD20 and pKD46 -Red recombinase plasmids developed for recombineering utilize 
the PBAD promoter system for strong expression of the -Red proteins (Datsenko and 
Wanner, 2000). pKD46 is known to offer better recombination efficiencies than pKD20 for 
reasons yet unclear (Datsenko and Wanner, 2000). Construction of a set of pSIM 
recombinase plasmids from a -prophage strain using both Red-catalyzed gap reaction and 
-Red recombineering has also been reported (Datta et al., 2006). These plasmids utilize 
the temperature-sensitive  CI857 repressor for the induction of protein expression via 
temperature shift to 42C. The constructed plasmids were shown be useful for -Red 
recombineering both E. coli and S. enterica, yielding 104 recombinants/108 viable cells in E. 
coli, offering 10-fold higher recombination efficiency when compared to pKD20/pKD46 
recombinase plasmids (Datta et al., 2006). A number of -Red vectors recombinase vector, 
possess a temperature-sensitive (ts) origin of replication, which functions optimally at 30C, 
and abrogates replication at temperatures from 37C. Thus after cultivating cells at 30C 
for the recombination event, recombinant cells are re-cultivated at 42C to cure the plasmid. 
Non-temperature sensitivity-based plasmid curing has been achieved by cloning the 
Bacillus subtilis sacB counter-selection marker into -Red recombinase plasmids. sacB 
gene encodes levansucrose (SacB), an enzyme that produces the toxic levan from sucrose. 
Accumulation of levan in the periplasm of Gram-negative bacteria causes cellular toxicity 
via cell lysis (Gay et al., 1985). Thus sucrose-induced cell death serves to impose a 
selection pressure for the propagation of recombinants whose recombinase plasmids have 
been lost due to plasmid instability. With the sacB system, plasmids are cured by plating 
cultures of recombinant cells on agar plates with 5% sucrose to select for recombinants 
with cured plasmids. pUCP18-RedS (Lesic and Rahme, 2008) and pKOBEG-sacB  
(Derbise et al., 2003) are two typical sacB-counter selection plasmids.… 
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Table 1.7: Some notable examples of -Red recombinase expression vectors and properties 
Recombinase 
Plasmid 
Origin Host 
range 
Drug marker Promoter Reference 
pSIM2 pBR322 Narrow Chloramphenicol λ PL Datta et al. (2006) 
pSIM4 pBR322 Narrow Ampicillin λ PL Datta et al. (2006) 
pSIM5 pSC101ts Narrow Chloramphenicol λ PL Datta et al. (2006) 
pSIM6 pSC101ts Narrow Ampicillin λ PL Datta et al. (2006) 
pSIM7 pBBR1 Broad Chloramphenicol λ PL Datta et al. (2006) 
pSIM8 pBBR1 Broad Ampicillin λ PL Datta et al. (2006) 
pSIM9 RK2ts Broad Chloramphenicol λ PL Datta et al. (2006) 
pSIM18 pSC101ts Narrow Hygromycin λ PL Datta et al. (2006) 
pSIM19 pSC101ts Narrow Spectinomycin λ PL Datta et al. (2006) 
pKM208  pSC101ts Narrow Ampicillin Ptac Murphy and 
Campellone (2003) 
pKD20 pSC101ts Narrow Ampicillin PBAD Datsenko and 
Wanner (2000) 
pKD46 pSC101ts Narrow Ampicillin PBAD Datsenko and 
Wanner (2000) 
pREDI pSC101ts Narrow Ampicillin PBAD Yu et al. (2008) 
pUCP18-RedS pMB1 
ori 
Broad Ampicillin PBAD Lesic and Rahme 
(2008) 
pKOBEG pSC101ts Narrow Chloramphenicol PBAD Chaveroche et al. 
(2000) 
pKOBEG-sacB pSC101ts Narrow Chloramphenicol PBAD Derbise et al. (2003) 
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1.16.3.2 Design of dsDNA cassette  
dsDNA cassette for gene inactivation are often designed as antibiotics selection markers 
flanked by 36-100 nucleotide sequences (homology arms) homologous to sequences 
upstream and downstream to the genomic region targeted for inactivation (Figure 1.23). 
Although 50-nt is often optimal for homologous recombination, some studies have shown 
that lengthy homology arms (>500-nt) are required for efficient recombination (Chaveroche 
et al., 2000, Derbise et al., 2003, Lesic and Rahme, 2008). Generally, lengthy homology 
arms increase the chances of recombination leading to higher recombination efficiencies 
(Chaveroche et al., 2000). To allow for excision of the antibiotics selection marker via a 
second recombination event, inverted repeats such as flippase recognition target (FRT) sites 
are placed in between the each homology arm and the antibiotics selection marker (Figure 
1.24).  loxP sites are also usable in place FRT sites. Marker excision using the FRT sites is 
mediated by FLP recombinase, while Cre-recombinase is mediated via loxP-based 
recombination. 
 
 
Figure 1.23: Simplified process of -Red recombineering for genomic integration of 
marker.  
The marker is amplified with a set of primers a and b, which possess 5’ flanking regions 
bearing targeting sequences homologous to the genomic regions upstream and downstream 
to the target Gene X. Electroporated PCR amplicon of marker undergoes homologous 
recombination with target sites leading to genomic insertion of the marker. Genomic 
insertion is confirmed by using a set of primers pairs (1, 2), (1, 3), (2,4) and (3,4). 
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Figure 1.24: Schematic of -Red recombineering with a dsDNA selectable marker. 
ssDNA intermediate from dsDNA cassette binds complementarily to genomic region 
flanking target gene using its flanking homology arms (H1 and H2). -Red recombinase 
proteins expressed from a -Red plasmid system mediate homologous recombination 
between target gene and linear dsDNA cassette. A second recombination event mediated by 
FLP recombinase expressed from FLP recombinase plasmid removes one of the FLT scars 
leaving behind one. 
 
 
1.16.3.3 Improving -Red recombineering methods and strategies in microbial 
systems 
Several intrinsic drawbacks exist in the use of the above traditional form of recombineering 
for genome editing. One of these drawbacks is the lengthy turnaround period for a single 
deletion experiment. The dependency of the process on plasmid vectors requires an extra 
plasmid curing stage to eliminate the recombinase plasmids from recombinant cells. 
Antibiotics selection marker excision stages and plasmid curing stages, requiring colony-
screening steps, thus increasing the turnaround time of the experimental protocol to up to a 
week or more, depending on the host organism. Another major drawback is the presence of 
an unwanted FRT scar (81-85 base pairs) left behind in the genome after the marker 
excision stage (Datsenko and Wanner, 2000). This culminates in unintended genomic 
disruption thus compromising the precision of genome editing, especially when more than 
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one round of genomic modification is intended (Blank et al., 2011, Nakashima and 
Miyazaki, 2014). 
 
An improved system of -Red recombineering was achieved by Yu et al. (2008), involving 
a more robust recombinase plasmid system cohosting the -Red and the I-SceI 
recombination modules. The robust plasmid pREDI, which was constructed from pKD46, 
has two independent inducible promoter systems for the expression of the -Red proteins, 
and an I-SceI endonuclease (Yu et al., 2008). As with the pKD20 and pKD46 plasmid 
systems, the -Red proteins are expressed with the PBAD promoter system, while the I-SceI 
endonuclease is expressed under control of a rhamnose-inducible promoter system. In this 
novel system, scarless excision of genome integrated antibiotics selection marker was 
achieved via homologous recombination via an I-SceI endonuclease-mediated double-
stranded break at an I-SceI site located in the dsDNA cassette (Figure 1.25). The dsDNA 
cassette was designed to have an extra homology arm (H3) possessing sequences further 
downstream of the genomic loci scheduled for gene inactivation. Screening of mutants with 
excised cassette was facilitated by the presence of sacB counter-selection marker between 
the antibiotic selection marker and the I-SceI site. This design ensured that mutants with 
successful excision of the antibiotics selection marker are selected by replica plating on 
agar plates supplemented with 5% sucrose (Gay et al., 1985). This system obviates the need 
for FRT or loxP sites in the design of the dsDNA. Also, unlike the use of FRT or loxP sites, 
use of the I-SceI endonuclease system for excising the antibiotics from the mutant does not 
leave behind unwanted scars in the genome, thus allowing for limitless number of gene 
inactivation. Additionally, the combined knock-in and knockout function of the pREDI 
plasmid reduces the time frame for a single gene inactivation experiment from a week to 
days. Reported recombination efficiencies at 70% and 100% for knock-in and knock-out of 
the linear dsDNA, respectively, trumps reported efficiencies in previous methods of -Red 
recombineering (Yu et al., 2008). This system was used for simultaneous deletion of two 
far apart genomic loci in E. coli K-12 strain MG1655. 
 
Another strategy for scarless excision of antibiotics selection marker after gene deletion is 
the use of a selection/counterselection dsDNA cassette in a two-step recombination process 
using the same -Red recombinase vector for both stages. This method is originally suitable 
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for the insertion of non-selectable genes, or the replacement of specific gene in the genome 
with non-selectable genes. An example of this is the use of a cat‐sacB cassette (Thomason 
et al., 2014, Ellis et al., 2001). In this method, recombinants with chloramphenicol 
resistance and sucrose sensitivity are subjected to a second recombination event to 
introduce the non-selectable gene while excising the cat‐sacB cassette. Successful 
recombination event is confirmed by screening for sucrose-resistance and chloramphenicol-
sensitivity from colonies that had previously shown chloramphenicol resistance and sucrose 
sensitivity.  
 
Figure 1.25: Mechanism of -Red recombineering with pREDI. 
-Red proteins expressed from pREDI mediate a first homologous recombination, which 
replaces target gene with marker, using the H1 and H2 homology arms. I-SceI 
endonuclease expressed from pREDI cleaves the I-SceI site via a double strand break 
mechanism (DSB). This initiates a second homologous recombination event at the H3 sites, 
thus removing the marker, the sacB counterselection marker and the H3 homology sites. 
Successful mutant possesses no marker or scar. 
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1.16.4 Comparative advantage to other genome editing methods 
 -Red recombineering compares well with other notable genome editing methods (Table 
1.8), especially due to the aforementioned technical improvisations. Aside not having some 
of the major drawbacks of these notable methods, the improved methods of -Red 
recombineering also possess some of the most vital advantages of notable methods, 
typically improved efficiencies. For example, genome editing with CRISPR-Cas is 
particularly known to offer one of the highest efficiencies (Nakashima and Miyazaki, 2014), 
owing to the fact that unedited cells are killed off by the cytotoxicity of the Cas9 
endonuclease. The efficiency of the CRISPR-Cas system has thus been leveraged on in 
improving the efficiency of -Red recombineering to as much as 100% in S. pneumoniae 
and 65% in E. coli (Jiang et al., 2013). However, the method suffers the typical drawback 
of unprecedented off-target mutagenesis causing death of mutant cells as well. Another 
method that offers high efficiencies and versatility in the types of genome editing options is 
the recent GETR method, with 100% efficiencies reported in E. coli (Enyeart et al., 2014). 
This method, which leverages Cre/lox-based recombineering and mobile group II 
retrohoming, requires three different plasmid systems for a each genome editing round. It 
utilizes one plasmid for expressing the retargeted intron, a delivery plasmid for genomic 
integration of gene insert, and a third plasmid vector for expressing the Cre-lox 
recombinase. Aside the complex plasmid requirement, a major drawback is unwanted 
genomic introduction of lox scars. However, major comparative advantages of this method 
over other notable genome editing techniques, are the potential for editing large genomic 
fragment (up to 1.5 megabases) and its independence selection markers, and hence 
antibiotics selection.  
Another crucial method of recombineering is the use of ssDNA oligos (~70-nt oligos), and 
hence only -Beta in mediating homologous recombination event (Yu et al., 2000, 
Oppenheim et al., 2004, Ellis et al., 2001). ssDNA cassettes have also been shown to offer 
better recombination efficiencies than dsDNA, at about 105 recombinants/108 viable cells 
(Costantino and Court, 2003). This figure sometimes reaches 25% of viable cells where 
small changes or point mutation are required, especially when the methyl-directed 
mismatch repair mechanism is mutated (Thomason et al., 2014, Mosberg et al., 2010, Boyle 
et al., 2013). The prospects of -beta recombineering as a high throughput genome editing 
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technique has also been leveraged for multiplex genome-scale manipulation techniques 
such as Multiplex Genome Engineering and Accelerated Evolution (MAGE) (Boyle et al., 
2013, Wang et al., 2009, Wang and Church, 2011). Although conventional -Beta 
recombineering with dsDNA offers 0.1 - 0.2% recombination efficiency (Yu et al., 2000, 
Thomason et al., 2014), it is still relatively preferred for making large chromosomal 
deletions and genomic insertion of up to several thousand bases. These applications include 
the creating of the Keio collection (Baba et al., 2006), which is a library of single-gene 
knockout of E. coli strains (Baba et al., 2006, Mosberg et al., 2010), chromosomal insertion 
of a complete heterologous pathway into an E. coli strain (Zhang et al., 1998), and the 
removal of up to 15% of the genome of an E. coli strain (Mosberg et al., 2010, Posfai et al., 
2006). Additionally, -Red recombineering has also been leveraged for combinatorial 
genome-scale techniques such as Trackable Multiplex Recombineering (Warner et al., 
2010).  
Overall, leveraging the most recent improvements, such as achieved with pREDI (Yu et al., 
2008) and pUCP18-RedS (Lesic and Rahme, 2008), -Red recombineering promises to 
compare well with other promising genome editing techniques (Table 1.8), with a number 
of comparative advantages.  
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Table 1.8: Comparison of -Red Recombineering to other notable genome editing methods 
Drawback of genome editing methods Comparative advantages of -Red Recombineering 
Allelic exchange versus -Red Recombineering 
Require large homology arms (>500 base 
pairs) for homologous recombination 
Requires only 35-70 base pairs homology arms for 
homologous recombination 
Require suicide vectors to introduce 
selection/counter-selection markers 
Linear dsDNA cassette is introduced via 
electroporation of electrocompetent cells 
Endogenous RecA/Rad51-mediated 
Homologous recombination has low 
probability  
Induction of -Red expression initiates homologous 
recognition 
Non-selectional homologous 
recombination makes screening of 
successful mutant more tedious 
Intended homologous recombination is selected for 
making screening easier 
Reversal of mutants to wild type No reversal of mutants to wild type 
Causes polar effects to neighbouring genes Design of cassette Reduce s occurrence of polar 
effects 
Transposon mutagenesis versus -Red Recombineering 
Bias for sequence integration No bias for sequence integration 
Indefinite manipulation of target sequence Specific manipulation of target genomic region 
Retrohoming versus -Red Recombineering 
Susceptible to bias in intron insertion No bias in cassette integration 
TALENS & ZFN versus -Red Recombineering 
Sequence homology-dependent off-
targeting, and cytotoxicity 
Design of dsDNA eliminates changes of off targeting. 
No cytotoxicity 
Laborious and expensive target-specific 
protein engineering requirement of the 
nuclease proteins 
No protein engineering requirement 
RNA interference versus -Red Recombineering 
Off-targeting  No off-targeting 
Incomplete and temporary knock-out Permanent knock-out event 
CRISPR-Cas versus -Red Recombineering 
Sequence homology dependent off-
targeting 
No off targeting 
Cellular toxicity No cellular toxicity 
Requires extra deep sequencing 
verification step to check for off-target 
mutagenesis 
Does not require deep sequencing. Colony PCR of 
region around genomic alteration is the major 
verification step 
GETR versus -Red Recombineering 
Unwanted scar formation of lox sites Cre 
recombination 
Latter methods do not require Cre recombination, 
hence scarless genomic modification is possible 
Susceptible to bias in intron insertion No bias in cassette integration 
λ-Red (Beta) versus -Red Recombineering 
Insertion/Deletion inefficiency for large 
DNA fragment 
Relatively for suitable for insertion/deletion of large 
DNA fragment 
Requires mutation of the methyl-directed 
mismatch repair system (MMR) for better 
efficiencies 
Does not require MMR mutation 
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1.16.5 -Red Recombineering application in Ralstonia eutropha: Opportunities and 
Challenges  
Transformation of R. eutropha with plasmid vectors is a significant milestone for genetic 
manipulation, especially for metabolic engineering strategies. The highly efficient 
transformation technique via electroporation has been utilized and optimized to harness the 
genetic tractability of R. eutropha (Park et al., 1995, Tee et al., 2017). However, despite 
high transformation efficiencies, a major uncertainty in the use of this method of genome 
editing is the question of if the Gam protein is able to effectively protect electroporated 
dsDNA from endogenous RecBCD nuclease attack in Ralstonia eutropha, as is the case in 
several bacteria. Studies by Mosberg et al. (2012) have shown that 5’-phosphorothiated 
dsDNA cassettes are relatively better protected from endogenous RecBCD nuclease attack 
and thus afford higher recombination efficiencies. Thus the use of 5’-phosphorothiated 
dsDNA cassettes might be good way to further improve recombination event in R. eutropha. 
 
On the other hand, it is uncertain if the -Red proteins when expressed are compatible with 
endogenous enzymes in Ralstonia eutropha. Some studies report cellular toxicity from 
expression of the -Red proteins, particularly high expression of Gam (Copeland et al., 
2001, Sergueev et al., 2001) and Exo (Katashkina et al., 2009) in some bacterial species. 
The potential effect this might have on -Red recombineering in Ralstonia eutropha is 
currently unknown, and thus worthy of investigation. 
 
Amongst the listed plasmid in Table 1.7, pUCP18-RedS (Lesic and Rahme, 2008), is by its 
functionality the most fitting recombinase expression system applicable to R. eutropha. 
This is largely owing to the fact that, aside being a broad host range plasmid; it uses the 
non-temperature dependent PBAD inducible promoter system for -Red expression, as well 
as the non-temperature-dependent sacB-counter-selection system. Temperature-
sensitive/dependent BHR -Red recombinase plasmids, such as pSIM9, may not be ideal as 
expression induction and plasmid-curing temperatures at 37C and 42C, respectively are 
not supportive of optimal cell growth in Ralstonia eutropha, which is known to grow 
optimally at 30C (Park et al., 2011). More so, sacB counter-selection has previously been 
shown to be compatible with Ralstonia eutropha (Lindenkamp et al., 2012, Boyle et al., 
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2013), as much as the PBAD promoter is a choice promoter for inducible gene expression in 
R. eutropha.  
 
Additionally, narrow host range -Red recombinase plasmids could be reconstructed into 
fitting recombinant broad host range -Red recombinase plasmids, using broad host range 
plasmids as plasmid backbones. Typically, the plasmid backbone template of pBBR1MCS 
with a BBR1 replicon could potentially be used as a plasmid backbone for constructing 
such recombinant plasmids from pKD20, pKD46, pREDI, and the narrow host range pSIM 
plasmids.  
 
1.17 Roadmap for the application of molecular tools for malonyl-CoA engineering in 
Ralstonia eutropha H16 
The natural ability of R. eutropha to utilize diverse carbon sources for growth and 
accumulation of bio-plastics essentially makes it a fitting microbial cell factory for the 
production of valuable chemicals using vital cellular metabolites such as malonyl-CoA as 
precursor intermediates. Although, the ease of readily enhancing acetyl-CoA accumulation 
for bioproduct synthesis in R. eutropha has been well studied (Table 1.1), the sheer lack of 
identified acetyl-CoA-responsive transcriptional regulators makes it rather difficult to 
develop genetic circuits to sense and/or to regulate acetyl-CoA accumulation, specifically.  
 
As malonyl-CoA is a product of the carboxylation of acetyl-CoA, established strategies for 
the up-regulation of acetyl-CoA for PHB production in R. eutropha H16 could potentially 
be leveraged on improve carbon flux towards malonyl-CoA accumulation. However, this 
will also require the deletion of the PHB operon - a non-essential acetyl-CoA sink pathway 
to ensure that increased acetyl-CoA flux is channeled into malonyl-CoA accumulation. 
These strategies could be applied synergistically with reported methods to improve 
malonyl-CoA accumulation in E. coli and S. cerevisiae. Identification of target genes to 
improve malonyl CoA biosynthesis will rely heavily on reported literature indicating 
crucial target genes in these model microbial cell factories. Target genes, which are 
potentially linked to malonyl-CoA production, are identified, primarily based on 
demonstrated impact on malonyl-CoA phenotype in microbial host such as E. coli and 
Saccharomyces cerevisiae.  
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Figure 1.26 describes how these may be applied synergistically. It is decided if these 
gene(s) should be expressed via heterologous pathways or deleted from the genome to 
achieve improved malonyl-CoA phenotypes. Genes from heterologous pathways will 
require the use of expression vectors with promoters that possess appropriate activities to 
achieve desired malonyl-CoA pheonotype. Malonyl-CoA sensors will be used to detect 
malonyl-CoA phenotypes, to validate the roles of target genes in malonyl-CoA production 
and/or to evaluate the effectiveness of gene expression/genome editing molecular tools in 
improving malonyl-CoA phenotype. The ensuing malonyl-CoA phenotype could be made 
permanent via the use of plasmid addiction sytems (Kroll et al., 2010) to maintain the 
plasmids in the cell. Genes meant to be deleted (knockout) to achieve malonyl-CoA 
phenotype are deleted from the genome using the developed genome editing tool, and with 
concomitant use of the sensors to detect improved malonyl-CoA phenotype. Finally, after 
rounds of pathway optimization to achieve a mutant strain with the desired malonyl-CoA 
phenotype, plasmid-curing procedures are performed to eliminate the expression vectors of 
the genome editing tool from cell.  
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Figure 1.26: Proposed application of developed tools for malonyl-CoA engineering in Ralstonia eutropha H16. 
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1.18 Aims and objectives of study 
Overall, synergistic application of the aforementioned molecular tools viz a toolbox of 
promoters, malonyl-CoA-responsive genetic circuits, and a facile genome editing method 
are required for malonyl-CoA engineering in Ralstonia eutropha H16.  
 
To this end, Chapter Two describes the construction of broad host range chassis-compatible 
expression vectors required to develop molecular tools for malonyl-CoA engineering in 
Ralstonia eutropha. These vectors were used to (1) study the induction range of the L-
arabinose inducible promoter using the red fluorescence protein, (2) to observe inducible 
expression the FapR repressor, and (3) to observe expression of the -Red genes in 
Ralstonia eutropha. Chapter Three describes the development of an engineered set of 
constitutive promoters for tunable gene expression in using Ralstonia eutropha within 
~137-fold range of activity. Chapter Four describes the selection and application of some of 
these promoters to engineer six functional malonyl-CoA-responsive genetic circuits for 
sensing varying intracellular concentrations of malonyl-CoA accumulation in Ralstonia 
eutropha. Chapter Five validates the functionality of a Ralstonia eutropha-compatible 
genome editing molecular tool in E. coli BW25113. Chapter Six describes the attempt to 
use this genome editing molecular tool for actual genome editing in Ralstonia eutropha. 
Chapter Seven concludes the thesis and highlights the novelty of the research findings, 
provides a critical discussion of the aforementioned chapters and also details future work 
required to further achieve the research objectives. 
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CHAPTER TWO 
Reproduced in part with permission from [Johnson, A. O., Gonzalez-Villanueva, M., Tee, 
K. L. & Wong, T. S. 2018. An Engineered Constitutive Promoter Set with Broad Activity 
Range for Cupriavidus necator H16. ACS Synthetic Biology] Copyright [2018] American 
Chemical Society. 
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2 DEVELOPMENT OF BROAD HOST EXPRESSION VECTORS FOR 
ENGINERING RALSTONIA EUTROPHA-COMPATIBLE MOLECULAR 
TOOLS  
 
2.1 INTRODUCTION 
Three essential molecular tools previously identified for regulating gene expression in R. 
eutropha H16 include a toolbox of promoters, a set of malonyl-CoA-responsive genetic 
cricuits and a -Red recombineering toolbox. These tools all require expression vectors that 
are compatible with the native transcriptional and replication machineries in R. eutropha 
H16. This is achieved by incorporating essential genetic elements and biological parts into 
the pBBR1 backbone of the broad host range, medium copy number plasmid pBBR1MCS-
1 (Kovach et al., 1994). Firstly, a broad host range expression vector was constructed by 
incorporating the PBAD promoter part (together with the araC gene) and the red fluorescence 
protein (RFP) gene from pBbA8k-RFP – a narrow range plasmid (Lee et al., 2011) into 
pBBR1MCS-1. The resultant plasmid vector, pBBR1c-RFP, was designed to evaluate the 
induction range of the PBAD promoter in R. eutropha and to explore its use for tunable 
expression of heterologous pathways in R. eutropha H16.  
 
The FapR transcriptional regulator protein has been identified as a crucial protein for 
regulating gene expression in synthetic malonyl-CoA genetic circuits in model biological 
factories like E. coli and Saccharomyces cerevisiae (Johnson et al., 2017). FapR expression 
was investigated in E. coli DH5 and Ralstonia eutropha H16 using the plasmid pBBR1c-
FapR (derived by replacing rfp with fapR) in order to evaluate its potential use for 
regulating gene expression in heterologous malonyl-CoA genetic circuits in Ralstonia 
eutropha H16.  
 
To develop a -Red recombineering in Ralstonia eutropha, the -Red proteins operon from 
the low copy number narrow host range -Red plasmids, pKD20 and pKD46 were 
incorporated into pBBR1c-RFP vector, hence replacing the rfp gene. The ensuing broad 
host range -Red expression vectors pBBR1c-RED1, pBBR1k-RED and pBBR1c-RED2 
were subsequently used to observe expression of the -Red proteins in E. coli BW25113 
and Ralstonia eutropha H16. 
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2.2 METHODS AND MATERIAL 
2.2.1 Bacterial Cultivation 
Ralstonia eutropha H16 (Genr) was grown in nutrient broth (NB) media supplemented with 
gentamicin (10 mg/L) and cultivated at 30C, 500 rpm. E. coli DH5 and E. coli BW25113 
were grown in 2XYT media at 37C, 500 rpm except otherwise stated. All media are 
prepared by dissolving components in deionized water followed by autoclave sterilization. 
NB media was made up of 1 g/L beef extract, 2 g/L yeast extract, 5 g/L peptone, 5 g/L 
sodium chloride. 2XYT media contained 16 g/L tryptone, 10 g/L yeast extract, 5 g/L 
sodium chloride. All inoculation and preparation of all reagents used for cultivation were 
performed under sterile condition. All cultivation was done in an incubator mini shaker 
(VWR, Germany). Kanamycin (50 mg/L for E. coli and 200-300 mg/L for Ralstonia 
eutropha), chloramphenicol (25 mg/L), ampicillin (100 mg/L) were used as selection 
antibiotics as appropriate. All antibiotics stock solutions were prepared under sterile 
conditions and filtered with the 0.2 m Whatman syringe filter. Overnight cultures of 
Ralstonia eutropha (wild-type or mutant) were set by inoculating 5 mL of nutrient broth 
supplemented with gentamicin with glycerol stock of Ralstonia eutropha H16 in a falcon 
tube. The culture was cultivated at 30C for 40 h. Overnight cultures of E. coli strains were 
set by inoculating 5 mL of 2XYT media supplemented with appropriate inoculum of E. coli. 
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Table 2.1: Bacteria strains used in this study 
Strain Description Reference 
E. coli DH5 F−, φ80dlacZΔM15, Δ(lacZYA-argF) U169, 
deoR, recA1, endA1, hsdR17(rk−, mk+), 
phoA, supE44, λ−, thi-1,  gyrA96, relA1 
Invitrogen 
E. coli BW25113 lacIq rrnBT14 lacZWJ16 hsdR514 araBADAH33 
rhaBADLD78 
Invitrogen 
Ralstonia eutropha H16 Genr, DSM-428 DSMZ, 
Braunschweig, 
Germany 
EcRFP E. coli DH5 with pBBR1c-RFP This study 
EcGFP E. coli DH5 with pBBR1c-eGFP This study 
EcFapR E. coli DH5 with pBBR1c-FapR This study 
ReRFP E. coli DH5 with pBBR1c-RFP This study 
ReGFP Ralstonia eutropha H16 with pBBR1c-GFP This study 
Re-null Ralstonia eutropha H16 with pBBR1MCS-1 This study 
ReFapR Ralstonia eutropha H16 with pBBR1c-FapR This study 
BWD20 E. coli BW25113 with pKD20 This study 
BWD46 E. coli BW25113 with pKD46 This study 
BWRed1 E. coli BW25113 with pBBR1c-RED1 This study 
BWRed2c E. coli BW25113 with pBBR1c-RED2 This study 
BWRed2k E. coli BW25113 with pBBR1k-RED This study 
ReRed1 Ralstonia eutropha H16 with pBBR1c-RED1 This study 
ReRed2 Ralstonia eutropha H16 with pBBR1c-RED2 This study 
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Table 2.2: Plasmids used in this study 
Plasmid Origin Description Reference 
pBBR1MCS1 BBR1  
OriV 
Broad host range, medium 
copy number plasmid 
compatible with IncQ, IncP, 
IncW, and colE1, camR 
Kovach et al. (1994) 
pBbA8k-RFP p15A Narrow host range, 1ow copy 
number ParaCBAD-RFP plasmid, 
kanR 
Lee et al. (2011) 
pKD20 pSC101 Narrow host range, 1ow copy 
number -Red recombinase 
vector, ampR 
Datsenko and Wanner (2000) 
pKD46 pSC101 Narrow host range, 1ow copy 
number -Red recombinase 
vector, ampR 
Datsenko and Wanner (2000) 
pEGFP pUC eGFP plasmid, ampR BD Biosciences Clontech 
pBBR1c-RFP BBR1 
 OriV 
Broad host range RFP plasmid 
construct, camR 
This study 
pBBR1c-EGFP BBR1  
OriV 
Broad host range EGFP 
plasmid construct, camR 
This study 
pBBR1c-FapR BBR1  
OriV 
Broad host range FapR 
plasmid construct, camR 
This study 
pBBR1k-RFP BBR1  
OriV 
Broad host range EGFP 
plasmid construct, kanR 
This study 
pBBR1c-RED1 BBR1 
 OriV 
Broad host range -Red 
plasmid construct, camR 
This study 
pBBR1c-RED2 BBR1 
 OriV 
Broad host range -Red 
plasmid construct, camR 
This study 
pBBR1k-RED BBR1 
 OriV 
Broad host range -Red 
plasmid construct, camR 
This study 
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Table 2.3: Primers used in this study 
 * Underlined nucleotides are restriction sites 
Primer Name Direction Sequence (5’-3’) 
Primers for 4.3 kb AvrII-pBBR1-camR-PstI amplicon 
AvrII-Cam-pBBR1 Forward  GATCCCTAGGATTGTTATCCGCTCACA
ATTCCACACAACATAC 
pBBR1MCS1-PstI Reverse GATCCTGCAGAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTT
TG 
Primers for 3.3 kb AvrII-pBBR1-SacI amplicon 
AvrII-pBBR1MCS1 Forward GATCCCTAGGGAAGACGAAAGGGCCTC
GTGATACG 
pBBR1MCS1-SacI Reverse GATCGAGCTCAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTT
TG 
Primers for 0.74 kb NdeI-eGFP-BamHI amplicon 
NdeI-EGFP-for Forward GATCCATATGATGGTGAGCAAGGGCGA
GG 
BamHI-EGFP-rev Reverse GATCGGATCCTTACTTGTACAGCTCGT
CCATGCC 
Primers for 1.9 kb NdeI-pKD20-BamHI amplicon 
NdeI-Gam-for Forward GATCCATATGATGGATATTAATACTGA
AACTGAGATCAAGCAAAAGC 
BamHI-Exo-rev Reverse GATCGGATCCTCATCGCCATTGCTCCC
CA 
Primers for 2.2 kb NdeI-pKD46-Lt-BamHI amplicon 
NdeI-Gam-for Forward GATCCATATGATGGATATTAATACTGA
AACTGAGATCAAGCAAAAGC 
BamHI-Lt-Exo-rev Reverse GATCGGATCCCTACTGGTATTGGCACA
AACCTGATT 
Primers for 579 bp pBBR1 NdeI-FapR-BamHI amplicon 
NdeI-FapR-for Forward GATCCATATGCGCCGCAACAAG 
BamHI-FapR-rev Reverse GATCGGATCCTTATCAGCTATGCTTG 
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2.2.2 Plasmid and linear dsDNA construction 
Plasmid construction was performed using ligase dependent restriction-based cloning. All 
polymerases (Pfu Turbo, Pfu Ultra, Q5, Phusion, Taq, OneTaq polymerases) used for PCR, 
restriction enzymes for restrictive digestion were obtained from the New England Biolabs 
together with associated reagents, and used according to the manufacturer’s protocol. All 
PCR reactions were performed using the Eppendorf Mastercycler Personal (Eppendorf, 
Germany) according to the manufacturer’s instructions. T4 ligase from New England 
Biolabs was used for ligation reactions, and used according to the manufacturer’s protocol. 
Where necessary, PCR with insert primers were used to verify presence and molecular size 
of inserts in constructed plasmids. Agarose gel electrophoresis (100 V, 70 minutes) was 
carried out with the Bio-Rad Mini-Sub Cell GT, using 0.6-1.0% agarose solution, 1.0 kb 
DNA ladder, 2-3 L of ethidium bromide to verify bands of PCR amplified inserts and 
linear dsDNA cassette where necessary. DNA on agarose gel was extracted using the 
QIAquick Gel extraction kit (Qiagen, Germany). All PCR products were purified using the 
QIAquick PCR purification kit (Qiagen, Germany) after 2-3 hours digestion with DpnI to 
remove template plasmid. DNA concentration was measured with Versawave Expedeon  
(Cambridge, UK) while DNA band imaging was performed with Genosmart2 (VWR, 
Europe).  
 
Correct construction of all plasmids was confirmed by restrictive analysis/DNA sequencing. 
All DNA products were stored temporarily or permanently at -20C in the refrigerator 
(Liebherr). All plasmids and linear dsDNA were a priori constructed in silico using 
SnapGene software (from GSL Biotech; available at snapgene.com).  
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Figure 2.1: Maps of plasmids possessing essential biological parts for constructing vital 
expression vectors for molecular tool development in Ralstonia eutropha H16. 
(A) pBBR1MCS is a broad host range plasmid possessing a mob gene for plasmid 
mobilization (mob), and the BBR1 origin of replication (pBBR1 oriV), and a 
chloramphenicol resistance gene (Pcat-camR). (B) pBbA8k-RFP is a narrow host range 
plasmid possessing the PBAD promoter (araC gene and the araBAD promoter), the rfp gene 
(mRFP1), and the double transcriptional terminators (rrnB T1 and T7). (C) pKD20 is a 
narrow host range -Red recombinase plasmid possessing the PBAD promoter (araC gene 
and the araBAD promoter) and the genes for Gam, Bet and Exo. (D) pKD46 is basically the 
pKD20 plasmid with a tL3 transcriptional terminator at the end of the -Red genes. 
A B 
C D 
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2.2.2.1 pBBR1c-RFP 
The recombinant BHR plasmid pBBR1c-RFP was constructed from the BHR pBBR1MCS-
1 and the synthetic plasmid pBbA8k-RFP, (Figure 2.1). A 4.3 kb AvrII-pBBR1-camR-PstI 
amplicon containing the chloramphenicol resistance, Pcat-camR gene for chloramphenicol 
resistance, the mob gene for plasmid mobilization, the BBR1 origin of replication was 
cloned from pBBR1MCS using forward and reverse primers AvrII-Cam-pBBR1MCS and 
pBBR1MCS-PstI, respectively. The PCR product was incubated with 1 L DpnI to remove 
plasmid template of pBBR1MCS, and subsequently purified. The purified product was then 
double digested with the enzymes AvrII and PstI, and re-purified. pBbA8k-rfp synthetic 
plasmid was double digested with both enzymes AvrII and PstI to obtain a 2.4 kb AvrII-
ParaCBAD-RFP-PstI product which was gel extracted. PCR product from pBBR1MCS and 
the restrictive digest product from pBbA8k-RFP were then ligated to obtain the 6.7 kb 
recombinant broad host range plasmid pBBR1c-RFP, (Figure 2.2). 
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Figure 2.2: In silico construction of pBBR1c-RFP 
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2.2.2.2 pBBR1k-RFP 
The recombinant BHR plasmid pBBR1k-RFP was constructed from the BHR pBBR1MCS-
1 and the synthetic plasmid pBbA8k-RFP, (Figure 2.1). A 3.3 kb AvrII-pBBR1-SacI 
amplicon containing the mob gene for plasmid mobilization, the BBR1 origin of replication 
was cloned from pBBR1MCS using forward and reverse primers AvrII-pBBR1 and 
pBBR1MCS-SacI, respectively, and pfu turbo polymerase. The PCR product was incubated 
with 1 l DpnI to remove the plasmid template of pBBR1MCS-1, and subsequently 
purified. The purified product was then double digested with the enzymes AvrII and SacI, 
and re-purified. pBbA8k-rfp synthetic plasmid was double digested with both enzymes 
AvrII and SacI to obtain a 3.0 kb AvrII-ParaCBAD-RFP-SacI product with the Pneokan-kanR 
gene for resistance to kanamycin. The digest was gel extracted. The 3.3 kb PCR product 
from pBBR1MCS and the 3.0 kb restrictive digest product from pBbA8k-RFP were then 
ligated to obtain the 6.3 kb recombinant broad host range plasmid pBBR1k-RFP, (Figure 
2.3). 
2.2.2.3 pBBR1c-eGFP 
The chloramphenicol resistant broad host range EGFP plasmid, pBBR1c-EGFP was 
constructed from the plasmids pBBR1c-RFP and pEGFP, (Figure 2.4). pBBR1c-RFP was 
double digested with the restrictive enzymes NdeI and BamHI, to obtain a 6.0 kb NdeI-
pBBR1c-BamHI linear DNA without the rfp gene. The product was gel extracted. The 
eGFP gene was amplified from pEGFP with pfu turbo polymerase, using the forward 
primer NdeI-EGFP-for and reverse primer BamHI-EGFP-rev to obtain a 0.74 kb NdeI-
eGFP-BamHI PCR product. The PCR product was incubated with 1l DpnI to remove the 
pEGFP plasmid template, and subsequently purified. The purified product was then double 
digested with NdeI and BamHI, and re-purified using the same kit. The 6.0 kb restrictive 
digest from pBBR1c-RFP, and the 0.74 kb PCR product from pEFGP were then ligated to 
obtain the 6.7 kb recombinant broad host range plasmid pBBR1c-eGFP, (Figure 2.4). 
2.2.2.4 pBBR1c-FapR 
The plasmid pBBR1c-FapR containing the fapR gene was constructed from the pBBR1c-
RFP plasmid as vector. The fapR gene was synthesized and codon-optimized for gene 
expression in R. eutropha H16 by GenScripts HK Limited. The fapR gene was amplified 
from the pUC57 plasmid containing the gene using primers NdeI-FapR-for and BamHI-
FapR-rev to generate 579 bp NdeI-FapR-BamHI amplicon where in the fapR gene is 
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flanked by NdeI and BamHI restriction sites. NdeI-FapR-BamHI was doule digested with 
NdeI and BamHI restriction enzymes and the product was purified. The purified 6.0 kb 
NdeI-pBBR1c-BamHI linear DNA was ligated with the purified NdeI-FapR-BamHI digest 
to yield the plasmid pBBR1c-FapR, (Figure 2.5). 
 
Protein sequence of codon-optimzed FapR 
MRRNKRERQELLQQTIQATPFITDEELAGKFGVSIQTIRLDRLELSIPELRERIKNVAEK 
TLEDEVKSLSLDEVIGEIIDLELDDQAISILEIKQEHVFSRNQIARGHHLFAQANSLAVA 
VIDDELALTASADIRFTRQVKQGERVVAKAKVTAVEKEKGRTVVEVNSYVGEEIVFSGRF 
DMYRSKHS 
 
 DNA sequence of codon-optimzed fapR gene 
ATGCGCCGCAACAAGCGCGAACGCCAGGAGCTCCTCCAGCAGACGATCCAGGCCACCCCGTTCATCACGGACG
AAGAACTGGCGGGCAAGTTCGGCGTGTCGATCCAGACCATCCGCCTGGACCGCCTGGAGCTGAGCATCCCGGA
GCTGCGCGAGCGCATCAAGAACGTGGCCGAGAAGACCCTGGAGGACGAGGTGAAGTCGCTGAGCCTGGACGAG
GTGATCGGCGAGATCATCGACCTGGAGCTGGACGACCAGGCCATCTCGATCCTGGAGATCAAGCAGGAGCACG
TGTTCAGCCGCAACCAGATCGCACGCGGCCACCACCTGTTCGCCCAGGCGAACTCGCTGGCGGTGGCCGTGAT
CGACGACGAGCTGGCCCTGACCGCCAGCGCGGACATCCGCTTCACCCGCCAGGTGAAGCAGGGCGAGCGCGTG
GTGGCCAAGGCCAAGGTGACCGCGGTGGAGAAGGAGAAGGGCCGCACCGTGGTGGAAGTGAACTCGTACGTGG
GCGAGGAAATCGTGTTCTCGGGCCGCTTCGACATGTACCGCAGCAAGCATAGC 
 
2.2.2.5 pBBR1c-RED1 
The chloramphenicol resistant broad host range -Red plasmid, pBBR1c-RED was 
constructed from the plasmids pBBR1c-RFP and pKD20, (Figure 2.6). pBBR1c-RFP was 
double digested with the restrictive enzymes NdeI and BamHI, to obtain a 6.0 kb NdeI-
pBBR1c-BamHI linear DNA without the rfp gene. The product was gel extracted. The gene 
operon for the -Red proteins (Gam, Exo and Bet) was amplified with Q5 polymerase from 
pKD20 using forward primer NdeI-Gam-for and reverse primer BamHI-Exo-rev to obtain 
the 1.9 kb NdeI-pKD20-BamHI PCR product. The PCR product was incubated with 1 L 
DpnI to remove pKD20 plasmid template, and subsequently purified. The purified product 
was then double digested with NdeI and BamHI, and repurified using the same kit. The 6.0 
kb restrictive digest from pBBR1c-RFP, and the purified digest of the 1.9 kb NdeI-pKD20-
BamHI PCR product from pKD20 were then ligated to obtain the 7.9 kb recombinant broad 
host range plasmid pBBR1c-RED1.  
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2.2.2.6 pBBR1c-RED2 and pBBR1k-RED 
The kanamycin resistant broad host range -Red plasmid, pBBR1k-RED and the 
chloramphenicol resistant broad host range -Red plasmid were constructed from the 
plasmids pBBR1k-RFP and pBBR1c-RFP and pKD46, respectively, (Figure 2.7 and 2.8). 
pBBR1k-RFP and pBBR1k-RFP was double digested with the restrictive enzymes NdeI 
and BamHI, to obtain the 5.63 kb NdeI-pBBR1k-BamHI and the 6.06 kb NdeI-pBBR1c-
BamHI the linear vectors. The product was gel extracted. The gene operon for the -Red 
proteins was amplified with Q5 polymerase from pKD46 using forward primer NdeI-Gam-
for and reverse primer BamHI-tL3-Exo-rev to obtain the 2.147 kb NdeI-pKD46-BamHI 
PCR product. The PCR products were incubated with 1 L DpnI to remove pKD46 plasmid 
template, and subsequently purified. The purified product were then double digested with 
NdeI and BamHI, and repurified using the same kit. The restrictive digest of the linear 
vectors and the purified digest of the 2.147 kb NdeI-pKD46-BamHI PCR product were then 
ligated to obtain the 7.8 kb pBBR1k-RED and the 8.2 kb pBBR1c-RED2 recombinant 
broad host range plasmids.  
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Figure 2.3: In silico construction of pBBR1k-RFP 
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Figure 2.4: In silico construction of pBBR1c-eGFP 
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Figure 2.5: In silico construction of pBBR1c-FapR 
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Figure 2.6: In silico construction of pBBR1c-RED1 
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Figure 2.7: In silico construction of pBBR1k-RED 
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Figure 2.8: In silico construction of pBBR1c-RED2 
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2.2.3 Plasmid propagation and circularization 
Ligation mixtures of all plasmids constructed were initially transformed into E. coli DH5 
for intact plasmid circularization and plasmid propagation. 5 l of ligation mixture was 
used for transformation into E. coli DH5. 
2.2.4 Bacterial Transformation  
Bacterial transformation in E. coli was done using heat shock with the Eppendorf 
Thermomixer C preset at 42C. 5 mL of 2XYT media was inoculated with fresh overnight 
cultures of E. coli in a 1:50 ratio. The culture was grown for 2 h to an OD600 value 0.5–0.6. 
The samples were then aliquoted into 1.5 mL microfuge tubes and centrifuged at 2,800 rpm 
to obtain cell pellets. Cell pellets were then washed with 500 L of pre-chilled 500 mM 
CaCl2 solution. Washed cells were resuspended in 500 L of prechilled 500 mM CaCl2 
solution and cooled in wet ice for 30 minutes. 100 ng of plasmid DNA was added into the 
cooled cell suspension as appropriate. The cell suspension was again cooled in wet-ice for 
10-30 minutes, after which the cell suspension was heat shocked at 42C for 1 min, and 
immediately incubated in wet-ice for 2 minutes. 1 mL of 2XYT media was added to this 
cell suspension, and the mixture was immediately cultivated at 37C for 1 h. The outgrowth 
culture was then centrifuged at 2,800 rpm, 1 mL of the supernatant was discarded and the 
cell suspension was resuspended before plating on Tryptone-Yeast (TYE) agar plates 
supplemented with appropriate antibiotics and incubated overnight in the VWR INCU-Line 
Incubator (Germany). As an exception, transformation of the plasmids pKD20 and pKD46 
into E. coli required cultivation/ incubation at 30C to prevent plasmid curing.  
 
Electroporation with the Eppendorf Eporator (Eppendorf AG, Hamaburg, Germany) was 
used for bacterial transformation of the broad host range plasmids pBBR1MCS1, into 
Ralstonia eutropha H16 the transformation protocol according to Tee et al. (2017). Briefly, 
fresh NB supplemented with gentamicn (10 mg/L) is inculated with overight culture of 
Ralstonia eutropha H16 in a 1:50 ratio. The culture is grown to OD600 of ~0.6 and cooled in 
ice briefly for up to 3 minutes. Competent cells are created by first resuspending and 
incubating the cells in 50 mM CaCl2 at a voume one-half the volume of cell culture. The 
cell suspension is incubated in ice for up to 15 minutes. Subsequently, the cells are washed 
twice in 0.2M sucrose at a volume one-half the volume of initial cell culture. The 
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competent cells are resuspended in 200 L of 0.2 M sucrose and 100 ng – 1 g of DNA is 
added to the cell suspension. The cells suspension is transferred to the pre-chilled 
electropration cuvettes and the cells is electroporated at 2.3 kV. 1 mL of NB supplemented 
with gentamicin (10 mg/L) is immediately added to the electroporated cells  and the 
mixture is transferred into 2 mL microfuge tubes to create and outgrowth culture. The 
outgrwoh culture is cultivated at 30C, 250 rpm for between 2 hours to overnight. The 
outgrowth is afterwards centrifuged to decant 1 mL of the supernatant. The cell pellet is re-
suspended in the remaining 100–200 L of supernatant and plated on NB agar plate 
supplemented with appropriate antibiotics.  
 
2.2.5 Cell density measurement 
Cell density at OD600 was measured using the Eppendorf Biophotometer (Eppendorf AG, 
Hamburg, Germany) when cells were cultivated in falcon tubes or conical flasks. When 
cells are cultured in 96-well micro-titre plates, cell density measured at OD595 using the 
MultiSkanTM FC Microplate Photometer (Thermo Fisher Scientific) or at OD600 using the 
SpectraMax M2e microplate/cuvette reader [Molecular Devices (Wokingham, UK)]. 
 
2.2.6 Plasmid Isolation 
After plasmid construction plasmids were isolated from E. coli DH5 transformant 
colonies for gene/protein expression in Ralstonia eutropha or E. coli. Plasmids were 
isolated from overnight cultures of E. coli DH5 using the QIAprep miniprep kit (Qiagen) 
according to the manufacturer’s protocol. Isolated plasmids were verified via restrictive 
analysis and/or DNA sequencing. Plasmids were stored at -20C before being used for 
bacterial transformation and gene expression.  
 
2.2.7 Colony PCR verification of transforamnts 
Where applicable colony PCR using OneTaq or Taq polymerase from New England 
Biolabs according to the manufacturer’s protocol was used to verify correct transformation 
of plasmids into Ralstonia eutropha H16. Forward and reverse Primers specific to the 
inserts present in the plasmids were used for the colony PCR verification. Amplicons were 
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checked using agarose gel electrophoresis (0.6-1% agarose). Transformant strains of E. coli 
and Ralstonia eutropha H16 are listed in Table 3.1. 
2.2.8 Protein expression: Expression of reporter proteins RFP and eGFP  
Fresh pBBR1c-RFP and pBBR1c-eGFP-transformant colonies of R. eutropha H16 (i.e. 
strains ReRFP and ReGFP) were inoculated into 5 mL of nutrient broth (NB) supplemented 
to 10 mg/L gentamicin and 25 mg/L chloramphenicol. Each inoculum was cultivated at 
30C, 500 rpm for up to 48 h to create overnight cultures. 100 mL of fresh NB media in 
500 mL cultivation flasks supplemented with aforementioned antibiotics was inoculated 
with 500 l of each seed culture. A 20% (w/v) stock solution of L-arabinose was prepared 
by dissolving 5 g of L-arabinose (Sigma Aldrich) in 25 mL of triple-filtered de-ionized 
water and filtered using the 0.2 m Whatman syringe filter. The new cultures were 
cultivated up to OD600 0.5–0.6, after which protein expression was induced with L-
arabinose solution at 0.1% (w/v). Control cultures were not induced for protein expression. 
All cultures were cultivated for 48 hours in the incubator shaker (New Brunswick Scientific 
Excella E24) at 30C, 250 rpm for up to 30 h. Expression cultures were collected in 50 mL 
falcon tubes and centrifuged at maximum speed to collect cell pellets with expressed 
proteins. Cell pellets were stored at -20C for further analyses of expressed proteins. 
 
2.2.9 Examining the induction range of the L-arabinose inducible PBAD promoter in 
Ralstonia eutropha H16 
Fresh media supplemented with gentamicin and chloramphenicol was inoculated in 1:50 
ratio with overnight cultures of R. eutropha H16 with pBBR1c-RFP and pBBR1MCS-1 (i.e. 
strains ReRFP and Re-null). 200 L of each culture was aliquoted into fresh clear-bottom 
96-well microtitre plates [Greiner Bio-One (Stonehouse, UK)]. The cultures were 
supplemented with L-arabinose of final concentrations between 0 and 0.2 % (w/v). All 
cultures were cultivated at 30C, 1050 rpm for up to 48 h. OD600 and fluorescence (Ex 584 
nm, Em 607 nm; bottom read) were measured using SpectraMax M2e microplate/cuvette 
reader [Molecular Devices (Wokingham, UK)] after 12 h of cultivation and repeated at 12 h 
intervals. Relative fluorescence unit (RFU) was calculated by normalizing fluorescence 
value with the fluorescence value of R. eutropha H16 carrying the pBBR1MCS-1 RFP-null 
vector (negative control). RFU/OD600 value was then calculated as the ratio of RFU and 
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OD600 value of the respective strain. The ratio was used to account for potential metabolic 
burden due to high protein expression level, affecting bacterial growth. Promoter activity 
(PA) was defined as the RFU/OD600 value after 48 h of cultivation. All experiments were 
done in triplicate. 
 
2.2.10 Protein expression: Expression of the FapR transcriptional regulator in R. 
eutropha H16 and E. coli DH5 
Overnight cultures of R. eutropha H16 and E. coli DH5 transformed with pBBR1c-FapR 
(i.e. ReFapR and EcFapR, respectively) were cultivated as already described. Fresh 5 mL 
cultures in 50 mL falcon tubes were inoculated in a 1:50 ratio with the overnight cultures, 
cultivated to OD600 0.5-0.6, and induced with L-arabinose at final concentrations of 0.01% 
and 0.1% L-arabinose. Control cultures were not induced. All cultures of ReFapR and 
EcFapR were then cultivated at 30C, 250 rpm for 36 h, and 37C, 250 rpm for 24 h, 
respectively. 2 mL of each expression cultures were collected in 2 mL falcon tubes and cell 
pellets were stored at -20C for further analyses of expressed proteins. 
 
2.2.11 Protein expression: Expression of the -Red genes in E. coli BW25113 and R. 
eutropha H16 
The -Red plasmids pKD20 and pKD46 are low copy number, narrow host range plasmids 
(Datsenko and Wanner, 2000). pBBR1c-RED1 possseses the pKD20 -Red operon 
(containing the three genes Gam, Exo and Bet) while pBBR1c-RED2 and pBBR1k-RED 
possess the pKD46 -Red operon (containing the three genes Gam, Exo, Bet and the tL3 
transciptional terminator), (Figure 2.1). Expression of the -Red proteins was examined in 
E. coli BW25113 using all the -Red plasmids in order to observe if the differences in copy 
number and components of -Red operon might affect expression of the the proteins. 
 
Overnight cultures of respective strains were cultivated in 5 mL 2XYT media. Fresh 5 mL 
2XYT media in 50 mL falcon tubes were inoculated with overnight cultures. Test cultures 
were induced with L-arabinose at final concentration of 0.1%. Control cultures were not 
induced. The cultures were cultivated at 30C (for BWD20 and BWD46) and 37C (for 
BWRed1, BWRed2c, and BWRed2k) at 500 rpm for 24 hours. Protein expression was 
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similarly examined in R. eutropha H16 (with ReRed1, ReRed2c) was performed in 5 mL 
nutrient broth (NB) in 50 mL falcon tubes at 30C, 500 rpm for 30 hours. 2 mL of each 
expression cultures were collected in 2 mL falcon tubes and cell pellets were stored at -
20C for further analyses of expressed proteins. 
 
2.2.12 Protein analysis with SDS-PAGE 
Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) with 2X 
SDS-reducing buffer (5% -mercaptoethanol) and 10-15% acrylamide-SDS gel was used to 
detect expressed proteins in protein fractions. Protein samples were treated with denatured 
with SDS-reducing buffer contaiining 5% -mercaptoethanol. 15% SDS-polyacrylamide 
gels were prepared from resolving and stalking gels. Resolving gel contained: 2.05 mL DDI 
water, 1.65 mL of 30 % acrylamide, 1.25 mL of 1.5 M Tris-HCl (pH 8.8), 0.05 mL SDS, 
2.5 L TEMED, 25 L APS. Stalking gel contained: 2.05 mL DDI water, 1.65 mL of 30 % 
acrylamide, 1.25 mL of 0.5 M Tris-HCl (pH 6.8), 0.05 mL SDS, 5.0 L TEMED, 25 L 
APS. 5 l of PageRulerTM unstained protein ladder was used as marker to detect the sizes of 
protein bands. Commassie Brillaint Blue staining dye was used as the protein gel staining 
solution followed by counter-staining with de-staining solution.  
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2.3 RESULTS AND DISCUSSION 
2.3.1 Bacterial transformation 
All plasmids were successfully constructed and transformed into E. coli DH5 and E. coli 
BW25113. Transformations into Ralstonia eutropha following the protocol by Tee et al. 
2017 had transformation efficiencies of (3.86±0.29) x 105 cfu/g (Tee et al., 2017). 
Transformant strains of E. coli and Ralstonia eutropha H16 are listed in Table 2.1. 
 
2.3.2 Protein expression of RFP and eGFP in Ralstonia eutropha H16 
Cell pellets of the cultures from L-arabinose-induced expression of the RFP and eGFP from 
pBBR1c-RFP and pBBR1c-eGFP in R. eutropha H16 (i.e. ReRFP and ReGFP, 
respectively) indeed were red and green, (Figure 2.9). This is in wide contrast to pellets 
from the un-induced culture of ReRFP, which only had an orange colour, which is quite 
typical of pellets of wild type R. eutropha H16, (Figure 2.9). This confirmed that the red 
and green fluorescence proteins were successfully expressed in R. eutropha from the 
plasmids pBBR1c-RFP and pBBR1c-eGFP, respectively following protein expression with 
0.1% L-arabinose. It also indicates that the PBAD promoter in pBBR1c-RFP and pBBR1c-
eGFP is tightly repressed under un-induced conditions thus validating potential use for 
tightly regulated gene expression, (Figure 2.9). 
 
 
 
Figure 2.9: Inducible expression of RFP and eGFP in Ralstonia eutropha  
A - Cell pellet of R. eutropha with pBBR1c-RFP (ReRFP) with inducible expression the 
RFP protein. B - Cell pellet of R. eutropha with pBBR1c-RFP (ReRFP) without L-
arabinose induction. C - Cell pellet of R. eutropha with pBBR1c-eGFP (ReGFP) with 
inducible expression the eGFP protein. 
 
A. B. C. 
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2.3.3 Induction fold of the PBAD promoter in pBBR1c-RFP in Ralstonia eutropha H16 
RFP fluorescence value of strain ReRFP at zero concentration of L-arabinose (92.84±25.19 
a.u.) was comparable to the activity of Re-null at 90±7 a.u. This very negiglible basal 
expression when not induced confirms that the araC repressor tightly represses the PBAD 
promoter in pBBR1c-RFP. RFU (i.e. relative fluorescence unit) values of 43.39±3.90-
8671.89±46.45 were obtained between 0.01-0.200% final concentrations of L-arabinose 
after 48 h of cultivation. A 162-fold of activity was detected between activities of the 
promoter upon induction with final concentrations of 0.001-0.200% L-arabinose, (Figure 
2.10B). 
 
 
 
Figure 2.10: Dose-dependent induction of PBAD promoter, using L-arabinose concentration 
from 0.001% (w/v) to 0.200% (w/v). (A) Graph of RFU versus L-arabinose concentration. 
(B) Graph of RFU/OD600 versus L-arabinose concentration. 
 
 
2.3.4 Protein expression of FapR 
SDS-PAGE analysis of the total protein fraction from L-arabinose induced cultures of 
EcFapR show a unique protein band at ~26 kDa, (Figure 2.11A). This band corresponds to 
the size of the FapR transcriptional regulator confirming that the protein is well expressed 
in E. coli DH5 particularly under induction with 0.1% L-arabinose. Only a faint band of 
the ~26 kDa FapR protein was observed from cultures induced with 0.01% L-arabinose 
suggesting that the protein was not well expressed at 0.01% L-arabinose induction in E. coli 
DH5, (Figure 3.11A). Additionally, the intensity of the ~26 kDa FapR protein band from 
EcFapR is relatively weaker compared to the intensity of RFP band (~30 kDa) from EcRFP 
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when both cultures were induced at 0.1% L-arabinose concentration, (Figure 2.11A). This 
suggested that the FapR protein was either not as well expressed as the RFP protein or not 
as freely available as the RFP protein in the intracellular space of E. coli DH5.  
 
In R. eutropha H16, SDS-PAGE analysis of the total protein fraction show that the ~26 
kDa FapR protein is well expressed from ReFapR when cultures were induced with both 
0.01% and 0.1% L-arabinose, (Figure 2.11B). However as was the case in E. coli DH5, 
the ~30 kDa RFP band was more intense than of the ~26 kDa FapR band. This also 
suggested that the FapR protein was also not as well expressed as was the RFP protein or 
not as freely available as the RFP protein in the intracellular space in R. eutropha H16. 
 
 
Figure 3.11: SDS-PAGE image showing expression of the ~26 kDa FapR transcriptional 
regulator (green arrow) and RFP (red arrow) in E. coli DH5 and R. eutropha H16.  
(A) SDS-PAGE image showing expression of total protein expressed EcFapR under 0.01% 
L-arabinose, EcFapR under 0.1% L-arabinose (4) EcRFP under 0.1% L-arabinose. (B) 
SDS-PAGE image showing expression of total protein expressed from (1) ReFapR, 
uninduced (2) ReFapR, under 0.01% L-arabinose (3) ReFapR under 0.1% L-arabinose (4) 
ReRFP under 0.1% L-arabinose. Ladder – 10 - 250 Protein Ladder. 
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2.3.5 Protein expression of -Red proteins 
SDS-PAGE analysis of expression of the -Red proteins in induced cultures of E. coli 
BW25113 strains BWRed1, BWRed2c, BWRed2k showed unique protein bands at ~15, 
~25 and ~29 kDa, (Figure 3.12A). These bands correspond to the -Red proteins Gam (~15 
kDa), Exo (~25 kDa) and Bet (~29 kDa), (Figure 2.12A). This indicates that the proteins 
are well expressed in E. coli BW25113 from the three broad host range plasmids (pBBR1c-
RED1, pBBR1k-RED, pBBR1c-RED2) at 0.1% L-arabinose induction, (Figure 2.12A).  
 
SDS-PAGE analysis of expression of the three -Red proteins from E. coli BW25113 
possessing the plasmids pKD20 and pKD46  (BWD20 and BWD46) barely revealed bands 
of the proteins despite induction with 0.1% L-arabinose, (Figure 2.12B). This suggested 
that the broad host range plasmids pBBR1c-RED1, pBBR1k-RED, pBBR1c-RED2 are 
better expression vectors of the -Red proteins than the pKD20 and pKD46 plasmids in E. 
coli BW25113. This might be due to the fact that the former are medium copy number 
plasmids while the later are low copy number plasmids. It also indicates that lack of 
identifiable expression bands of the -Red proteins from pKD20 and pKD46 does not 
entirely define the performance of these plasmids as they have reportedly been well utilized 
for -Red recombineering in E. coli.  
 
In R. eutropha H16, expression bands of -Red proteins from pBBR1c-RED1 and 
pBBR1c-RED2 were not detected via SDS-PAGE analysis. This is in wide contrast to 
marked expression of the proteins from these plasmids in E. coli BW25113. It is also in 
wide contrast to the observed vivid expression of FapR and RFP observed from the 
plasmids pBBR1c-FapR and pBBR1c-RFP, respectively. This suggested that the proteins 
might not be well expressed in R. eutropha H16. The poor yield of protein expression may 
be attributed to possible proteolytic degradation of the proteins as a native cellular defense 
mechanism to protect the cell from potential detrimental effects the recombinase proteins 
might have on cell viability. On the other hand, expression of the proteins in R. eutropha 
H16 may be repressed by the action of native global transcriptional regulator on the L-
arabinose inducible PBAD promoter. It is also possible that due to these cellular responses, 
the proteins are expressed in only very amounts too little to be detected by the SDS-PAGE 
procedure.  
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Figure 2.12: SDS-PAGE showing expression of the -Red proteins Bet (~29 kDa, red 
arrow), Exo (~25 kDa, blue arrow), and Gam (~15 kDa, green arrow) in E. coli BW25113. 
(A) The -Red proteins Bet and Exo and Gam are expressed at 0.1% L-arabinose in strain 
BWRed1, BWRed2c and BWRed2k (B) The -Red proteins are more vividly expressed in 
strains BWRed1, BWRed2c and BWRed2k than in strains BWD20 and BWD46. 
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2.4 CONCLUSION 
The plasmid pBBR1c-RFP is a viable expression vector for tunable protein expression in R. 
eutropha H16 as confirmed by red fluorescent protein expression studies. The dose-
dependent induction of the PBAD promoter in this plasmid revealed a ~160 fold of activity 
between 0.01-0.200% L-arabinose induction concentrations. However, the rather costly 
concomitant need for an inducer to achieve this activity spectrum, especially in large-scale 
fermentation, necessitates a compilation of constitutive promoters that span the breadth of 
activity of the L-arabinose inducible PBAD promoter. Benchmarking the activities of such 
promoters to the activity spectrum of the PBAD promoter will definitely help to identify 
constitutive promoter substitutes to achieve the varied activities within and beyond the 
activity spectrum of the PBAD promoter. Additionally, the size of the PBAD promoter (1238 
bp together with the araC repressor gene and other genetic elements) is a potential limiting 
factor where compact modularity is required in designing complex heterologous pathways. 
This again accentuates the need for properly characterized constitutive promoters with 
easily adjustable lengths to suit the design of complex expression circuitries. 
 
Expression of the FapR repressor from the PBAD promoter in pBBR1c-FapR was confirmed 
in R. eutropha H16 at 0.01% and 0.10% L-arabinose induction concentrations, thus 
demonstrating that the protein could potentially be applied in the design of malonyl-CoA-
responsive genetic circuits in R. eutropha H16. As carefully tuning expression of the FapR 
repressor is highly crucial in optimizing the functionality of such circuits, properly 
characterized constitutive promoters are required in the design-test-build cycles required to 
optimize the performance of such genetic circuits in R. eutropha H16.  
 
The broad host range -Red plasmids (pBBR1c-RED1, pBBR1c-RED2 and pBBR1k-RED) 
were especially designed to mediate -Red recombineering in Ralstonia eutropha H16. 
Poor -Red protein expression presumably might severely compromise chances of 
successful recombineering events or recombineering efficiency in Ralstonia eutropha H16. 
Nonetheless, validating the functionality of these vectors E. coli BW25113 in place of the 
conventional pKD20/pKD46 vectors is required to test the general effectiveness of the -
Red vectors in microbial chassis where they are compatible. 
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The constructed expression vectors can thus be used to engineer promoters, metabolite-
sensitive genetic circuits, and -red genome editing methods for the metabolic engineering 
of R. eutropha H16. 
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CHAPTER THREE 
Reproduced with permission from [Johnson, A. O., Gonzalez-Villanueva, M., Tee, K. L. & 
Wong, T. S. 2018. An Engineered Constitutive Promoter Set with Broad Activity Range for 
Cupriavidus necator H16. ACS Synthetic Biology] Copyright [2018] American Chemical 
Society. 
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3 AN ENGINEERED CONSTITUTIVE PROMOTER SET WITH BROAD 
ACTIVITY RANGE FOR RALSTONIA EUTROPHA H16 
 
 
Abstract 
Well-characterized promoters with variable strength form the foundation of heterologous 
pathway optimization. It is also a key element that bolsters the success of microbial 
engineering and facilitates the development of biological tools like biosensors. In 
comparison to microbial hosts such as Escherichia coli and Saccharomyces cerevisiae, the 
promoter repertoire of Ralstonia eutropha H16 is highly limited. This limited number of 
characterized promoters poses a significant challenge during the engineering of R. eutropha 
H16 for biomanufacturing and biotechnological applications. In this article, we first 
examined the architecture and genetic elements of the 4 most widely used constitutive 
promoters of R. eutropha H16 (i.e., PphaC1, PrrsC, Pj5 and Pg25), and established a narrow 6-
fold difference in their promoter activities. Next, using these 4 promoters as starting points 
and applying a range of genetic modifications (including point mutation, length alteration, 
incorporation of regulatory genetic element, promoter hybridization and configuration 
alteration), we created a library of 42 constitutive promoters; all of which are functional in 
R. eutropha H16. Although these promoters are also functional in E. coli, they show 
different promoter strength and hierarchical rank of promoter activity. Subsequently, the 
activity of each promoter was individually characterized, using L-arabinose-inducible PBAD 
promoter as a benchmark. This study has extended the range of constitutive promoter 
activities to 137 folds, with some promoter variants exceeding the L-arabinose-inducible 
range of PBAD promoter. Not only has the work enhanced our flexibility in engineering R. 
eutropha H16, it presented novel strategies in adjusting promoter activity in R. eutropha 
H16 and highlighted similarities and differences in transcriptional activity between this 
organism and E. coli. 
 
Keywords: Ralstonia eutropha H16, Cupriavidus necator H16, gene expression, 
constitutive promoter, synthetic biology, metabolic engineering 
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3.1 INTRODUCTION 
Ralstonia eutropha H16 (or Cupriavidus necator H16) is a chemolithoautotrophic soil 
bacterium, most widely known for its ability to accumulate polyhydroxyalkanoates (PHA) 
(Pohlmann et al., 2006). This metabolically versatile organism is capable of utilizing a wide 
range of energy and carbon sources (including H2 and CO2) to support growth and 
achieving high cell density (Volodina et al., 2016). These intrinsic properties have 
cemented its potential applications in biological CO2 capture and utilization (Jajesniak et al., 
2014, Peplow, 2015) as well as commercial-scale production of diverse bio-products 
(Brigham et al., 2012) including polymers (Lutke-Eversloh and Steinbüchel, 2003, 
Steinbüchel and Pieper, 1992, Voss and Steinbuchel, 2006, Valentin et al., 1995) 
hydrocarbons (Chen et al., 2015, Crépin et al., 2016, Marc et al., 2017, Bi et al., 2013, Lu et 
al., 2012) and amino acids (Luette et al., 2012). Its potential will rapidly come into fruition, 
aided by the development of molecular tools. These include genome engineering methods 
to permanently alter its metabolic phenotype (Park et al., 2010), expression vectors to 
assemble heterologous pathway (Voss and Steinbuchel, 2006, Gruber et al., 2014) 
transposon-based random mutagenesis (Raberg et al., 2015) and transformation method to 
introduce recombinant plasmids (Tee et al., 2017). 
 
Maximal product yield and titre are key requirements in biomanufacturing. To this end, 
metabolic pathway optimization is vital in eliminating metabolic bottlenecks that 
compromise cellular productivity and metabolic phenotypes that are detrimental to cell 
viability. Proven strategies of tuning gene expression of a metabolic pathway include 
varying plasmid copy number, gene dosage and promoter strength, among others. 
Leveraging on promoter strength for pathway optimization is the most straightforward 
strategy, which involves tuning promoter activity at both transcriptional and translational 
levels. 
 
L-arabinose-inducible PBAD promoter and anhydrotetracycline-inducible Ptet promoter are 
most widely applied to tune expression of genes, gene clusters or operons in R. eutropha 
H16 (Bi et al., 2013, Fukui et al., 2011, Guzman et al., 1995b, Li and Liao, 2015). With a 
PBAD promoter, high inducer concentration (up to 1 g/L) is required to achieve high 
expression yield. The leaky Ptet promoter, on the other hand, is induced by a weak antibiotic 
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that is undesirable and its promoter strength is comparatively weaker. These factors greatly 
limit the use of these two promoters for large-scale fermentation. The more recently 
developed 3-hydroxypropionic acid-inducible systems (Hanko et al., 2017) and the p-
cumate- and IPTG-inducible Pj5 promoters (Gruber et al., 2016) are promising alternatives. 
Nonetheless, achieving scalable and tunable gene expression of a multi-gene pathway by 
solely relying on inducible expression systems is severely limited by the poor modularity of 
inducer-based systems (or potential risk of unwanted inducer crosstalk) and limited number 
of R. eutropha H16-compatible inducible promoters. Further, the use of inducers such as L-
arabinose or anhydrotetracycline on a large scale is commercially uneconomical. 
 
In this regard, engineering constitutive promoters with a broad range of activities is a more 
facile means to modularly adjust gene expressions of a multi-gene pathway to the desired 
levels or ratios. In addition to facilitating static metabolic control, constitutive promoters 
are used to engineer more efficient inducible promoters (Li and Liao, 2015) and to 
construct metabolite-sensing genetic circuits that in turn facilitate dynamic metabolic 
control in microorganisms (Johnson et al., 2017). Examples of constitutive promoters for 
use in R. eutropha H16 include Plac and Ptac promoters, native R. eutropha H16 promoters 
such as PphaC1 promoter and coliphage T5 promoter and its variants such as Pj5, Pg25, Pn25 
and Pn26 promoters (Arikawa and Matsumoto, 2016, Fukui et al., 2011, Gruber et al., 2014). 
Despite these precedent studies, there are knowledge gaps that hinder constitutive promoter 
utilization and engineering for R. eutropha H16, which are (1) lack of a universal definition 
of promoter architecture, (2) lack of a universal reference scale for hierarchical ranking of 
constitutive promoter activities and (3) limited examples of rational promoter engineering. 
The latter is in stark contrast to promoter engineering reported for E. coli and yeast. 
 
In this study, we first examined the architecture of four notable R. eutropha H16-
compatible constitutive promoters: the native PphaC1 promoter, a semi-synthetic PrrsC 
promoter, and two coliphage T5 promoters Pj5 and Pg25. We then evaluated their activities 
using in vivo fluorescence measurement of red fluorescent protein (RFP) expression to 
establish an understanding of the relationship between promoter architecture and activity. 
Guided by these structure-function relationships, we next proceeded to rational engineering 
of these 4 parental promoters. Our engineering strategies include combinations of point 
mutation, length alteration, incorporation of regulatory genetic element, promoter 
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hybridization and configuration alteration. This resulted in a collection of 42 promoters 
displaying a range of promoter activities. Of these there are composite promoter variants 
that are stronger than the Pj5 promoter; the latter has previously been acclaimed to be the 
strongest known constitutive promoter for gene expression in R. eutropha H16 (Gruber et 
al., 2014). This new promoter library is envisaged to further propel the biotechnological 
applications of R. eutropha H16. 
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3.2 RESULTS AND DISCUSSION 
3.2.1 Defining a promoter and quantifying its activity 
Standardizing the definition of a promoter is deemed necessary and particularly relevant to 
this study for 4 obvious reasons: (1) to objectively benchmark the activities of wild-type 
and engineered promoters, (2) to critically assess promoter structure-function relationships, 
(3) to measure the effectiveness of various promoter engineering strategies, and (4) to 
compare promoters reported by various research groups. In this study, we describe a 
promoter as a constellation of three distinct genetic elements as shown in Figure 3.1A: (Part 
1) a core promoter sequence comprising -35 box, -10 box (or the Pribnow box), +1 
transcriptional start, spacer of 16-18 bp between the -35 and the -10 boxes as well as the 
spacer between the -10 box and +1 site, (Part 2) an upstream element (UP) that refers to the 
entire DNA sequence upstream of the core promoter sequence, and (Part 3) a downstream 
element spanning the nucleotide after the +1 transcriptional start and the nucleotide before 
the translation initiation codon. Therefore, the 5’-untranslated region (5’-UTR) consists of 
the +1 transcriptional start and the downstream element, with the latter typically containing 
cis-acting regulatory elements such as the ribosome binding site (RBS). Putting it simply, a 
promoter is a defined stretch of sequence upstream of the translational start. This definition 
is not uncommon in genome annotation, particularly when the promoter boundary is 
unclear or ambiguous. This definition also pre-supposes that the functional characteristics 
of a given promoter are composite effect of all genetic elements within the pre-defined 
promoter architecture. To quantify promoter activity in R. eutropha H16, RFP was used as 
a reporter protein (Figure 3.1B). Briefly, DNA fragments corresponding to a promoter and 
rfp gene were cloned, in tandem, into a broad host range pBBR1MCS plasmid backbone 
harbouring a chloramphenicol resistance gene (Figures 3.1B & S3.1).   
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Figure 3.1: (A) Promoter definition used in this study. (B) High-throughput 
characterization of engineered promoters using a fluorescence-based assay. (5’-UTR: 5’-
untranslated region; bp: base pair; CamR: chloramphenicol resistance gene; Rep: replication 
gene; RFP: red fluorescent protein)  
 
3.2.2 Defining the boundaries and architectures of 4 parental promoters 
Since the 4 parental promoters, PphaC1, PrrsC, Pj5 and Pg25, form the basis of this entire study, 
clearly defining their boundaries and examining their architectures are essential, such that 
all subsequently engineered promoters can be compared against these 4 ‘standards’. All 4 
parental promoters contain -35 box and -10 box that are almost identical to the hexameric 
promoter consensus sequences recognized by the E. coli housekeeping sigma factor 70 
(Figures 3.2A & 3.2B) (Kutuzova et al., 1997). PphaC1 is known to be a relatively strong 
native promoter (Arikawa and Matsumoto, 2016, Fukui et al., 2011, Li and Liao, 2015). It 
has been widely studied and applied for improved PHA-based biopolymer production in R. 
eutropha H16 (Arikawa and Matsumoto, 2016, Fukui et al., 2011). However, PphaC1 
promoters of different lengths are used in various studies, making objective comparison 
impossible. In this study, PphaC1 promoter is defined as a 466-bp DNA sequence upstream of 
the translation start of the phaC1 gene. Previous studies of this promoter affirmed the 
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presence of a 7-bp “AGAGAGA” Shine-Dalgarno (SD) sequence within its 5’-UTR. This 
native RBS is located 11 bp upstream of the translational start (Arikawa and Matsumoto, 
2016). The PrrsC promoter used in this study is a combination of a 210-bp DNA sequence 
upstream of the +1 transcriptional start of the native rrsC gene, the first 5 bp of the native 
5’-UTR and a 26-bp synthetic genetic element. The latter comprises a 20-bp RBS found in 
the pBBR1c-RFP PBAD promoter (see Supplementary Information) flanked by an upstream 
6-bp BglII restriction site. The synthetic RBS contains a purine-rich 5-bp “AGGAG” SD 
sequence known to markedly improve translation efficiency. Finally, the Pg25 and Pj5 
promoters used in this study are both 75-bp DNA sequences, identical to those previously 
reported by Gentz and Bujard (Gentz and Bujard, 1985). 
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Figure 3.2: (A) Boundaries and architectures of the 4 parental promoters, PphaC1, PrrsC, Pj5 and Pg25, used in this study. (B) 
Comparison of the 4 parental promoters to an Escherichia coli 70 promoter. (C) Activities of the 4 parental promoters. 
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3.2.3 Narrow range of promoter activities between the 4 parental promoters 
Fluorescence measurement of RFP expression revealed a narrow range of promoter 
activities (defined as relative fluorescence unit normalized by optical density; see Methods 
& Materials) between the 4 parental promoters (Figure 3.2C). The ratio of promoter 
activities between the strongest (Pg25) and the weakest (PphaC1) is only 6.3. The promoter 
activity of PrrsC is 1.7-fold higher than that of PphaC1. This difference may be attributed to 
the synthetic RBS in PrrsC being more effective in promoting translation compared to the 
native RBS in PphaC1. The coliphage T5 promoters, Pj5 (75 bp) and Pg25 (75 bp), are much 
shorter in length compared to PphaC1 (466 bp) and PrrsC (241 bp). They have previously been 
reported as some of the strongest constitutive promoters in E. coli (Gentz and Bujard, 1985). 
The strong transcriptional activity was also verified in R. eutropha H16 (Gruber et al., 
2014). The A/T rich sequence of many coliphage T5 promoters, particularly in their 
upstream elements, has been implicated in accounting for their high transcriptional activity 
(Gentz and Bujard, 1985). Indeed, the upstream elements of both Pj5 and Pg25 promoters 
show high A/T contents (65% for Pj5 and 85% for Pg25), and the difference in the A/T 
content may partly be responsible for the higher activity of Pg25 relative to Pj5 (Figure 3.2B). 
In addition, Pg25 possesses within its 5’-UTR the purine-rich 5-bp SD sequence used in 
most commercially available pET and pBAD vectors, which is lacking in Pj5 (Figure 3.2A). 
This initial examination highlighted two critical points which guided our subsequent 
promoter engineering: (1) conservation of -35 and -10 boxes is important for maintaining 
high transcriptional activity in R. eutropha H16, (2) promoter length or A/T content or cis-
acting genetic regulatory element (such as a synthetic RBS) could potentially influence 
promoter activity in R. eutropha H16 significantly.  
 
3.2.4 Expanding the range of promoter activities through rational engineering 
Informed by our understanding of the 4 ‘standard” promoters, we proceed to increase the 
range of promoter activities beyond the existing 6.3 folds between PphaC1, PrrsC, Pj5 and Pg25. 
Our objectives are 3-fold: (1) creating both weaker (‘tuning down’) and stronger (‘tuning 
up’) promoter variants to further expand the promoter activity range, (2) generating 
promoter variants that exceed or at least cover the entire L-arabinose inducible range of 
PBAD promoter, and (3) developing a set of promoters with gradual increase in activity (i.e., 
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having promoters with activities evenly distributed across the entire promoter activity 
scale). 
 
To this end, we applied a range of rational engineering approaches. These strategies, 
summarized in Table S4.1 and Figure S4.3, can be loosely classified into 5 categories: (A) 
point mutation, (B) length alteration, (C) incorporation of regulatory genetic element, (D) 
promoter hybridization and (E) configuration alteration. Category A, point mutation, 
includes base substitution, single-base insertion and single-base deletion. Category B, 
length alteration, refers to truncation or extension of a promoter from either terminus and 
insertion or deletion of a stretch of random DNA sequence. Incorporating cis-acting 
translational regulatory elements such as T7 stem-loop and RBS are grouped within 
category C. Category D, promoter hybridization, encompasses both creating hybrid 
promoters and incorporating cis-acting transcriptional regulatory element such as an 
operator. Category E, configuration alteration, involves transcriptional amplification using 
a secondary promoter that is placed in divergent configuration to a primary promoter. In 
other words, composite promoters are placed in category E. Each category is further 
divided into sub-categories (e.g., C1 for T7 stem-loop and C2 for RBS in Category C) and 
sub-sub-categories (e.g., B1a for truncation of 25 bp upstream of -35 box and B1b for 
truncation of 50 bp upstream of -35 box in Category B) to pinpoint specific modification 
made. Using a combination of the aforementioned strategies, we created in total 38 
promoter variants as summarized in Table 3.1. 
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Figure 3.3: Architectures of parental promoters and their engineered variants. 
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Figure 3.4: Activities of parental promoters and their engineered variants. 
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17 bp fapO unit 
PrrsC[D6]  
PrrsC[D4]  TTGCCA TAATATT CGCCCCCTCGC TTTAAGAAGGAGATATACAT 
-35 -10 17 bp fapO unit RBS 
TTAGTACCTGATACTAA 
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Table 3.1: Summary of 42 parental promoters and their variants engineered using a combination of promoter engineering strategies (A = 
point mutation, B = length alteration, C = incorporation of regulatory genetic element, D = promoter hybridization and E = configuration 
alteration). Numbers in bracket represent promoter digital identifier, in the format of [Activity level – Relative activity to PphaC1[A1] – 
Promoter length]. 
Parental 
promoter 
A B C D 
E 
Transcriptional amplifier (Secondary promoter) 
PphaC1 Pg25 Pj5[A1C1C2] 
PphaC1 
[1-6-466] 
 
PphaC1[A1] 
[1-1-466] 
 
PphaC1[B1a]  
[1-8-441] 
 
 
    
PphaC1[B1b]  
[1-10-416] 
PphaC1[B1c]  
[1-6-366] 
PphaC1[B1d]  
[1-12-342] 
PrrsC 
[1-11-241] 
 
 
 
 
 
 
 
PrrsC[E1]  
[2-34-713] 
 
PrrsC[E3]  
[1-22-434] 
PrrsC[D6]  
[1-1-258] 
PrrsC[E1D6]  
[2-31-730] 
PrrsC[E3D6]  
[1-21-451] 
PrrsC[D4]  
[1-1-241] 
PrrsC[E1D4]  
[1-14-713] 
PrrsC[E3D4]   
[1-9-434] 
Table continues below 
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Parental 
promoter 
A B C D 
E 
Transcriptional amplifier (Secondary promoter) 
PphaC1 PphaC1 PphaC1 
Pj5 
[1-25-75] 
 
  
Pj5[C1]  
[1-26-136] 
   
 
Pj5[C1C2]  
[4-91-162] 
 
Pj5[E1C1C2]  
[5-120-634] 
Pj5[E2C1C2]  
[4-106-268] 
Pj5[A1C1C2]  
[3-64-162] 
 
Pj5[E1A1C1C2]  
[4-104-634] 
Pj5[E2A1C1C2]  
[4-84-268] 
Pj5[A1D6aC1C2]  
[3-70-179] 
 
Pj5[E1A1D6aC1C2]  
[4-112-651] 
Pj5[E2A1D6aC1C2]  
[4-90-285] 
Pj5[A1D6bC1C2]   
[3-68-196] 
 
Pj5[E1A1D6bC1C2]  
[4-111-668] 
Pj5[E2A1D6bC1C2]  
[4-87-302] 
Pj5[C2]  
[5-117-101] 
 
Pj5[E1C2]  
[5-134-573] 
Pj5[E2C2]  
[5-125-207] 
Pj5[A3C2]  
[5-116-100] 
Pj5[E1A3C2]  
[5-137-572] 
Pj5[E2A3C2]  
[5-128-206] 
Pg25 
[2-39-75] 
 
  
  
Pg25[E1]  
[3-61-547] 
Pg25[E2]  
[2-46-181] 
Pg25[E3]  
[2-45-268] 
 
Pg25[D1]  
[2-53-130] 
   
Pg25[C2]  
[2-57-101] 
 
Pg25[D1C2]  
[3-75-156] 
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3.2.5 Promoter nomenclature  
Based on the classification of our promoter engineering strategies, we devised a promoter 
nomenclature system to systematically name all 38 engineered promoters (Table 3.1). The 
system is designed to provide 3 pieces of key information: parental promoter, modifications 
made and promoter architecture, using the standard format of Pparent[M1M2M3…]. In this 
nomenclature system, capital P signifies a promoter. Italic subscript parent indicates the 
parental promoter from which the engineered promoter is derived. All modifications made 
are summarized in bracketed subscript [M1M2M3…], with the modifications arranged in 
sequence of appearance to reflect the engineered promoter architecture. As an example, 
Pj5[C1C2] is a promoter variant engineered from the parental promoter Pj5 by inserting a T7-
stem loop (denoted by C1) as well as an RBS (denoted by C2) in its 5’-UTR. The T7-stem 
loop was placed upstream of the RBS, as indicated by C1 that comes before C2. 
 
3.2.6 Mutations in -35 box tuned transcriptional activity down 
Li and Liao previously reported PphaC1-G3 promoter, in which its -35 box was mutated from 
“TTGACA” to “TTCGGC” (Figure 4.3A) (Li and Liao, 2015). This promoter variant was 
shown to retain 15% of the activity of its PphaC1 parent, when characterized using enhanced 
green fluorescent protein (eGFP) as a reporter (Li and Liao, 2015). To validate our initial 
hypothesis that conserved -35 and -10 boxes are necessary in maintaining high 
transcriptional activity in R. eutropha H16, we recreated PphaC1-G3 and this variant was 
named PphaC1[A1] in our nomenclature system. RFP fluorescence measurement ascertained 
that PphaC1[A1] retains 16% of the activity of PphaC1 (Figure 3.4B). This data also indicated 
that both reporter proteins, RFP and eGFP, give similar outcome in transcriptional activity 
quantification. RFP and eGFP are commonly used in synthetic biology for characterization 
of biological parts (e.g., promoter, terminator) (Guo et al., 2015, Phelan et al., 2017). Li and 
Liao also created a promoter library with mutated -35 box (TTNNNN). All promoter 
variants screened showed lower activity in comparison to the wild type promoter (Li and 
Liao, 2015). Therefore, mutations in -35 box likely tune the transcriptional activity down. 
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Figure 3.5: (A) For gene pairs in HH arrangement, promoters that effect divergent 
transcription can be organized in 3 possible ways: back-to-back, overlapping or face-to-face. 
(B) Composite promoters engineered using Pg25 as parental promoter. (C) Composite 
promoters engineered using PrrsC as parental promoter. (D) Composite promoters 
engineered using Pj5 as parental promoter. (E) Composite promoters with PphaC1 as 
secondary promoter. (F) Composite promoters with Pg25 as secondary promoter. (G) 
Composite promoters with Pj5[A1C1C2] as secondary promoter. In graphs E to G, red, blue 
and orange symbols represent primary promoter activity, composite promoter activity and 
fold change, respectively.   
 
3.2.7 A minimal PphaC1 promoter with enhanced activity 
PphaC1 (466 bp) is the longest promoter among the 4 parental promoters. To find the 
minimal functional sequence, we created 5’3’ truncated variants of PphaC1: 25 bp 
truncation in PphaC1[B1a], 50 bp in PphaC1[B1b], 100 bp in PphaC1[B1c], and 124 bp in PphaC1[B1d] 
(Figure 3.3). Interestingly, removing the entire upstream element (124 bp) in PphaC1[B1d] 
resulted in highest promoter activity, which is 2-fold higher compared to that of its PphaC1 
parent (Figure 3.4). This suggested that cis-acting elements exist within the upstream 
element of PphaC1 and contribute to transcriptional suppression. 
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3.2.8 Synthetic RBS and RBS repeat increased promoter activity 
Our initial study with the 4 parental promoters, along with a previous study conducted by 
Bi et al. (2013) motivated us to further investigate the effects of cis-acting translational 
regulatory elements on promoter activity. We focused specifically on the 26-bp synthetic 
genetic element derived from PrrsC (containing a 20-bp RBS found in the pBBR1c-RFP 
PBAD promoter flanked by an upstream 6-bp BglII restriction site; herein denoted as 
synthetic RBS) and the 37-bp T7 stem-loop reported by Bi et al. (2013). We observed a 
4.7-fold increase in promoter activity when a synthetic RBS was added to Pj5 (the Pj5[C2] 
variant) (Figure 3.4). On the contrary, there was no significant change in promoter activity 
when a T7 stem-loop was added to Pj5 (the Pj5[C1] variant). A drop in promoter activity was 
observed when a T7 stem-loop was added to Pj5[C2] (the Pj5[C1C2] variant). As such, synthetic 
RBS is an effective means to amplify promoter activity. We then added the same synthetic 
RBS to Pg25 and created a variant Pg25[C2] that also showed ~50% increase in promoter 
activity. A smaller promoter activity increase in Pg25[C2] could be attributed to a pre-existing 
effective SD sequence (“AGGAG”) in Pg25. 
 
3.2.9 Repeat of -35 and -10 boxes increased transcriptional activity 
-35 and -10 boxes are highly conserved regions in prokaryotic promoters, essential for the 
binding of RNA polymerases. To test if creating more binding sites for RNA polymerase 
would further increase transcriptional activity, we created Pg25[D1] variant. In this variant, 
we duplicated the DNA sequence spanning -35 box and -10 box. In essence, this hybrid 
promoter is a tandem repeat of two Pg25 promoters and we observed ~40% increase in 
promoter activity (Figure 3.3 & 3.4). Again, incorporating a synthetic RBS (Pg25[D1C2]) gave 
an additive effect, resulting in further increase in promoter activity. 
 
3.2.10 Operator insertion reduced transcriptional activity drastically 
Hybrid promoters are crucial genetic elements in the construction of biosensors. Using a 
malonyl-CoA biosensor (Johnson et al., 2017) as an example, we inserted the fapO operator 
sequence “TTAGTACCTGATACTAA” in PrrsC promoter to create two variants: PrrsC[D4] 
(fapO inserted between -35 and -10 boxes) and PrrsC[D6] (fapO inserted within the 5’-UTR) 
(Figure 3.3). fapO operator is conserved in Gram-positive bacteria such as Bacillus subtilis 
and acts as a cis-regulatory unit for transcriptional regulation of fatty acid biosynthesis. For 
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both promoter variants, we observed a drastic activity reduction to ~10% of their PrrsC 
parent (Figure 3.4). The position of operator and the copy number of operator could 
therefore significantly change the transcriptional activity of the resultant hybrid promoters. 
Our data corroborated a previous study by Li and Liao, where tetO operators were inserted 
to create PrrsC hybrid promoters (Li and Liao, 2015). 
 
3.2.11 Divergent promoters, arranged in back-to-back, increased transcriptional 
activity  
The distance between and the relative transcriptional directions of adjacent genes are 
known to be important in some organisms. Neighbouring genes arranged in head-to-head 
(HH) orientation, for instance, could be co-regulated and this has been proven 
experimentally (Gherman et al., 2009). For gene pairs in HH arrangement, promoters that 
effect divergent transcription can be organized in 3 possible ways: back-to-back, 
overlapping or face-to-face (Figure 3.5) (Beck and Warren, 1988). In a recent attempt to 
construct a malonyl-CoA biosensor for R. eutropha H16 (publication in preparation), we 
discovered the significance of divergent transcription in this organism. Therefore, we 
created 21 composite promoters to systematically investigate divergent transcription in R. 
eutropha H16. Each composite promoter is made up of two promoters arranged in back-to-
back (or divergent to each other). The promoter driving the RFP expression is termed the 
primary promoter, while the counterpart is called the secondary promoter. 
 
When PphaC1 (denoted as modification E1), Pg25 (modification E2) and Pj5[A1C1C2] 
(modification E3) was applied individually as secondary promoters, they generally served as 
transcriptional amplifiers, increasing the transcriptional activity of the primary promoters 
(Figures 3.5B-G). The promoter activities of these three secondary promoters follow the 
order of Pj5[A1C1C2] > Pg25 > PphaC1 (eq. E3 > E2 > E1). Interestingly, transcriptional 
amplification depends on the transcriptional activities of both the primary and the 
secondary promoters. For the same primary promoter, activity enhancement typically 
decreases with the increased activity of the secondary promoter (Figures 3.5B-D; herein 
described as secondary promoter effect). 
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Also, for the same secondary promoter, activity enhancement decreases with the increased 
activity of the primary promoter (Figures 3.5E-G; herein described as primary promoter 
effect). We postulate that secondary promoter effect is attributed to the fact that weaker 
secondary promoter competes less with the primary promoter for transcriptional machinery 
or factors. If a secondary promoter of very high activity is used, the competition is so strong 
that it diminishes the activity of the primary promoter (data not shown). The primary 
promoter effect observed is perhaps more intuitive and easier to comprehend. If the primary 
promoter displays high activity, it is more difficult to further improve its activity using an 
amplifier. Important to point out, transcriptional enhancement resulted from divergent 
promoters is not universal to all prokaryotic systems. Generally, we did not observe such 
behaviours when we tested our composite promoters in E. coli (data not shown). 
 
3.2.12 Promoter characterization using PBAD as reference scale  
This study resulted in a set of 42 constitutive promoters, including the 4 parental promoters. 
The ratio of promoter activities between the strongest (Pj5[E1A3C2]) and the weakest 
(PphaC1[A1], eq. PphaC1-G3 reported by Li and Liao (Li and Liao, 2015)) is 137. These 
promoters showed gradual increase in activity across the entire scale (Figure 3.6A). To 
promote the widespread use of these promoters, we benchmarked each of them using L-
arabinose inducible PBAD promoter as a reference scale. Figure S3.4 illustrates the dose-
dependent induction of PBAD promoter, using L-arabinose concentration from 0.001% (w/v) 
to 0.200% (w/v). Expression maxima was reached at 0.200% (w/v) L-arabinose. As 
depicted in Figure 3.6B, our engineered promoters covered the entire L-arabinose inducible 
range (indicated by scattered data points). We categorized all promoters into 5 activity 
levels to aid promoter selection: Level 1 (with promoter activity between 0 a.u. – 2000 a.u.), 
Level 2 (2000 a.u. – 4000 a.u.), Level 3 (4000 a.u. - 6000 a.u.), Level 4 (6000 a.u. – 8000 
a.u.) and Level 5 (> 8000 a.u.). With a PBAD promoter, one could only achieve expression 
levels between 1 – 4. Through promoter engineering, we obtained seven Level 5 variants 
(Pj5[A3C2], Pj5[C2], Pj5[E1C1C2], Pj5[E2C2], Pj5[E2A3C2], Pj5[E1C2] and Pj5[E1A3C2]) with promoter 
activities exceeding that of PBAD (Table S3.2). For easy classification of all engineered 
promoters, we developed a numerical coding system (Table 3.1) and assigned a digital 
identifier to each promoter. This will allow us to develop a R. eutropha H16-specific 
promoter database (work in progress). Each promoter code is in the format of [X-Y-Z], 
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with X representing activity level, Y representing relative activity to PphaC1[A1] and Z 
representing promoter length. While conceptualizing our engineered promoter 
nomenclature and coding systems, we have endeavoured to make them universal such that 
they can be applied to other promoters yet to be developed. 
 
 
Figure 3.6: (A) Hierarchical ranking of all 42 constitutive promoters reported in this study. 
(B) The range of promoter activity was expanded from 6 folds to 137 folds, after applying 
combination of promoter engineering strategies. 
(A = point mutation, B = length alteration, C = incorporation of regulatory genetic element, 
D = promoter hybridization and E = configuration alteration). Promoters derived from 
PphaC1, PrrsC, Pj5 and Pg25 were coloured in blue, green, pink and red, respectively. Promoters 
were categorized into 5 activity levels: Level 1 (with promoter activity between 0 a.u. – 
2000 a.u.), Level 2 (2000 a.u. – 4000 a.u.), Level 3 (4000 a.u. - 6000 a.u.), Level 4 (6000 
a.u. – 8000 a.u.) and Level 5 (> 8000 a.u.). Each promoter was benchmarked against PBAD 
promoter, induced using various concentrations of L-arabinose, from 0.001% (w/v) to 
0.200% (w/v).  
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3.2.13 Summary of rational promoter engineering for R. eutropha H16  
Figure 3.7 provides an overview of the rational promoter engineering strategies discussed 
in this article. It shows the effect of a specific modification by looking at the promoter 
activity difference before and after that particular modification. Creating mutation(s) within 
-35 box and inserting operator sequence(s) resulted in drastic reduction in promoter activity 
(represented by red data points), while inserting a T7 stem-loop caused almost no change in 
promoter activity. On the contrary, inserting a synthetic RBS and applying a transcriptional 
amplifier (specifically PphaC1 or Pj5[A1C1C2]) gave the highest increase in promoter activity 
(>100%). In fact, those promoters that are stronger than PBAD promoter (indicated as blue 
data points) were mostly created using either one of these strategies or combination of them. 
All the other strategies provided marginal promoter activity increase (from 10% to 50%). 
Also clearly reflected in Figure 3.6B, creating divergent promoters is the most effective 
way of broadening the range of promoter activity. Worthy of note, relative promoter 
activity change is dependent on the parental promoter, judging on the work presented in 
this article. 
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Figure 3.7: Relative promoter activity change upon application of promoter engineering 
strategies. 
(A = point mutation, B = length alteration, C = incorporation of regulatory genetic element, 
D = promoter hybridization and E = configuration alteration). Modifications that resulted in 
loss of promoter activity were indicated as red data points. Promoters with activities higher 
than PBAD promoter were indicated as blue data points. 
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3.2.14 The use of engineered constitutive promoters in R. eutropha H16 
The use of strong constitutive promoters could potentially result in (a) bacterial growth 
impairment due to high metabolic burden and/or (b) protein excretion/leakage due to high 
protein expression level. To study these effects, we selected representative promoters from 
each activity level (Table S3.3) and conducted further characterization. We observed 
similar growth for most of the strains (Figure 3.8), with growth rates (max) falling between 
0.21 h-1 and 0.24 h-1 (Table S4.3). For promoter Pj5[E2C2], which is a Level 5 promoter, we 
noticed a slight drop in growth rate with max of 0.18 h-1 (Table S3.3). Comparing 
fluorescence of cell culture and of spent medium (Figure 3.9) confirmed that there was no 
protein excretion/leakage. Fluorescence of spent medium was maintained at the level of 
~1000 a.u, throughout the bacterial cultivation. This value was almost identical to that of 
the control (R. eutropha H16 harbouring pBBR1MCS-1). To study the time-dependent 
increase in fluorescence signal, we fitted the cell culture fluorescence vs time data to a 4-
parameter dose-response curve (Figure S3.5 and Table S3.4) for all promoters from Level 2 
and above. The fluorescence increase was mainly caused by bacterial growth. If we divided 
the fluorescence measured (Figure 3.9) by the OD600 (Figure 3.8), the ratio was kept almost 
constant at cultivation times above 12 h (Figure S3.6), further verifying our approach in 
promoter activity quantification in 96-well plate by taking the RFU/OD600 at t = 48 h. 
 
 
 
Figure 3.8: Growth curves of R. eutropha H16 harbouring either pBBR1MCS-1 (control; 
black line) or plasmids containing various engineered constitutive promoters [Pg25 (red line), 
PphaC1[B1d] (blue line), PrrsC[E1D4] (brown line), Pg25[E3] (green line), Pg25[D1C2] (pink line), 
Pj5[E1A1C1C2] (orange line) and Pj5[E2C2] (purple line)]. 
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Figure 3.9: Fluorescence of cell culture (black columns) and of spent medium (grey 
columns) of R. eutropha H16 harbouring either pBBR1MCS-1 (control) or plasmids 
containing various engineered constitutive promoters (Pg25, PphaC1[B1d], PrrsC[E1D4], Pg25[E3], 
Pg25[D1C2], Pj5[E1A1C1C2] and Pj5[E2C2]). 
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3.3 CONCLUSION 
This article (1) reported and characterized a set of 42 constitutive promoters with a broad 
range of promoter activity, which are derived from the 4 most widely used constitutive 
promoters for R. eutropha H16 (PphaC1, PrrsC, Pj5 and Pg25), (2) introduced a nomenclature 
system and a coding system for engineered promoters, (3) sketched out the relationship 
between promoter architecture and its resultant activity, (4) highlighted similarities 
(conservation of -35 and -10 boxes) and differences (composite promoters) in 
transcriptional activity between R. eutropha H16 and E. coli, and (5) provided guidelines 
for rational promoter engineering. We strongly believe our constitutive promoter toolbox 
that exceeds the activity range of the inducible PBAD promoter will serve the biotechnology 
community working on R. eutropha H16, be it strain engineering for industrial 
biomanufacturing or developing advanced molecular biology tools for this organism. 
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3.4 MATERIALS & METHODS 
3.4.1 Materials 
All DNA modifying enzymes were purchased from either New England Biolabs (Hitchin, 
UK) or Agilent (Craven Arms, UK). Nucleic acid purification kits were purchased from 
Qiagen (Manchester, UK). All oligonucleotides were synthesized by Eurofins (Ebersberg, 
Germany).  
3.4.2 Strains 
Escherichia coli DH5 was used for all molecular cloning, plasmid propagation and 
maintenance. Ralstonia eutropha H16 (DSM-428, purchased from DSMZ, Braunschweig, 
Germany) was used for all experiments described in this article. 
3.4.3 Bacterial cultivation and transformation 
R. eutropha H16 was cultivated at 30C in nutrient broth (NB: 5 g/L peptone, 1 g/L beef 
extract, 2 g/L yeast extract, 5 g/L NaCl; pH 7.0  0.2 @ 25C) supplemented with 10 
g/mL of gentamicin. Cells were transformed with plasmids using the electroporation 
protocol described by Tee et al. (2017) plated on NB agar supplemented with 10 g/mL of 
gentamicin and 25 g/mL of chloramphenicol, and incubated at 30C for 40–60 h. E. coli 
DH5 was transformed with plasmids using the standard CaCl2 method, plated on TYE 
agar (10 g/L tryptone, 5 g/L yeast extract, 8 g/L NaCl, 15 g/L agar) supplemented with 25 
g/mL of chloramphenicol and incubated overnight at 37C. 
3.4.4 Promoter engineering and sequences 
All plasmids were derived from pBBR1c-RFP (see Supplementary Information) and 
constructed using standard molecular biology techniques. All engineered promoters were 
verified by restrictive analysis and/or DNA sequencing and their sequences were provided 
in the Supplementary Information. 
3.4.5 Promoter activity quantification using fluorescence assay 
Transformants of R. eutropha H16, carrying either an RFP-null or an RFP-expressing 
vector, were pre-cultured in 96-well microtitre plate containing 200 L/well of NB 
supplemented with 10 g/mL of gentamicin and 25 g/mL of chloramphenicol at 30C for 
40 h. This pre-culture was used to inoculate a fresh clear-bottom 96-well microtitre plate 
[Greiner Bio-One (Stonehouse, UK)] containing 200 L/well of NB supplemented with 10 
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g/mL of gentamicin, 25 g/mL of chloramphenicol as well as 0–0.2% (w/v) L-arabinose 
(when required) to induce RFP expression. The plate was cultivated at 30C for a total of 
48 h. OD600 and fluorescence (Ex 584 nm, Em 607 nm; bottom read) were measured using 
SpectraMax M2e microplate/cuvette reader [Molecular Devices (Wokingham, UK)] after 
12 h of cultivation and repeated at 6 h intervals. Relative fluorescence unit (RFU) was 
calculated by normalizing fluorescence value with the fluorescence value of R. eutropha 
H16 carrying an RFP-null vector (negative control). The RFU value therefore represents 
the fluorescence fold increase owing to RFP expression. RFU/OD600 value was then 
calculated as the ratio of RFU and OD600 value of the respective strain. The ratio was used 
to account for potential metabolic burden due to high protein expression level, affecting 
bacterial growth. Promoter activity (PA) was defined as the RFU/OD600 value after 48 h of 
cultivation. The ratio of RFU/OD600 was more or less a constant at cultivation time more 
than 12 h.  All experiments were done in triplicate. 
3.4.6 Effects of engineered constitutive promoters on bacterial growth and protein 
excretion 
Selected plasmids were freshly transformed into R. eutropha H16 and single colonies were 
picked to prepare overnight cultures. Falcon tubes, containing 6 mL of fresh mineral salts 
medium (MSM) (Schlegel et al., 1961) supplemented with 10 g/L sodium gluconate 
(carbon source), 10 g/mL gentamicin and 25 g/mL chloramphenicol, were inoculated at 
a starting OD600 of 0.2. Cells were cultivated at 30C and sampled at regular time intervals. 
OD600 of each sample was measured using BioPhotometer Plus [Eppendorf (Stevenage, 
UK)]. For all samples collected, the fluorescence (Ex 584 nm, Em 607 nm; bottom read) of 
the cell culture (90 L) and of the spent medium (90 L) was measured using SpectraMax 
M2e microplate/cuvette reader [Molecular Devices (Wokingham, UK)]. 
3.4.7 Fold change and relative promoter activity change 
Fold change and relative promoter activity change were calculated using the formulae 
below: 
𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 =  
𝑃𝐴2
𝑃𝐴1
 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑝𝑟𝑜𝑚𝑜𝑡𝑒𝑟 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑐ℎ𝑎𝑛𝑔𝑒 =  
|𝑃𝐴𝑎𝑓𝑡𝑒𝑟 − 𝑃𝐴𝑏𝑒𝑓𝑜𝑟𝑒|
𝑃𝐴𝑏𝑒𝑓𝑜𝑟𝑒
 ×  100% 
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The cell culture fluorescence versus time data was according to the 4-parameter dose-
response model: 
𝐸𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝐹𝑙𝑜𝑢𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 = 𝐵𝑜𝑡𝑡𝑜𝑚 + (𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚)/[1 + (
𝑇50
𝑇𝑖𝑚𝑒
)Hillscope] 
 
3.5 SUPPLEMENTARY INFORMATION 
 
3.5.1 Materials & Methods 
3.5.1.1 Construction of pBBR1c-RFP 
pBBR1c-RFP plasmid (6733 bp; Figure S1) was constructed from both the broad-host-
range plasmid pBBR1MCS1 (Kovach et al., 1994) and the pBbA8k-RFP (Lee et al., 2011) 
that carries an rfp gene whose expression is driven by an L-arabinose-inducible promoter 
system (PBAD and araC). A 4.3-kb fragment containing the chloramphenicol resistance 
cassette, the mob gene which enables plasmid mobilization and the BBR1 origin of 
replication was amplified from pBBR1MCS and digested with restriction enzymes AvrII 
and PstI. A 2.4-kb fragment containing the rfp gene and its promoter system (PBAD and 
araC) was excised from pBbA8k-RFP using restriction enzymes AvrII and PstI. Both 
fragments were subsequently ligated to form the 6.7-kb pBBR1c-RFP plasmid.  
3.5.1.2 Reporter plasmids harbouring either a parental or an engineered constitutive 
promoter 
All reporter plasmids harbouring either a parental or an engineered constitutive promoter 
were constructed from pBBR1c-RFP (Figure S4.1), by replacing the L-arabinose-inducible 
promoter system (PBAD and araC) with the respective promoter (see Promoter List).   
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Figure S3.1: Plasmid map of pBBR1c-RFP 
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Figure S3.2: Alignment of Pj5 and Pg25 promoters used in Gruber et al. (2014) and those 
used in this study. 
 
 
 
Figure S3.3: Rational promoter engineering strategies applied in this study. (A) Point 
mutation. (B) Length alteration. (C) Incorporation of regulatory genetic element. (D) 
Promoter hybridization. (E) Configuration alteration. 
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Figure S3.4: Dose-dependent induction of PBAD promoter, using L-arabinose concentration 
from 0.001% (w/v) to 0.200% (w/v). 
 
 
0.00 0.05 0.10 0.15 0.20
0
2000
4000
6000
8000
L-arabinose concentration [% (w/v)]
R
F
U
/O
D
6
0
0
 [
a
.u
.]
 153 
Figure S3.5: Fitting of cell culture fluorescence vs time data (scattered points) to a 4-
parameter dose response curve (red line). 
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Figure S3.6: Fluorescence of cell culture (Figure S3.5) normalized by OD600 value 
(Figure 3.8). 
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3.5.1.3 Promoter list 
 
Colour code 
Colour Genetic element 
Dark orange Upstream element 
Red -35 box 
Purple -10 box 
Light pink Spacer between the -35 and -10 boxes 
Green 5’-untranslated region 
Green (upper case) TRANSCRIPTIONAL START 
Light brown Synthetic or native ribosome binding site 
Dark blue fapO sequence 
Grey T7 stem-loop 
Black Region between -10 box and transcriptional start 
Cyan (underlined) Spacer between the Pphac1-based secondary promoter and its 
primary promoter 
Cyan Spacer between the Pj5[A1C1C2]-based secondary promoter or the 
Pg25-based secondary promoter and its primary promoter 
 
PphaC1 
caatggccacgatgtacatcaaaaattcatccttctcgcctatgctctggggcctcggcagatgcgagcgctgcataccgtcc
ggtaggtcgggaagcgtgcagtgccgaggcggattcccgcattgacagcgcgtgcgttgcaaggcaacaatggactCaa
atgtctcggaatcgctgacgattcccaggtttctccggcaagcatagcgcatggcgtctccatgcgagaatgtcgcgcttgcc
ggataaaaggggagccgctatcggaatggacgcaagccacggccgcagcaggtgcggtcgagggcttccagccagttcc
agggcagatgtgccggcagaccctcccgctttgggggaggcgcaagccgggtccattcggatagcatctccccatgcaaa
gtgccggccagggcaatgcccggagccggttcgaatagtgacggcagagagacaatcaaatc 
 
PphaC1[A1] 
caatggccacgatgtacatcaaaaattcatccttctcgcctatgctctggggcctcggcagatgcgagcgctgcataccgtcc
ggtaggtcgggaagcgtgcagtgccgaggcggattcccgcattcggcgcgcgtgcgttgcaaggcaacaatggactCaa
atgtctcggaatcgctgacgattcccaggtttctccggcaagcatagcgcatggcgtctccatgcgagaatgtcgcgcttgcc
ggataaaaggggagccgctatcggaatggacgcaagccacggccgcagcaggtgcggtcgagggcttccagccagttcc
agggcagatgtgccggcagaccctcccgctttgggggaggcgcaagccgggtccattcggatagcatctccccatgcaaa
gtgccggccagggcaatgcccggagccggttcgaatagtgacggcagagagacaatcaaatc 
  
PrrsC 
ccttcaactgctctgcttggcattcgacgtctatatataaagaggacgtctcgggttgggccgacgcccacggtctcagctta
agccgaggcgccgctggatgctgtcaccaccgcgacatttgagcctcgtgcgccgcttttacggggggttcgaattatttcgc
gaaatcgcttgccagtcggtcctgcgtcccttaatattcgccccCtcgcagatcttttaagaaggagatatacat 
 
PrrsC[D6]  
ccttcaactgctctgcttggcattcgacgtctatatataaagaggacgtctcgggttgggccgacgcccacggtctcagctta
agccgaggcgccgctggatgctgtcaccaccgcgacatttgagcctcgtgcgccgcttttacggggggttcgaattatttcgc
gaaatcgcttgccagtcggtcctgcgtcccttaatattcgccccCtcgcttagtacctgatactaaagatcttttaagaagga
gatatacat 
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PrrsC[D4]  
ccttcaactgctctgcttggcattcgacgtctatatataaagaggacgtctcgggttgggccgacgcccacggtctcagctta
agccgaggcgccgctggatgctgtcaccaccgcgacatttgagcctcgtgcgccgcttttacggggggttcgaattatttcgc
gaaatcgcttgccattagtacctgatactaataatattcgccccCtcgcagatcttttaagaaggagatatacat 
 
Pj5 
agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtAaacctaatggatcgacctt 
 
Pj5[C2]  
agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtAaacctaatggatcgaccttagatctt
ttaagaaggagatatacat 
 
Pj5[A3C2]  
agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtAaacctaatggatcgacctagatcttt
taagaaggagatatacat 
 
Pj5[C1]  
agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtAaacctaatggatcgaccttgaattca
aaagatctgggagaccacaacggtttccctctagaaataattttggaattcaaa 
 
Pj5[C1C2]  
agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtAaacctaatggatcgaccttgaattca
aaagatctgggagaccacaacggtttccctctagaaataattttggaattcaaaagatcttttaagaaggagatatacat 
 
Pj5[A1C1C2]  
agcggatataaaaaccgttattgacacaggtggaaatttaaaatatactgttagtAaacctaatggatcgaccttgaattca
aaagatctgggagaccacaacggtttccctctagaaataattttggaattcaaaagatcttttaagaaggagatatacat 
 
Pj5[A1D6aC1C2] 
agcggatataaaaaccgttattgacacaggtggaaatttaaaatatactgttagtAaacctaatggatcgaccttttagtac
ctgatactaagaattcaaaagatctgggagaccacaacggtttccctctagaaataattttggaattcaaaagatcttttaag
aaggagatatacat 
 
Pj5[A1D6bC1C2] 
agcggatataaaaaccgttattgacacaggtggaaatttaaaatatactgttagtAaacctaatggatcgaccttttagtac
ctgatactaattagtacctgatactaagaattcaaaagatctgggagaccacaacggtttccctctagaaataattttggaat
tcaaaagatcttttaagaaggagatatacat 
 
Pg25 
tatggaaaaataaaaatttcttgataaaattttccaatactattataatattgttAttaaagaggagaaattaac 
 
Pg25[C2]  
tatggaaaaataaaaatttcttgataaaattttccaatactattataatattgttAttaaagaggagaaattaacagatctttt
aagaaggagatatacat 
 
Pg25[D1]  
tatggaaaaataaaaatttcttgataaaattttccaatactattataatattgtttatggaaaaataaaaatttcttgataaaat
tttccaatactattataatattgttAttaaagaggagaaattaac 
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Pg25[D1C2]  
tatggaaaaataaaaatttcttgataaaattttccaatactattataatattgtttatggaaaaataaaaatttcttgataaaat
tttccaatactattataatattgttAttaaagaggagaaattaacagatcttttaagaaggagatatacat 
 
Spacer between the PphaC1-based secondary promoter and its primary promoter 
ctgcag 
 
Spacer between the Pj5[A1C1C2]-based secondary promoter or Pg25-based secondary promoter 
and its primary promoter  
gactcaaggatgctagtgtaagcatctgcag 
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Table S3.1: Promoter engineering strategies. 
Strategy Description 
A Point mutation 
A1 Base substitution 
A2 Base insertion 
A3 Base deletion 
B Length alteration 
B1 Truncation of DNA sequence upstream of -35 box 
B2 Truncation of DNA sequence downstream of +1 transcriptional start 
B3 Extension of DNA sequence upstream of -35 box 
B4 Extension of DNA sequence downstream of +1 transcriptional start 
B5 Deletion of DNA sequence upstream of -35 box 
B6 Deletion of DNA sequence between -35 and -10 boxes 
B7 Deletion of DNA sequence between -10 box and +1 transcriptional start 
B8 Deletion of DNA sequence in the 5'-UTR 
B9 Insertion of DNA sequence upstream of -35 box 
B10 Insertion of DNA sequence between -35 and -10 boxes 
B11 Insertion of DNA sequence between -10 box and +1 transcriptional start 
B12 Insertion of DNA sequence in the 5'-UTR 
C Incorporation of regulatory genetic element 
C1 T7 stem-loop 
C2 Ribosome binding site 
D Promoter hybridization 
D1 Hybrid promoter comprises DNA sequences derived from two identical 
promoters 
D2 Hybrid promoter comprises DNA sequences derived from two different 
promoters 
D3 Incorporating cis-acting transcriptional regulatory element upstream of -35 box 
D4 Incorporating cis-acting transcriptional regulatory element between -35 and -10 
boxes 
D5 Incorporating cis-acting transcriptional regulatory element between -10 box and 
+1 transcriptional start 
D6 Incorporating cis-acting transcriptional regulatory element in the 5'-UTR 
E Configuration alteration 
E1 Placing PphaC1 promoter divergent to the primary promoter 
E2 Placing Pg25 promoter divergent to the primary promoter 
E3 Placing Pj5[A1C1C2] promoter divergent to the primary promoter 
E4 Placing PphaC1[A1] promoter divergent to the primary promoter 
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Table S3.2: A list of all 42 promoters in ascending order of activity  
Promoter Activity ranking Serial number PBAD ranking Level 
PphaC1[A1] 1  1 
0.001 – 
0.006 % (w/v) 
Level One 
PrrsC[D4]  1 2 
PrrsC[D6] 1 3 
PphaC1[B1c]  6 4 
PphaC1 6 5 
PphaC1[B1a] 8 6 
PrrsC[E3D4]  9 7 
PphaC1[B1b] 10 8 
PrrsC 11 9 
PphaC1[B1d] 12 10 
PrrsC[E1D4]  14 11 
PrrsC[E3D6] 21 12 
PrrsC[E3] 22 13 
Pj5 25 14 
Pj5[C1]  26 15 
PrrsC[E1D6]  31 16 
0.006 – 
0.010 % (w/v) 
Level Two 
PrrsC[E1]  34 17 
Pg25 39 18 
Pg25[E3]  45 19 
Pg25[E2]  46 20 
Pg25[D1]  53 21 
Pg25[C2]  57 22 
Pg25[E1]  61 23 
0.010 – 
0.020 % (w/v) 
Level 
Three 
Pj5[A1C1C2]  64 24 
Pj5[A1D6bC1C2]   68 25 
Pj5[A1D6aC1C2]   70 26 
Pg25[D1C2]  75 27 
Pj5[E2A1C1C2]  84 28 
Pj5[E2A1D6bC1C2]  87 29 
0.020 – 
0.200 % (w/v) 
Level Four 
Pj5[E2A1D6aC1C2]  90 30 
Pj5[C1C2]  91 31 
Pj5[E1A1C1C2]  104 32 
Pj5[E2C1C2]  106 33 
Pj5[E1A1D6bC1C2]  111 34 
Pj5[E1A1D6aC1C2] 112 35 
Pj5[A3C2] 116 36 
 Level Five 
Pj5[C2]  117 37 
Pj5[E1C1C2]  120 38 
Pj5[E2C2]  125 39 
Pj5[E2A3C2]  128 40 
Pj5[E1C2]  134 41 
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Pj5[E1A3C2]  137 42 
 
 
Table S3.3: Growth rates of R. eutropha H16 harbouring either pBBR1MCS-1 (control) or 
plasmids containing various engineered constitutive promoters. 
Engineered constitutive 
promoter 
max [h-1] Promoter activity level 
pBBR1MCS-1 (control) 0.2342 N/A 
PphaC1[B1d] 0.2357 1 
PrrsC[E1D4] 0.2120 1 
Pg25 (parental promoter) 0.2194 2 
Pg25[E3] 0.2160 2 
Pg25[D1C2] 0.2269 3 
Pj5[E1A1C1C2] 0.2147 4 
Pj5[E2C2] 0.1796 5 
 
 
Table S3.4: Fitting of cell culture fluorescence vs time data to a 4-parameter  
dose response curve according to the Hill’s equation 
Engineered 
constitutive 
promoter 
Promoter 
activity 
level 
Bottom Hillslope Top T50 R2 
Pg25 (parental 
promoter) 
2 691 5.737 3023 23.01 0.9772 
Pg25[E3] 2 897 5.652 4023 25.69 0.9754 
Pg25[D1C2] 3 926 5.450 6445 24.19 0.9803 
Pj5[E1A1C1C2] 4 982 4.011 10384 24.46 0.9937 
Pj5[E2C2] 5 972 4.428 11569 25.89 0.9971 
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CHAPTER FOUR 
This chapter has been adapted from the manuscript: Johnson, A. O.; Tee, K. L.; Wong, T. 
S., Malonyl-CoA biosensors engineered for Cupriavidus necator H16, Submitted. 2018. 
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4 MALONYL-COA BIOSENSORS ENGINEERED FOR RALSTONIA 
EUTROPHA H16 
 
 
Abstract 
Knallgas bacterium, Ralstonia eutropha H16, has increasingly been used for 
biomanufacturing, owing to the rapid expansion of the synthetic biology toolbox available 
for this microbial host. That being said, transcription factor-based genetic circuit has not 
been applied for detecting, quantifying and regulating metabolite accumulation in R. 
eutropha H16. This is primarily due to chassis-specific complexity in constructing such a 
metabolite-sensing biological device (or a biosensor). In this article, we reported a set of 6 
malonyl-CoA biosensors for R. eutropha H16. These single-plasmid bimodular biosensors 
are designed based upon the naturally existing fatty acid metabolism regulon found in 
Gram-positive bacteria. Using cerulenin as a fatty acid biosynthesis inhibitor, we showed 
that all 6 biosensors were responsive to changes in intracellular malonyl-CoA concentration 
and displayed a high degree of orthogonality. The biosensor performance was optimized 
through careful selection of constitutive promoter combination to give a broad dynamic 
range and sensitivity. We envisage that this biosensor set will propel more advanced 
metabolic engineering of R. eutropha H16 in the near future. 
 
Keywords  
Ralstonia eutropha H16, Cupriavidus necator H16, malonyl-CoA, FapR, cerulenin  
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4.1 INTRODUCTION 
Ralstonia eutropha H16 (or Cupriavidus necator H16) is a non-pathogenic Gram-negative 
bacterium, widely known for its natural ability to accumulate polyhydroxyalkanoate (PHA) 
(Pohlmann et al., 2006). This has informed its use as a microbial host for commercial scale 
production of bio-plastics. Its intrinsic capability to sense, adapt to, assimilate and conserve 
carbon supply from a broad range of carbon sources (Volodina et al., 2016) has also 
expanded its potential industrial applications (Brigham et al., 2012) in the synthesis of 
value-added chemicals, such as polymers (Arikawa and Matsumoto, 2016, Lutke-Eversloh 
and Steinbüchel, 2003, Steinbüchel and Pieper, 1992, Valentin et al., 1995, Voss and 
Steinbuchel, 2006) hydrocarbons of various chain lengths and functional groups (Chen et 
al., 2015, Crépin et al., 2016, Marc et al., 2017, Bi et al., 2013) as well as amino acids 
(Luette et al., 2012). 
 
Engineering R. eutropha for biomanufacturing requires introduction and optimization of a 
heterologous pathway to produce a target chemical from precursor molecule(s). However, 
as is the case in several other microbial cell factories, a synthetic metabolic pathway often 
perturbs the host’s metabolic network and cellular phenotypes, potentially imposing 
metabolic bottlenecks thereby limiting product yield and titre (Keasling, 2012). To work 
around this challenge, metabolic engineers endeavour to achieve a dynamic regulation of 
heterologous pathway to provide a systemic metabolic control over intracellular 
accumulation of precursor metabolite(s) and downstream metabolism into target chemical, 
whilst forging for a win-win between cell viability and product yield (Brockman and 
Prather, 2015, Cress et al., 2015, Holtz and Keasling, 2010, Keasling, 2012, McNerney et 
al., 2015, Nielsen and Keasling, 2016). 
 
Achieving systemic metabolic control requires efficient quantification of intracellular 
concentration and accumulation of precursor metabolite, under defined growth and 
environmental conditions (Dekker and Polizzi, 2017, Johnson et al., 2017, Rogers et al., 
2016, Schallmey et al., 2014, Zhang et al., 2015). Malonyl-CoA is one of the most vital 
precursor metabolites for a myriad of commercially valuable molecules such as fatty acids, 
flavonoids, bio-polymers, bio-fuels and polyketides (Johnson et al., 2017). It is also a rate-
limiting central metabolite in the fatty acid biosynthesis. Conventional analytical 
techniques for malonyl-CoA quantification (e.g., HPLC/MS, HPLC and capillary 
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electrophoresis with UV detection) are laborious. As such, malonyl-CoA-responsive 
biological devices (or biosensors) have been constructed to report intracellular malonyl-
CoA concentration (Johnson et al., 2017). Malonyl-CoA biosensor is a synthetic mimicry 
of the transcriptional regulon of fatty acid biosynthesis found naturally in Gram-positive 
bacteria such as Bacillus subtilis. This regulation is modulated by the interaction between 
transcription factor FapR (Fatty acid and phospholipid Regulator) and its operator fapO. 
FapR represses the fatty acid operon through binding to the 17-bp cis-regulatory fapO 
operator localized within or in proximity to the operon’s promoter. Malonyl-CoA acts as an 
inducer of the FapR regulon by impairing the FapR-fapO interaction. Through replacing the 
fatty acid operon with a gene encoding a reporter protein, for instance a fluorescence 
protein, a biosensor that is transcriptionally regulated by malonyl-CoA is created, where the 
reporter protein activity reflects the intracellular malonyl-CoA concentration. 
 
Dynamic quantification of malonyl-CoA has been widely demonstrated in mammalian cells 
(Ellis and Wolfgang, 2012) and model microbial cell factories (e.g., E. coli and S. 
cerevisiae) (Li et al., 2015, Xu et al., 2014b) using chemical agents such as cerulenin and 
triclosan, known to block the fatty acid biosynthesis thereby inducing intracellular 
accumulation of malonyl-CoA (Johnson et al., 2017, Zhang et al., 2006). Increased 
malonyl-CoA concentration resulting from heterologously expressed source pathways has 
also been quantified (Johnson et al., 2017). Examples include acetyl-CoA carboxylase 
(ACC), which converts acetyl-CoA into malonyl-CoA, and malonyl-CoA synthetase 
(MatB), which converts malonate, channeled into the cell via malonate carrier protein 
(MatC), into malonyl-CoA. Using malonyl-CoA biosensors, malonyl-CoA levels ranging 
from 0.1–1.1 nmol/mg DW can be detected in the aforementioned hosts. Some of these 
biosensors have in fact been applied as a negative feedback loop (Liu et al., 2015b) and a 
metabolic switch (Xu et al., 2014b) for dynamic regulation of malonyl-CoA to improve 
product titre and yield of various metabolites (e.g., 3-hydroxypropionic acid) (Rogers and 
Church, 2016). 
 
In this article, we reported the design and engineering of a set of genetically-encoded 
malonyl-CoA biosensors that are compatible with R. eutropha H16. To our best knowledge, 
these are the first malonyl-CoA biosensors engineered for this industrially promising 
microbial host. We also looked at the application of this sensor set for the dynamic 
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quantification of intracellular malonyl-CoA concentration. We envisage that this biosensor 
set will be of high relevance to the dynamic regulation of malonyl-CoA source and sink 
pathways in R. eutropha H16, as well as other applications previously reported for E. coli 
and S. cerevisiae. 
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4.2 RESULTS AND DISCUSSION 
4.2.1 Single-plasmid bimodular malonyl-CoA biosensor 
The design of a functional malonyl-CoA biosensor for a microbial cell factory requires the 
contextual knowledge of both DNA replication and gene transcription of the chassis in 
question (Johnson et al., 2017). We have adapted the bacterial FapR transcriptional 
regulatory system to generate a malonyl-CoA biosensor that can be used to detect malonyl-
CoA changes in R. eutropha H16. To achieve a compact and flexible design, we modified 
pBBR1c-RFP developed in-house (Figure S1) that was originally derived from the broad-
host-range pBBR1MCS plasmid (Kovach et al., 1994). pBBR1MCS is compatible with 
IncQ, IncP, IncW, and colE1. This medium-copy-number plasmid (<40 copies per cell)(Bi 
et al., 2013) carries a chloramphenicol resistance gene and is the most widely used plasmid 
system for R. eutropha H16. Each of our biosensor has two modules working in tandem, a 
repressor module and a reporter module as depicted in Figure 4.1A. The repressor module 
consists of a gene encoding Bacillus transcription factor FapR (NCBI reference sequence 
WP_003232044.1) and its promoter termed P1 henceforth. The gene sequence of FapR was 
codon-optimized for expression in R. eutropha H16. The reporter module, on the other 
hand, consists of a gene encoding a monomeric DsRed protein variant (GenBank 
BAD52341.1) and its promoter termed P2 henceforth. P2 is a fapO-hybrid promoter, 
containing one or more units of the 17 bp-fapO operator sequence (5’-
TTAGTACCTGATACTAA-3’). The two neighbouring genes (fapR and rfp) are arranged 
in head-to-head orientation with their promoters, P1 and P2, in back-to-back configuration 
(or divergent to one another). Important to note, by having both modules on the same 
plasmid, the relative ratio of repressor activity to reporter activity is governed by the 
relative strengths of P1 and P2 promoters, the interaction between FapR and fapO, and the 
number of fapO units. Variability due to plasmid copy number, plasmid compatibility and 
plasmid stability is therefore removed to simplify the design and subsequent optimization. 
Also worthy of mention, the repressor and reporter modules are flanked by restriction sites 
Bsu36I|PstI and PstI|XhoI, respectively. This enables flexible exchange of each module (i.e., 
changing P1 and P2 combination) to optimize the performance of the resultant biosensor. 
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Figure 4.1: (A) Bimodular malonyl-CoA biosensor. (B) Three negative control genetic 
circuits constructed for each biosensor (FapR, fapO): control A (FapR, fapO), control B 
(FapR, fapO) and control C (FapR, fapO). (C) Promoters used in this study.  
Pj5-, PphaC1- and PrrsC-derived promoters are indicated by white circles, yellow circles and 
cyan circles, respectively. The letters ‘S’, ‘M’ and ‘W’ are used to indicate strong, medium 
and weak promoter, respectively. Data was obtained from a previous study.(Johnson et al., 
2018).  
 
 
4.2.2 Control genetic circuits for validating the design of malonyl-CoA biosensor 
A malonyl-CoA-responsive biosensor requires the simultaneous presence of two essential 
genetic elements, i.e., FapR repressor and fapO operator [(FapR, fapO) was used to indicate 
the presence of both elements]. To validate our design, we also constructed three control 
genetic circuits (controls A to C in Figure 4.1B). In control A (FapR, fapO) and control B 
(FapR, fapO), one of these genetic elements was either non-functional (a 5’-TAATGA-3’ 
double stop codon was introduced in the fapR gene resulting in pre-mature truncation of 
FapR) or removed (fapO was deleted). In control C (FapR, fapO), both genetic elements 
were ‘absent’. Ideally, all control circuits should not respond to changes in malonyl-CoA 
concentration (i.e., negative controls). If a constitutive promoter is applied for P2 (which is 
the case in our designs; Tables 4.1 & 4.2), RFP expression is not repressed and is therefore 
permanently turned on. These three control genetic circuits are essential to fully 
comprehend our biosensor design: (1) By comparing biosensor with its control A, one 
could determine the level of rfp gene repression owing to FapR, (2) By comparing controls 
A and B or controls A and C, one would know the effect of introducing fapO unit(s) on P2 
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promoter strength, (3) By comparing controls B and C, one could verify if FapR binds non-
specifically to P2, and (4) By comparing biosensor with its control A or control B or 
control C in increasing concentration of chemical that induces malonyl-CoA accumulation 
(e.g., cerulenin), one could demonstrate biosensor orthogonality. 
 
Table 4.1: Promoters used in this study 
Promoter Description 
PphaC1 466-bp native promoter of the R. eutropha H16 phaC1 gene 
PphaC1[A1] PphaC1 variant with mutations in -35 box 
PrrsC Semi-synthetic promoter of R. eutropha H16 rrsC gene 
PrrsC[D6] PrrsC variant containing one 17-bp fapO unit within its downstream 
element 
PrrsC[D4] PrrsC variant containing one 17-bp fapO unit between its -35 and -10 
boxes  
Pj5[A1C1C2] Coliphage T5 Pj5 variant containing a T7 stem-loop and a synthetic 
RBS in its 5’-UTR 
Pj5[A1D6aC1C2] Pj5[A1C1C2] variant containing one 17-bp fapO unit within its 
downstream element 
Pj5[A1D6bC1C2] Pj5[A1C1C2] variant containing two tandem 17-bp fapO units within 
its downstream element 
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Table 4.2: Six malonyl-CoA biosensors described in this study 
Biosensor 
Repressor module Reporter module 
Promoter P1 
Promoter 
strength 
Repressor Promoter P2 
Promoter 
strength 
Number of 
fapO unit(s) 
Reporter 
S1 PphaC1 M FapR PrrsC[D6] W 1 RFP 
S2 PphaC1 M FapR PrrsC[D4] W 1 RFP 
S3 PphaC1[A1] W FapR PrrsC[D6] W 1 RFP 
S4 PphaC1[A1] W FapR PrrsC[D4] W 1 RFP 
S5 PphaC1 M FapR Pj5[A1D6aC1C2] S 1 RFP 
S6 PphaC1 M FapR Pj5[A1D6bC1C2] S 2 RFP  
  
 170 
4.2.3 Constructing a set of 6 malonyl-CoA biosensors by careful selection of 
constitutive promoter combinations 
Although single-plasmid bimodular design (Figure 4.1A) is comparatively simpler than 
having FapR and fapO on separate plasmids, judicious choice of P1 and P2 promoter 
combination remains crucial. It determines a biosensor’s dynamic range and sensitivity. 
Since we did not modify the gene sequence of FapR and the DNA sequence of fapO 
operator (i.e., KD between FapR-fapO interaction is kept constant), we focused our attention 
on the relative strength between P1 and P2 promoters. Of course, the strength of fapO-
hybrid promoter P2 depends also on the location and the number of fapO units. We have 
previously constructed and comprehensively characterized a set of broad-activity-range 
constitutive promoters for R. eutropha H16 (Johnson et al., 2018). Based on this prior 
knowledge, we selected 8 promoters and they were derived from either promoter PphaC1 
(indicated by yellow circles), PrrsC (cyan circles) or Pj5 (white circles) (Table 4.1, Figure 
4.1C). Of these 8 promoters, those three Pj5-based promoters are comparatively stronger 
(indicated by an ‘S’), compared to PphaC1- or PrrsC-based promoters. Using different 
combinations of these promoters, we constructed a set of 6 malonyl-CoA biosensors (S1–
S6; Table 2) and their respective negative controls (Table 4.3). Important to highlight, 
promoters P1 and P2 are not independent to one another in R. eutropha H16. When placed 
in back-to-back configuration, they form a composite promoter with the secondary 
promoter serving as a transcriptional amplifier of the primary promoter. If we use RFP as a 
reference point, the activity of primary promoter P2 is amplified by the presence of the 
secondary promoter P1, as we have previously demonstrated (Johnson et al., 2018). This 
factor needs to be taken into consideration when analysing the performance of a biosensor. 
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Table 4.3: Controls for all six malonyl-CoA biosensors described in this study. Biosensors S1 and S2 share the same promoter P1. Therefore, 
these two biosensors share the same control B and control C. The same applies to biosensor pairs S3 and S4 as well as S5 and S6. 
Biosensor 
Control A Control B Control C 
Repressor Promoter P2 
Promoter 
strength 
Repressor Promoter P2 
Promoter 
strength 
Repressor Promoter P2  
Promoter 
strength 
S1 
Truncated 
FapR 
PrrsC[D6] W 
FapR PrrsC M 
Truncated 
FapR 
PrrsC M 
S2 
Truncated 
FapR 
PrrsC[D4] W 
S3 
Truncated 
FapR 
PrrsC[D6] W 
FapR PrrsC M 
Truncated 
FapR 
PrrsC M 
S4 
Truncated 
FapR 
PrrsC[D4] W 
S5 
Truncated 
FapR 
Pj5[A1D6aC1C2] S 
FapR Pj5[A1C1C2] S 
Truncated 
FapR 
Pj5[A1C1C2] S 
S6 
Truncated 
FapR 
Pj5[A1D6bC1C2] S 
 
 172 
4.2.4 RFP expression in all 6 biosensors was repressed by FapR 
Repression of RFP expression by FapR is the first and foremost criterion of a functional 
biosensor. The level of repression is quantitatively described by fold repression, which is 
the ratio of the reporter activity from control A (FapR, fapO) to the reporter activity from 
biosensor (FapR, fapO). Another characteristic of a good biosensor is low basal RFP 
expression when placing the biosensor in a “repressed” or an “un-induced” state (i.e., low 
noise level). Measurement of reporter activity from all biosensors (Figure 4.2A) and their 
control As (Figure 4.2B) revealed a 2–15-fold repression (Figure 4.2C) between the 6 
designs (S1–S6). Reporter activity is predominantly governed by the strength of P2. When 
strong promoters (Pj5[A1D6aC1C2] and Pj5[A1D6bC1C2]) were used in biosensors S5 and S6 as P2, 
we observed a high basal RFP expression (Figure 4.2A) and a low repression of 2–3 folds 
(Figure 4.2C). In other words, the promoters P2 in S5 and S6 are leaky. Further, this “leaky” 
RFP expression in Pj5-based promoters increases with cultivation time (Figure 4.2A). RFP 
expression from biosensor S1, on the contrary, is most effectively repressed by FapR, 
judging on its highest ~15-fold repression. This is achieved via the right level of FapR 
expression (driven by a promoter of medium strength ‘M’) and of RFP expression (driven 
by a weak promoter ‘W’). Even though PrrsC[D6] (P2 of biosensor S1) is a weak promoter 
when characterized independently, it was transcriptionally amplified when placed in back-
to-back with PphaC1 (P1 of biosensor S1) to achieve a more balanced ratio of repressor to 
reporter activity. Likewise, the FapR expression driven by the PphaC1 could also be 
amplified by the presence of neighbouring PrrsC[D6], which in turn, contributed to the more 
optimal repressor to reporter ratio in biosensor S1. Comparing biosensors S1 and S2 also 
revealed the importance of the location of fapO operator in achieving an appropriate level 
of repression. In biosensor S1, fapO unit was placed within the downstream element of 
PrrsC, whereas in biosensor S2, the same unit was located between -35 and -10 boxes of 
PrrsC. We then proceeded to measuring the reporter activity from control Bs and control Cs. 
As indicated in Figure 4.2D, both controls B and C gave almost identical RFP expression 
level. This proves that there is no non-specific FapR-binding site within the chosen P2 
promoters. In other words, RFP repression is a direct consequence of FapR-fapO 
interaction. 
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Figure 4.2: (A) Reporter activity from each biosensor (FapR, fapO). Promoter P2 of each 
biosensor is indicated above each data set. (B) Reporter activity from control A (FapR, 
fapO) of each biosensor. Promoter P2 of each control genetic circuit is indicated above the 
respective data set. (C) Fold repression of each biosensor, after 12 h cultivation in 96-well 
deep well plate. Promoter strength is indicated above each data point, written in the format 
of (Strength of promoter P1, Strength of promoter P2). (D) Reporter activity from control B 
(FapR, fapO) and control C (FapR, fapO). Promoter P2 of the control genetic circuit is 
indicated above each data set. 
 
4.2.5 All 6 biosensors are responsive to changes in intracellular malonyl-CoA 
concentration 
To show that our biosensors can be applied to detect changes in intracellular malonyl-CoA 
concentration, we cultivated R. eutropha H16 in 96-well deep well plate with varying 
concentration of cerulenin ([C]) from 0 to 20 M (Figure 4.3). Cerulenin is a known 
inhibitor of -ketoacyl-ACP synthase I/II (FabB/F); addition of which into microbial 
culture medium results in intracellular accumulation of malonyl-CoA (Zhang et al., 2006). 
The cerulenin concentration range that we tested did not affect the growth of R. eutropha 
H16 significantly. We observed only a 20 % drop in OD595 at 20 M cerulenin (Figure 
S4.2). As shown in Figure 5.4, reporter activity correlated with cerulenin concentration for 
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all 6 biosensors. Important qualities of a good response (R) from a biosensor include broad 
dynamic range (i.e., high [C]max/[C]min, in which [C]max is the highest non-saturating 
cerulenin concentration and [C]min is the lowest cerulenin concentration that still gives a 
detectable response) and high sensitivity (i.e., high R/[C]). To examine these qualities 
more closely, each data set in Figure 4.4 was fit to a dose-response curve with a variable 
slope. Each curve fitting therefore returned 4 parameters: top value, bottom value, half 
maximal effective concentration (EC50) and Hillslope. Broad dynamic range is typically 
characterized by a large EC50 along with a gentle slope. On the other hand, high sensitivity 
is reflected by a large span (top value minus bottom value). Biosensor S1 gave the largest 
dynamic range as indicated by its EC50 of ~4.5 M (Table S4.1), which is the highest 
among the 6 designs, and a gentle slope. Biosensor S2 showed a similar dynamic range 
compared to S1, but with a lower sensitivity as indicated by a smaller span (~40 for S1 and 
~10 for S2). Interestingly, at 20 M cerulenin, the reporter activity of biosensor S1 was 
almost identical to that of its control A (Figure S4.3). This showed that FapR was almost 
completely relieved from binding to fapO operator, when 20 M cerulenin was used. In 
other words, we observed similar fold repression and maximal fold induction (Figure 4.5). 
The fold induction is defined as the reporter activity at X μM cerulenin divided by the 
reporter activity at 0 μM cerulenin. Hence, the maximal fold induction is the maximum fold 
induction value measured at [C] = [C]max. For all biosensors, we achieved induction 
efficiency between 74–99% (Table S4.2). Also apparent from Figure S4.3, introducing a 
fapO unit between -35 and -10 boxes of PrrsC resulted in loss of promoter activity, as 
indicated by the obvious difference in reporter activity from controls A and B of both 
biosensors S4.2 and S4.4. 
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Figure 4.3: High-throughput characterization of malonyl-CoA biosensors using a 
fluorescence-based assay. 
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Figure 4.4: Reporter activity from biosensor (FapR, fapO) S1 to S6 in the presence of 
increasing cerulenin concentration, measured after 12 h (red line), 18 h (blue line) and 24 h 
(black line) of cultivation in 96-well microtitre plate. 
 
 
 
Figure 4.5: Fold repression (black column) and maximal fold induction (grey column) of 
each biosensor. Promoter strength is indicated above each data point, written in the format 
of (Strength of promoter P1, Strength of promoter P2). 
 177 
4.2.6 All 6 biosensors displayed high degree of orthogonality 
We also measured the reporter activity from controls A and B of each biosensor, in the 
presence of identical range of cerulenin concentration. In Figure 4.6, data was reported as 
cerulenin concentration vs fold induction of each sensor and its respective controls A and B. 
For all biosensors, reporter activity from control A or from control B did not change with 
increase in cerulenin concentration (i.e., fold induction close to value 1). Figure 4.6 clearly 
verified the orthogonality of our biosensors. Cerulenin-induced de-repression of reporter 
module was indeed a direct result of FapR being relieved from binding to fapO operator.
 178 
 
 
 
Figure 4.6: Fold induction from biosensor [(FapR, fapO); black line], control A [(FapR, fapO); blue line] and control B [(FapR, fapO); 
red line] for each design in the presence of increasing cerulenin concentration. 
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4.2.7 S1 is the best biosensor and works in E. coli 
Of the 6 biosensors described, S1 showed the best performance, judging on its low basal 
RFP expression (low ‘leakiness’ or low noise level), broad dynamic range ([C] from 0 to 20 
M), high fold repression (14.7), high fold induction (14.1) and high induction 
efficiency (96%). S5, on the other hand, is the most sensitive biosensor (high R/[C]) at 
low range of cerulenin concentration (0 to 5 M), even though its response is cultivation 
time-dependent. Therefore, this set of 6 biosensors provides us with the flexibility in 
choosing the most appropriate sensing device depending on the application and the range of 
malonyl-CoA concentration to be quantified. All 6 biosensor constructs are also functional 
in E. coli (data not shown), although the response curves differ significantly. This is largely 
due to the fact that the promoters we have chosen showed very different relative strengths 
in E. coli (Johnson et al., 2018). This particular fact further supported the need to design 
chassis-specific biosensor. In essence, there is no one size fits all, when it comes to 
designing transcription-based genetic devices.   
 
4.3 CONCLUSION 
In constructing malonyl-CoA biosensors, as described in this article, we considered chassis-
specific design constraints, which include promoter combination, relative promoter strength, 
promoter strength amplification by neighbouring promoter, intracellular malonyl-CoA 
concentration and cerulenin tolerance, among others. All biosensors presented in this study 
were functional and responsive to changes in malonyl-CoA concentration in R. eutropha 
H16 induced by cerulenin addition. This was achieved via careful balancing of all chassis-
specific design constraints. We strongly believe this set of malonyl-CoA biosensors would 
be useful for future quantification of malonyl-CoA source/sink pathways and for dynamic 
regulation of intracellular malonyl-CoA pool in R. eutropha H16. 
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4.4 MATERIALS & METHODS 
4.4.1 Materials 
All DNA modifying enzymes were purchased from either New England Biolabs or 
Agilent. Nucleic acid purification kits were purchased from Qiagen. All oligonucleotides 
were synthesized by Eurofins.  
4.4.2 Strains 
Escherichia coli DH5 was used for all molecular cloning, plasmid propagation and 
maintenance. Ralstonia eutropha H16 was used for all experiments described in this 
article.  
4.4.3 Biosensor construction and FapR/promoter sequences 
All plasmids harbouring a genetic circuit for a malonyl-CoA biosensor were derived from 
pBBR1c-RFP (see Supplementary Information) and constructed using standard molecular 
biology techniques. All genetic circuits were verified by restrictive analysis and/or DNA 
sequencing. FapR and promoter sequences were provided in the Supplementary 
Information. 
4.4.4 Bacterial cultivation and transformation 
R. eutropha H16 was cultivated at 30C in nutrient broth (NB) supplemented with 10 
g/mL of gentamicin. Cells were transformed with plasmids using the electroporation 
protocol described by Tee et al. (2017) plated on NB agar supplemented with 10 g/mL 
of gentamicin and 25 g/mL of chloramphenicol, and incubated at 30C for 40–60 h. E. 
coli DH5 was transformed with plasmids using the standard CaCl2 method, plated on 
TYE agar supplemented with 25 g/mL of chloramphenicol and incubated overnight at 
37C. 
4.4.5 Biosensor characterization using fluorescence assay 
Fresh NB, supplemented with 10 g/mL of gentamicin and 25 g/mL of chloramphenicol, 
was inoculated with overnight culture of R. eutropha H16 (transformants carrying either 
a biosensor plasmid or a negative control plasmid) at a dilution factor of 1:50 and was 
grown at 30C. When OD595 reached ~0.2, the culture was aliquoted to a fresh clear-
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bottom 96-well deep well plate (Thermo Fisher Scientific) at 500 L per well. Cerulenin 
of final concentration ranging from 0 M to 20 M was added at this point. The plate 
was cultivated at 30C for a further 24 h. OD595 and fluorescence (Ex 589 nm, Em 604 
nm) were measured using MultiSkanTM FC Microplate Photometer (Thermo Fisher 
Scientific) and Fluoroskan AscentTM Microplate Fluorometer (Thermo Fisher Scientific), 
respectively, after 12 h, 18 h and 24 h of cultivation in 96-well microtitre plate. Relative 
fluorescence unit (RFU) was calculated by normalizing fluorescence value with the 
fluorescence value of R. eutropha H16 carrying no plasmid. RFU/OD595 value was then 
calculated as the ratio of RFU and OD595 values. All experiments were done in triplicate. 
4.4.6 Fold repression, fold induction and induction efficiency 
Fold repression, fold induction and induction efficiency were calculated using the 
formulae below: 
𝐹𝑜𝑙𝑑 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =  
(
𝑅𝐹𝑈
𝑂𝐷595
)
𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝐴
(
𝑅𝐹𝑈
𝑂𝐷595
)
𝑏𝑖𝑜𝑠𝑒𝑛𝑠𝑜𝑟
 
 
𝐹𝑜𝑙𝑑 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =  
(
𝑅𝐹𝑈
𝑂𝐷595
)
𝑏𝑖𝑜𝑠𝑒𝑛𝑠𝑜𝑟 𝑎𝑡 [𝑐𝑒𝑟𝑢𝑙𝑒𝑛𝑖𝑛]= 𝑥 𝜇𝑀
(
𝑅𝐹𝑈
𝑂𝐷595
)
𝑏𝑖𝑜𝑠𝑒𝑛𝑠𝑜𝑟 𝑎𝑡 [𝑐𝑒𝑟𝑢𝑙𝑒𝑛𝑖𝑛]= 0 𝜇𝑀
 
 
𝐼𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =  
𝑀𝑎𝑥𝑖𝑚𝑎𝑙 𝑓𝑜𝑙𝑑 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛
𝐹𝑜𝑙𝑑 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛
 ×  100% 
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4.5 SUPPLEMENTARY INFORMATION 
4.5.1 Methods and Material 
4.5.1.1 FapR 
The gene sequence encoding Bacillus subtilis FapR (NCBI reference sequence 
WP_003232044.1) was codon optimized for expression in Ralstonia eutropha H16. The 
sequence containing PphaC1 and fapR gene was synthesized by GenScript. The optimized 
fapR sequence is provided below: 
 
atgcgccgcaacaagcgcgaacgccaggagctcctccagcagacgatccaggccacccc
gttcatcacggacgaagaactggcgggcaagttcggcgtgtcgatccagaccatccgcc
tggaccgcctggagctgagcatcccggagctgcgcgagcgcatcaagaacgtggccgag
aagaccctggaggacgaggtgaagtcgctgagcctggacgaggtgatcggcgagatcat
cgacctggagctggacgaccaggccatctcgatcctggagatcaagcaggagcacgtgt
tcagccgcaaccagatcgcacgcggccaccacctgttcgcccaggcgaactcgctggcg
gtggccgtgatcgacgacgagctggccctgaccgccagcgcggacatccgcttcacccg
ccaggtgaagcagggcgagcgcgtggtggccaaggccaaggtgaccgcggtggagaagg
agaagggccgcaccgtggtggaagtgaactcgtacgtgggcgaggaaatcgtgttctcg
ggccgcttcgacatgtaccgcagcaagcatagc 
 
4.5.1.2 Construction of pBBR1c-P2-RFP 
All pBBR1c-P2-RFP plasmids were derived from pBBR1c-RFP. To construct pBBR1c-
PrrsC-RFP, DNA fragment containing the L-arabinose-inducible promoter system (PBAD 
and araC) was first excised from pBBR1c-RFP using restriction enzymes PstI and NdeI. 
This fragment was subsequently replaced by a fragment containing PrrsC promoter. To 
construct pBBR1c-Pj5[A1C1C2]-RFP, DNA fragment containing the L-arabinose-inducible 
promoter system (PBAD and araC) and rfp gene was first excised from pBBR1c-RFP 
using restriction enzymes PstI and XhoI. This fragment was subsequently replaced by a 
fragment containing Pj5[A1C1C2] promoter and rfp gene. pBBR1c-PrrsC[D6]-RFP and 
pBBR1c-PrrsC[D4]-RFP were created from pBBR1c-PrrsC-RFP using the recommended 
NEBaseChanger protocol. Similarly, pBBR1c-Pj5[A1D6aC1C2]-RFP and pBBR1c-
Pj5[A1D6bC1C2]-RFP were created from pBBR1c-Pj5[A1C1C2]-RFP using the same protocol. 
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4.5.1.3 Construction of pBBR1c-P1-FapR-P2-RFP 
PphaC1-fapR or PphaC1[A1]-fapR was amplified and digested with restriction enzymes 
Bsu36I and PstI. The fragment was subsequently ligated to pBBR1c-P2-RFP plasmid that 
was pre-digested with the same restriction enzymes set to generate pBBR1c-P1-FapR-P2-
RFP (i.e., the sensor). 
4.5.1.4 Effect of cerulenin on cell growth 
Five mL NB was inoculated with an overnight culture at a dilution factor of 1:50 and 
grown at 30C. When OD595 reached 0.20.3, the culture was aliquoted to a 96-well deep 
well plate and cerelenin of final concentration from 0 to 20 M was added to give a total 
volume of 500 L per well. The plate was cultivated at 30C for additional 12 h. Each 
experiment was done in triplicate. 
 
Figure S4.2: Effect of cerulenin on the growth of Ralstonia eutropha H16 
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Figure S4.3: Comparison of reporter activities from biosensor (FapR, fapO), control A (FapR, fapO) and control B (FapR, fapO) of each 
design, measured after 12 h (black), 18 h (light grey) and 24 h (dark grey) of cultivation in 96-well deep well plate. 
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Table S4.1: Fitting of data in Figure S4.4 to a dose-response curve with variable slope (4-parameter) 
12 h 
 S1 S2 S3 S4 S5 S6 
Bottom 2.77 2.337 4.797 3.132 43.11 45.72 
Hillslope 2.111 1.854 2.79 3.658 3.55 3.1 
Top 38.31 12.88 36.18 15.54 84.71 97.86 
EC50 4.4 4.966 3.112 2.652 1.705 1.735 
Span 35.54 10.55 31.38 12.41 41.6 52.15 
R2 0.9881 0.9977 0.9984 0.9958 0.9928 0.9965 
 
18 h 
 S1 S2 S3 S4 S5 S6 
Bottom 3.086 2.818 5.163 3.223 48.48 52.28 
Hillslope 2.409 1.964 2.681 3.097 2.515 2.296 
Top 44.25 13.82 36.72 18.33 111.8 102.8 
EC50 4.646 4.774 3.13 2.617 2.136 1.901 
Span 41.17 11.01 31.55 15.1 63.33 50.55 
R2 0.9997 0.9981 0.9954 0.9995 0.998 0.9936 
 
24 h 
 S1 S2 S3 S4 S5 S6 
Bottom 3.455 3.107 5.248 3.724 74.64 66.11 
Hillslope 2.749 2.043 2.605 3.835 4.098 2.404 
Top 43.11 13.4 38.14 19.33 178.7 124.4 
EC50 4.483 4.455 3.105 2.499 2.663 1.514 
Span 39.65 10.29 32.89 15.61 104.1 58.25 
R2 0.9979 0.9965 0.9935 0.9998 0.9841 0.9748 
 
    186 
Table S4.2: Induction efficiencies of all 6 biosensors 
Biosensors Induction efficiency [%] 
S1 96 
S2 74 
S3 84 
S4 99 
S5 85 
S6 90 
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CHAPTER FIVE 
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5 DEVELOPING A -RED RECOMBINEERING METHOD OF GENOME 
EDITING IN R. EUTROPHA H16 (PART I) 
 
5.1 INTRODUCTION 
The absence of fast, efficient and reliable singleplex genome engineering techniques limits 
the metabolic engineering strategies to further enhance the chemical biomanufacturing 
applications of R. eutropha H16. The work presented here explores a promising genome 
engineering technique, -Red recombineering, and its potentials and immediate 
applications for facilitating metabolic engineering in Ralstonia eutropha. To validate the 
effectiveness of the broad host range plasmids pBBR1c-RED1, pBBR1c-RED2 and 
pBBR1k-RED, we used them to mediate non-lethal deletion of the zwf gene which encodes 
the glucose-6-phosphate dehydrogenase protein in E. coli BW25113 (NCBI reference 
sequence (WP_000301727.1). The zwf gene (1476 bp) spans position 1929096 and 
1930571 of the genome of E. coli BW25113. This was achieved using kanamycin or 
chloramphenicol resistance dsDNA cassettes as the gene targeting selectable markers. 
Successful integration was confirmed via colony PCR of the ensuing mutant strains. The 
phenotype of identified mutant was verified by examining their resistance to the antibiotics 
corresponding to the antibiotics resistance markers used in design of corresponding dsDNA 
cassettes. 
 
5.2 METHOD 
5.2.1 Linear dsDNA cassettes 
The linear dsDNA cassettes zwf-kanR-zwf and zwf-camR-zwf carrying kanamycin and 
chloramphenicol resistance genes, respectively were designed to target the zwf gene 
encoding the glucose-6-phosphate dehydrogenase protein in E. coli BW25113. The kanR 
dsDNA cassette contained the neokan promoter (Pneokan) and the kanR gene whilst the 
camR dsDNA cassette contained the chloramphenicol acetyl transferase (cat) promoter 
(Pcat) and camR gene. PCR products of linear dsDNA cassette were incubated with 1 l 
DpnI to remove plasmid template where there were no PCR side products. In the presence 
of PCR side products, the intended PCR products were gel extracted.  
 
 189 
Table 5.1: Description of dsDNA cassettes for -Red recombineering in E. coli BW25113 
dsDNA 
cassette 
Antibiotics 
resistance 
marker 
Template for 
antibiotics 
resistance 
marker 
Length of 
cassette (bp) 
Length of 
each 
homology 
arm (bp) 
Targeted 
gene 
zwf-kanR-zwf kanR pBbA8K-RFP 1031 50 zwf 
zwf-camR-zwf camR pBBR1MCS1 836 50 zwf 
 
 
 
Table 5.2: Primers used in thus study 
*Nucleotides in bold represent 50 bp homology arm 
dsDNA Cassette Primer name Sequence  
1.031 kb zwf-kanR-zwf zwf-kanR-for 5’-
GCGCAAGATCATGTTACCGGTAAAATAACCATAA
AGGATAAGCGCAGATATCAGAAGAACTCGTCAAG
AAGGCG-3’ 
zwf-kanR-rev 5’-
CAAGTATACCCTGGCTTAAGTACCGGGTTAGTTA
ACTTAAGGAGAATGACGGAATTGCCAGCTGGGGC
-3’ 
0.836 kb zwf-camR-zwf zwf-camR-for 5’-
GCGCAAGATCATGTTACCGGTAAAATAACCATAA
AGGATAAGCGCAGATAAAACTGTTGTAATTCATT
AAGCATTCTGC-3’ 
zwf-camR-rev 5’-
CAAGTATACCCTGGCTTAAGTACCGGGTTAGTTA
ACTTAAGGAGAATGACTGATCGGCACGTAAGAGG
TTCC-3’ 
1331 bp UPzwf-kanR-
DOWNzwf OR 1136 bp 
UPzwf-camR-DOWNzwf 
OR 1876 bp UPzwf-zwf-
DOWNzwf 
UPzwf-for 5’-GATTCACAACGCGTTTCATTCAG-3’ 
DOWNzwf-rev 5’-TCAGTGTCAGATTTTTACCCAATG-3’ 
- camR-for 5’-AGACGGTGAGCTGGTGATATGG-3’ 
camR-rev 5’-AGGCGGGCAAGAATGTGAATAAAG-3’ 
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5.2.1.1 zwf-kanR-zwf 
A 1.031 kb zwf-kanR-zwf amplicon was amplified using pBbA8k-RFP plasmid template as 
a source of the Pneokan-kanR gene. Forward primer: zwf-kanR-for and reverse primer: zwf-
kanR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to the 5’-
upstream and 5’-downstream sequences flanking the zwf gene in E. coli BW25113, 
respectively. 
 
Table 5.3: PCR protocol for zwf-kanR-zwf 
PCR Mixture components Volume (L)  Final concentration 
Nuclease free water 37  
10X pfu turbo buffer 5 1X 
dNTP (10 mM) 2 0.2 mM 
zwf-kanR-for (20 mM) 1.5 0.5 M 
zwf-kanR-rev (20 mM) 1.5 0.5 M 
pBbA8K-RFP 1 variable 
Pfu turbo polymerase (2.5 U/L) 2 2.5U/ 50L 
 
Table 5.4: PCR programme for zwf-kanR-zwf 
Step Temperature Time 
Initial denaturation 95C 2 minutes 
30X 95C 
65C (Anneal) 
72C (Extend) 
30 s 
30 s 
1min/kb i.e. 58 s 
Final Extension 72C 10 minutes 
Hold 8C - 
 
5.2.1.2 zwf-camR-zwf 
A 0.836 kb zwf-camR-zwf amplicon was amplified using pBBR1MCS-1 plasmid template 
as a source of the Pcat-camR cassette. Forward primer:  zwf-camR-for and reverse primer 
zwf-camR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to the 5’-
upstream and 5’-downstream sequences flanking the zwf gene in E. coli BW25113, 
respectively. 
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Table 5.5: PCR protocol for zwf-camR-zwf 
PCR Mixture components Volume (L) Final 
concentration 
Nuclease free Water 35.7  
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
zwf-camR-for (20 M) 1.25 0.5 M 
zwf-camR-rev (20 M) 1.25 0.5 M 
pBBR1MCS1 0.3 Variable 
Q5 Polymerase (2 U/L) 0.5 1 U/50 L PCR 
 
Table 5.6: PCR programme for zwf-camR-zwf 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
55C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e 30 s 
Final Extension 72C 10 minutes 
Hold 8C  
 
5.2.2 -Red Recombination protocol 
-Red-mediated gene inactivation in E. coli BW25113 was performed according the 
protocol by Datsenko and Wanner (2000), with few modifications. Transformation of the -
Red plasmids was carried out according to the protocol previously discussed (Chapter 3). 
Overnight cultures of E. coli BW25113 -Red plasmid transformant strain were inoculated 
in fresh 2YT media in 5 mL falcon tubes supplemented with antibiotics corresponding to 
the selection marker on each -Red plasmid type. Protein expression cultures of each strain 
were prepared as previously described (Chapter 3). The test cultures for -Red 
recombination were also supplemented with 0.4 % L-arabinose solution at the start of 
cultivation, while the control cultures were not. Cultures were cultivated to OD600 ~0.6 and 
pretreated for electroporation according to protocol detailed in Chapter 3. Samples were 
then transformed via electroporation with appropriate linear dsDNA cassette according to 
previously detailed protocol.  
 
Outgrowth culture of BW25113 transformed with pKD20 and pKD46 were cultivated at 
30C to allow for sufficient expression of the -Red proteins, and recombination event. 300 
L of cells were plated on appropriate TYE agar plates supplemented with antibiotics 
according to the selectable maker present in the linear dsDNA antibiotics resistance cassette. 
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For selection of mutant cells possessing the kanR gene, TYE agar plates supplemented to 
50 mg/L kanamycin were used. For selection of mutant cells possessing the camR gene, 
TYE agar plates supplemented to 25 mg/L were used. 
 
 
Table 5.7: Strains used in this study 
Strain Description Reference 
BWD20 E. coli BW25113 with pKD20 Chapter 3 
BWD46 E. coli BW25113 with pKD46 Chapter 3 
BWRed1 E. coli BW25113 with pBBR1c-RED1 Chapter 3 
BWRed2c E. coli BW25113 with pBBR1c-RED2 Chapter 3 
BWRed2k E. coli BW25113 with pBBR1k-RED2 Chapter 3 
BWD20K Kanamycin resistant E. coli BW25113 with pKD20 and a 
genome integrated kanR gene, zwf 
This study 
BWRed1K Kanamycin resistant E. coli BW25113 with pBBR1c-
RED1 and a genome integrated kanR gene, zwf 
This study 
BWRed2cK Kanamycin resistant E. coli BW25113 with pBBR1c-
RED2, zwf 
This study 
BWRed2kC Chloramphenicol resistant E. coli BW25113 with 
pBBR1k-RED2, zwf 
This study 
 
5.2.3 Verification of genomic integration of linear dsDNA cassette 
The number of colonies of E. coli BW25113 observed on test agar plates were counted 
and compared to number of colonies observed on control plates from samples without 
induction of protein expression. A colony count ratio of >10:1 between test plates and 
control plate was set as an arbitrary standard for preliminary confirmation of successful 
genomic integration. Transformant colonies of E. coli BW25113 after the gene 
inactivation experiment were re-streaked on TYE agar plates supplemented with 
appropriate antibiotics according to selectable maker in the linear dsDNA cassette.  Re-
streaked agar plates were incubated overnight at 37C. Emerging colonies regrown on 
new TYE agar plates indicated that the colonies observed were due to genomic 
integration of dsDNA linear cassette. Further verification of these colonies was 
performed via colony PCR with the primers used to design the linear dsDNA cassette. 
Colony PCR was performed with OneTaq or Taq polymerase by New England Biolabs, 
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and used according to the manufacturer’s instructions. Different primers pairs were used 
to confirm genomic integration, (Figure 5.1). 
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Figure 5.1:  Methods of screening for successful genomic integration of antibiotics resistance marker.  
(A) Primers used in constructing the cassette will yield corresponding PCR amplicon of the cassette in mutant strains and will not yield PCR 
amplicon in wild type strains. (B) Primers targeting genomic regions upstream and downstream to the target gene will yield PCR amplicon 
of the cassette flanked by upstream and downstream genomic regions in mutant strains and will yield PCR amplicons corresponding to the 
target gene flanked by the upstream and downstream genomic regions in wild type strains. (C) Primers targeting genomic region upstream or 
downstream of the target gene and the centre of the cassette will yield corresponding PCR amplicon in mutant strains but will not yield 
corresponding PCR amplicon in wild type strains.  
A. Screening with cassette primers B. Screening with genomic primers 
C. Screening with genomic and cassette primers 
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5.2.3.1 Colony PCR verification 
Colonies were picked from each TYE agar plates P200 pipette tip under sterile conditions. 
The colonies on the tips were swirled vigorously in 30 L of nuclease free water in 200 L 
tubes. The liquid colony suspension were used as DNA template for colony PCR using 
OneTaq polymerase from NEB Biolabs as follows: 
  
Table 5.8: Colony PCR protocol with cassette primers 
Colony PCR mixture component Volume [L] Final concentration 
Nuclease free water 36 - 
5X Standard OneTaq Reaction Buffer 10 1X 
10 mM dNTPs 1 0.2 mM 
20 M zwf-kanR-for/ zwf-camR-for 0.75 300 nM 
20 M zwf-kanR-rev/ zwf-camR-rev 0.75 300 nM 
Colony suspension 1 - 
OneTaq DNA polymerase (5 U/L) 0.5 2.5 units/50 L PCR mix 
 
 
Table 5.9: Colony PCR programme with cassette primers 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
55 
68 
30 secs 
45 secs 
1 minutes/kb i.e. 1 
minute 20 secs  
Final extension 68 5 minutes 
Hold 8 - 
 
 
Table 5.10: Colony PCR protocol with upstream-downstream Primers 
Colony PCR mixture component Volume [L] Final concentration 
Nuclease free water 37.25 - 
5X Standard OneTaq Reaction Buffer 10 1X 
10 mM dNTPs 0.5 0.2 mM 
20 M UPzwf-for 0.5 200 nM 
20 M DOWNzwf-rev 0.5 200 nM 
Colony suspension 1 - 
OneTaq DNA polymerase (5 U/L) 0.25 1.25 units/50 L PCR mix 
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Table 5.11: Colony PCR programme with upstream-downstream Primers 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
49 
68 
30 secs 
30 secs 
1 minutes/kb i.e. 1 minute 20 secs  
Final extension 68 5 minutes 
Hold 8 - 
 
Table 5.12: Colony PCR protocol with upstream-midstream and midstream-downstream 
Primers (for checking zwf-kanR-zwf integration) 
Colony PCR mixture component Volume [L] Final concentration 
Nuclease free water 37.25 - 
5X Standard OneTaq Reaction Buffer 10 1X 
10 mM dNTPs 0.5 0.2 mM 
20 M UPzwf-for/ zwf-kanR-for 0.5 200 nM 
20 M zwf-kanR-rev/DOWNzwf-rev 0.5 200 nM 
Colony suspension 1 - 
OneTaq DNA polymerase (5 U/L) 0.25 1.25 units/50 L PCR mix 
 
Table 5.13: Colony PCR Programme for 1181 bp UPzwf-kanR amplicon using primers 
UPzwf-for and zwf-kanR-rev 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
51 
68 
30 secs 
30 secs 
1 minutes/kb i.e. 1 min 15 
seconds  
Final extension 68 5 minutes 
Hold 8 - 
 
 
Table 5.14: PCR Programme for 1181 bp kanR-DOWNzwf amplicon using primers zwf-
kanR-for and DOWNzwf-rev 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
49 
68 
30 secs 
30 secs 
1 minutes/kb i.e. 1 minute 15 
seconds  
Final extension 68 5 minutes 
Hold 8 - 
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Table 5.15: Colony PCR protocol with upstream-midstream and midstream-downstream 
primers (for checking zwf-camR-zwf integration) 
Colony PCR mixture component Volume [L] Final concentration 
Nuclease free water 37.25 - 
5X Standard OneTaq Reaction Buffer 10 1X 
10 mM dNTPs 0.5 0.2 mM 
20 M UPzwf-for/ camR-for 0.5 200 nM 
20 M camR-rev/ DOWNzwf-rev 0.5 200 nM 
Colony suspension 1 - 
OneTaq DNA polymerase (5 U/L) 0.25 1.25 units/50 L PCR mix 
 
 
Table 5.16: Colony PCR programme for 600 bp zwf-camR amplicon using upstream-
midstream primers: UPzwf-for and camR-rev 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
51 
68 
30 secs 
30 secs 
1 minutes/kb i.e. 40 seconds  
Final extension 68 5 minutes 
Hold 8 - 
 
Table 5.17: Colony PCR programme for 500 bp zwf-camR amplicon using upstream-
midstream primers: UPzwf-for and camR-rev 
Step Temperature [C] Time 
Initial denaturation 94 5 mins 
30 cycles 94 
49 
68 
30 secs 
30 secs 
1 minutes/kb i.e. 30 seconds  
Final extension 68 5 minutes 
Hold 8 - 
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5.2.4 -Red Recombineering in E. coli BW25113 with pKD20  
First, the gene inactivation protocol was tested in E. coli BW25113 using pKD20 to 
establish a proof of principle of the protocol. ~300 ng of zwf-kanR-zwf PCR product or 
~180 ng of gel extracted zwf-kanR-zwf PCR product was transformed into pKD20-
transformed E. coli BW25113 cultures. All transformation cultures were induced except for 
the control, which was transformed with 300 ng of PCR product zwf-kanR-zwf but not 
induced. All outgrowth cultures were cultivated overnight at 30C. The experiment was set 
up in duplicate such that one set of plates were incubated at 30C and the other at 37C to 
observe if curing the plasmid during overnight incubation compromised recombination 
event and hence genomic integration of the dsDNA cassette.  
 
5.2.5 -Red Recombineering in E. coli BW25113 with pKD20 and pBBR1c-RED1 
Next, to verify the functionality of the pBBR1c-RED1 vector, the same protocol was 
adapted for gene inactivation in E. coli BW25113 by separately using the pKD20 and 
pBBR1c-RED1 vectors with the ~180 ng of gel extracted zwf-kanR-zwf cassette. Each 
plasmid type has a control culture, which was un-induced for protein expression but 
transformed with the same quantity of zwf-kanR-zwf cassette as the induced culture. All 
outgrowth cultures were cultivated for 2 hours. Transformed samples of BWD20 were 
incubated at 30C while transformed samples of BWRed1 were incubated at 37C. A 
number of colonies observed from on the agar plates from the test cultures were re-streaked 
on new selection TYE agar plates with 50 mg/L kanamycin. Re-grown colonies on these 
plates for use for colony PCR verification of the successful recombination. 
 
5.2.6 -Red Recombineering in E. coli BW25113 with pBBR1c-RED1, pBBR1c-
RED2, pBBR1k-RED 
The -Red recombineering was performed using the pBBR1c-RED1, pBBR1k-RED, 
pBBR1c-RED2 vectors for gene inactivation in E. coli BW25113. ~300 ng of zwf-kanR-zwf 
was transformed into BWRed1 and BWRed2c, while ~300 ng of zwf-camR-zwf was 
transformed into BWRed2k. To screen for successful insertion of the antibiotics resistance 
gene in both instances, primers that would amplify genomic regions further upstream and 
downstream of the insertion loci (Upstream-Downstream Primers) were applied. In this 
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instance, successful genomic integration was confirmed by size of the ensuing amplicon, 
which could either include the target gene (in the event of unsuccessful insertion or the 
antibiotics resistance marker (in the event of successful insertion). Subsequently, upstream-
midstream and midstream-downstream were further applied to further confirm successful 
genomic integration event(s).  
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5.3 RESULTS AND DISCUSSION 
5.3.1 -Red recombineering with pKD20  
Test samples of BWD20 induced for expression of the -Red proteins and transformed with 
the zwf-kanR-zwf cassette all produced at least 100 kanamycin resistant colonies when 
plated on TYE agar plate with 50 mg/L kanamycin. This suggested that the recombination 
event between the dsDNA cassette and the genomic region the zwf gene was successful. 
The control culture transformed with PCR purified linear dsDNA but was not induced, had 
only 2 colonies, (Table 6.17). The colonies on the control plate could have been due to 
kanamycin resistance conferred by presence of residual pBbA8k-RFP plasmid template, 
which escaped DpnI digestion in the zwf-kanR-zwf PCR product.  
 
Table 5.18: Colony count -Red recombineering with pKD20 at different conditions 
Induction zwf-kanR-zwf Incubation  
Temperature [C] 
Colony count 
+ PCR, 300 ng 30 924 
+ PCR, 300 ng 37 685 
+ Gel extracted, 180 ng 30 486 
+ Gel extracted, 180 ng 37 151 
- PCR, 300 ng 30 2 
 
The colony count ratio from induced to un-induced cultures was > 10:1 - confirming that an 
appreciable number of colonies observed from the test cultures were indeed zwf mutant 
colonies. It is important to note that previous protocol on -Red recombineering using 
dsDNA with antibiotics selection markers suggest lower concentration of antibiotics (20 
mg/L for kanamycin) for selecting for recombinant cells. However, using this concentration 
in preliminary experiments produced lots of E. coli BW25113 colonies from the controls 
samples thus leading to lower colony count ratio of <10:1 (data not shown). As this made 
screening for actual recombinants difficult, the antibiotics selection was increased to 50 
mg/L for kanamycin. 
 
More colonies were observed at 30C incubation where the pKD20 plasmid was not cured 
than at 37C under plasmid curing conditions, Table 6.18. This suggested that extending 
the expression of the -Red proteins by keeping the plasmid uncured during incubation had 
a positive effect on recombination efficiency. Overall, at both incubation temperatures, 
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cultures transformed with the PCR product (300 ng) had more colonies than cultures 
transformed with the gel-extracted product (180 ng), of course owing to higher DNA mass 
from the former.  
5.3.2 -Red recombineering in E. coli BW25113 with pKD20 and pBBR1c-RED1 
Proof of principle of -Red recombineering in E. coli BW25113 was used to test the 
pBBR1c-RED1 construct for its recombineering functionality. pBBR1c-RED1 elicited 
similar results as pKD20 in mediating the knockout of the zwf gene in E. coli BW25113. 
From this experimental set-up, the complete absence of colonies from all controls was a 
good indicator that the colonies obtained from induced samples of BWD20 and BWRed1 
were largely deletion strains with the zwf gene replaced with a kanR gene. The ~ 1 kb band 
from colony PCR screening of three colonies per test plate with cassette-specific primers 
zwf-kanR-for and zwf-kanR-rev further confirmed genomic integration of the kanR cassette, 
(Figure 6.2). Additionally, whilst BWD20 produced 75 zwf colonies, BWRed1 produced 
80 zwf colonies, suggesting that the pBBR1c-RED1 plasmid is only marginally more 
efficient in mediating -Red recombineering than pKD20. This further suggests that the 
more marked expression of the -Red proteins observed from BWRed1 compared to 
BWD20 (Chapter 3) does not create a marked difference in recombination efficiency 
between pKD20 and pBBR1-RED1. It also supports the position that marked expression (as 
observed by SDS-PAGE analysis) may not be absolutely definite in comparatively 
evaluating the performance of pKD20. 
 
 
Table 5.19: Colony count from -Red recombineering with pKD20 and pBBR1c-RED1 
Induction Original strain Plasmid Final strain Colony count 
- BWD20 pKD20 BWD20 0 
- BWRed1 pBBR1c-RED1 BWRed1 0 
+ BWD20 pKD20 BWD20K 75 
+ BWRed1 pBBR1c-RED1 BWRed1K 80 
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Figure 5.2: Agarose gel electrophoresis image from colony PCR with cassette-specific 
primers to identify zwf BWD20K and BWRed1K strains of E. coli BW25113 after -Red 
recombineering. 
The ~1.0 kb band from the pKD20/zwf-kanR-zwf and pBBR1c-RED1/zwf-kanR-zwf 
colonies are the zwf-kanR-zwf amplicon from the genome of selected colonies indicating 
that all colonies are zwf BWD20K and BWRed1K strain, respectively. L – 1 kb DNA 
ladder. 
 
 
5.3.3 -Red Recombineering in E. coli BW25113 with pBBR1c-RED1, pBBR1c-
RED2, and pBBR1k-RED 
The -Red protocol was adapted using the pBBR1c-RED1, pBBR1k-RED, pBBR1c-RED2 
vectors for gene inactivation in E. coli BW25113. ~300 ng of zwf-kanR-zwf was separately 
transformed into BWRed1 and BWRed2c while ~300 ng of zwf-camR-zwf was transformed 
into BWRed2k. To screen for successful insertion of the antibiotics resistance gene in both 
instances, primers that would amplify genomic regions further upstream and downstream of 
the insertion loci (Upstream-Downstream Primers) were applied. In this instance, 
successful genomic integration was confirmed by size of the ensuing amplicon, which 
could either include the target gene (in the event of unsuccessful insertion or the antibiotics 
resistance marker (in the event of successful insertion). Subsequently, upstream-midstream 
and midstream-downstream were further applied to further confirm successful genomic 
integration event(s).  
kb 
3.0 
1.0 
2.0 
1.5 
BWD20K 
L	
BWRed1K 
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All three plasmid types (pBBR1c-RED1, pBBR1k-RED, pBBR1c-RED2) in combination 
with appropriate antibiotics resistance cassettes (zwf-kanR-zwf and zwf-camR-zwf) effected 
genomic deletion of the zwf gene in E. coli BW25113. Strains BWRed1 and BWRed2c 
with pBBR1c-RED1 and pBBR1c-RED2, respectively produced 1840 and 4000 colonies, 
respectively on the kanamycin selection plate. Strain BWRed2k with the pBBR1k-RED 
plasmid produced only 10 colonies. Colony-PCR screening of 5 colonies obtained from 
BWRed1 and BWRed2c confirmed that all colonies screened were indeed BWRed1K and 
BWRed2cK mutants as they possessed the screening yielded a ~1.3 kb band indicative of 
an amplicon from the genomic loci containing the zwf-kanR-zwf cassette, (Table 6.20, 
Figure 6.3). On the other hand, of all 4 colonies screened BWRed2k, only one yielded the 
~1.1 kb band indicative of an amplicon from the genomic loci containing the zwf-camR-zwf 
cassette, (Table 6.20, Figure 6.3). This identified mutant was further confirmed to be a 
BWRed2kC mutant as screening with the upstream-midstream and midstream-downstream 
pair of primers produced ~0.6 and ~0.5 kb bands indicative of amplicons of a genomic loci 
containing part of the zwf-camR-zwf cassette, (Figure 6.4). 
 
Single colonies of colony-PCR verified zwf strains BWRed1K and BWRed2cK were 
cultivated in 2YT media supplemented with kanamycin (50 mg/L) and chloramphenicol (25 
mg/L), respectively. Wild type E. coli BW25113 was also cultivated in kanamycin and 
chloramphenicol media as controls. The zwf strains BWRed1cK and BWRed2cK mutants 
grew to saturation in their respective media after 24 hour of cultivation. However, the wild 
type E. coli BW25113 control did not survive in the kanamycin or chloramphenicol 
selection pressure in the 2YT media. 
 
pBBR1c-RED2 had a ~2-fold higher recombination efficiency (3.3*10-5) relative to 
pBBR1c-RED1 (1.5*10-5). This could be a result of the reportedly higher efficiency of 
pKD46 (parent plasmid of pBBR1c-RED2) compared to pKD20 (parent plasmid of 
pBBR1c-RED1), as pKD46 has been previously reported to be more efficient than pKD20 
(Datsenko and Wanner, 2000). On the other hand, the significantly lower efficiency of 
pBBR1k-RED using the camR cassette might be due to unsuitable chloramphenicol 
selection concentration and/ or insufficient expression of the cat gene from the Pcat-camR 
cassette.
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Table 5.20: Colony count from -Red recombineering with pBBR1c-RED1, pBBR1c-RED2 and pBBR1k-RED 
 Original strain Linear DNA Induction Selection Antibiotics Colony count Recombination efficiency Final strain 
1. BWRed1 zwf-kanR-zwf + 50 g/ml Kan  1840 1.5*10-5 BWRed1K 
2. BWRed2k zwf-camR-zwf + 25 g/ml Cam 10 N/A BWRed2kC 
3. BWRed2c zwf-kanR-zwf + 50 g/ml Kan  4000 3.3*10-5 BWRed2cK 
4. BWRed1 zwf-kanR-zwf - 50 g/ml Kan 16 N/A BWRed1 
5. BWRed2k zwf-camR-zwf - 25 g/ml Cam 0 N/A BWRed2k 
6. BWRed2c zwf-kanR-zwf - 50 g/ml Kan  2 N/A BWRed2c 
7. BWRed2c zwf-kanR-zwf - 25 g/ml Cam 1200 *105 N/A BWRed2c 
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Figure 5.3:  Agarose gel electrophoresis from colony PCR screening with upstream-
downstream primers to identify zwf strains BWRed1K, BWRed2cK and BWRed2kC of E. 
coli BW25113 after -Red recombineering.  
Colony PCR was performed with primers binding to genomic regions upstream and 
downstream to the genomic integration site of the antibtiotics resistance cassette. All 5 
colonies out of >1000 colonies tested for both BWRed1/zwf-kanR-zwf and BWRed2c/zwf-
kanR-zwf systems show successful integration, as confirmed by the 1331 bp kanR amplicon. 
Of all 4 colonies out of 5 colonies tested from the BWRed2k/zwf-camR-zwf system, only 
one colony (D) showed gene replacement (1136 bp camR amplicon), while other colonies 
(A-C) show still possessed the zwf gene of E. coli BW25113 (1876 bp zwf amplicon). L – 1 
kb DNA ladder.  
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Figure 5.4: Agarose gel electrophoresis of colony PCR screening with upstream-midstream 
primers to confirm zwf strains BWRed2kC E. coli BW25113 after -Red recombineering.  
A - PCR amplicon of a false positive colony using primers specific to upstream of genomic 
region and midstream of camR cassette show multiple bands confirming no successful 
integration. B - PCR amplicon of a false positive colony using primers specific to 
midstream of camR cassette and downstream of genomic region show no band specific to 
expected PCR amplicon. C - PCR amplicon of the identified BWRed2kC mutant colony 
using primers specific to upstream of genomic region and midstream of camR cassette 
show a 0.6 kb band confirming successful integration of camR cassette. D - PCR amplicon 
of identified BWRed2kC mutant colony using primers specific to midstream of camR 
cassette and downstream of genomic region show a 0.5 kb band confirming successful 
integration of camR cassette successful integration of camR cassette into the genome of 
BW25113. L -100 bp ladder.  
 
 
1.0 
L 
0.5 0.5 kb amplicon 
0.6 kb amplicon 
A B 
1.2 
1.5 
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5.4 CONCLUSION 
The result herein confirm that the plasmid constructs pBBR1c-RED1, pBBR1c-RED2, and 
pBBR1k-RED are useful for mediating -Red recombineering in E. coli BW25113. The 
observed recombination efficiency, particularly with the pBBR1c-RED1 and pBBR1c-
RED2 plasmids strongly suggests that the plasmids should be effective, and thus may be 
employed as broad host range -Red recombineering vectors in other microbial cell 
factories. 
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CHAPTER SIX
 209 
6 DEVELOPING A -RED RECOMBINEERING METHOD OF GENOME 
EDITING IN R. EUTROPHA H16 (PART II) 
 
6.1 INTRODUCTION 
Building on the results obtained from -Red recombineering in E. coli BW25113, the 
plasmids pBBR1c-RED1 and pBBR1c-RED2 were tested for mediating -Red 
recombineering in R. eutropha H16. The phaC1 gene encoding the polyhydroxyalkanaote 
synthase was targeted using a kanamycin resistance (kanR) dsDNA cassette. The 1770 bp 
phaC1 gene (H16_A1437) spans the 1557353 and 1559122 nucleotides of chromosome 1 
of the genome of Ralstonia eutropha H16. Two different kanR genes from pBbA8K-RFP 
were separately used in designing linear dsDNA cassette for targeting the phaC1 gene. 
Successful integration of a kanR resistance marker could not be confirmed, thus suggesting 
that Ralstonia eutropha H16 may not be amenable to -Red recombineering. 
 
6.2 METHODS 
6.2.1 Linear dsDNA cassettes 
Linear dsDNA cassettes carrying the kanR genes from pBbA8k-RFP and pBHR1 designed 
to target the phaC1 gene. The phaC1-nkanR-phaC1, 100H.phaC1-nkanR-100H.phaC1, 
1000H.phaC1-nkanR-1000H.phaC1 linear dsDNA cassettes were also designed to target 
the phaC1 gene. PCR products of linear dsDNA cassette were incubated with 1 L DpnI to 
remove plasmid template where there were no PCR side products. In the presence of PCR 
side products, the intended PCR products were gel extracted. To improve chances of 
successful recombination, 5’-phosphorothiolated versions of some of the cassettes were 
created re-amplying the cassettes with primers with 5’-phosphorothiolated ends (Mosberg 
et al., 2012). 
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Table 6.1: Description of dsDNA cassettes for -Red recombineering in R.eutropha H16 
dsDNA cassette Length of 
cassette 
(bp) 
Description Orientation of 
sense strand of 
kanR gene 
phaC1-nkanR-phaC1 1220 A kanR cassette with the kanR 
from pBHR1 and 50 bp homology 
arms flanking the phaC1 gene 
Top strand 
100H.phaC1-nkanR-100H.phaC1 1320 A kanR cassette with the kanR 
from pBHR1 and 100 bp 
homology arms flanking the 
phaC1 gene 
Top strand 
phaC1-kanR-phaC1 1031 A kanR cassette with the kanR 
from pBbA8k-RFP and 50 bp 
homology arms flanking the 
phaC1 gene 
Top strand 
phaC1-rckanR-phaC1 1031 A kanR cassette with the kanR 
from pBbA8k-RFP and 50 bp 
homology arms flanking the 
phaC1 gene 
Bottom strand 
100H.phaC1-kanR-100H.phaC1 1131 A kanR cassette with the kanR 
from pBbA8k-RFP and 100 bp 
homology arms flanking the 
phaC1 gene 
Top strand 
100H.phaC1-rckanR-100H.phaC1 1131 A kanR cassette with the kanR 
from pBbA8k-RFP and 100 bp 
homology arms flanking the 
phaC1 gene 
Bottom strand 
5'.pT.100H.phaC1-kanR-5'.pT. 
100H.phaC1 
1131 A variant of 100H.phaC1-kanR-
100H.phaC1 5’-
phosphorothiolated at both ends  
Top strand 
5'.pT.100H.phaC1-rckanR-5'.pT. 
100H.phaC1 
1131 A variant of 100H.phaC1-rckanR-
100H.phaC1 5’-
phosphorothiolated at both ends 
Bottom strand 
5'.pT.100H.phaC1-kanR-
100H.phaC1 
1131 A variant of 100H.phaC1-kanR-
100H.phaC1 5’-
phosphorothiolated at the 
beginning of the upstream 
homology arm 
Top strand 
5'.pT.100H.phaC1-rckanR-
100H.phaC1 
1131 A variant of 100H.phaC1-rckanR-
100H.phaC1 5’-
phosphorothiolated at the 
beginning of the upstream 
homology arm 
Bottom strand 
100H.phaC1-kanR-
5'.pT.100H.phaC1 
1131 A variant of 100H.phaC1-kanR-
100H.phaC1 5’-
phosphorothiolated at the end of 
the downstream homology arm 
Top strand 
100H.phaC1-rckanR-
5'.pT.100H.phaC1 
1131 A variant of 100H.phaC1-rckanR-
100H.phaC1 5’-
phosphorothiolated at the end of 
the downstream homology arm 
Bottom strand 
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Table 6.2: Primers used in this study 
 
 
 
PCR product PCR Template Primer name Sequence 
1.9 kb NdeI-Gam.Bet.Exo-BamHI pBBR1c-RED1 NdeI-Gam-for 5’-
GATCCATATGATGGATATTAATACTG
AAACTGAGATCAAGCAAAAGC-3’ 
BamHI-Exo-rev 5’-
GATCGGATCCTCATCGCCATTGCTCC
CCA-3’ 
2.2 kb NdeI-Gam.Bet.Exo.Lt -
BamHI 
pBBR1c-RED2 NdeI-Gam-for 5’-
GATCCATATGATGGATATTAATACTG
AAACTGAGATCAAGCAAAAGC-3’ 
BamHI-Lt-Exo-rev 5’-
GATCGGATCCCTACTGGTATTGGCAC
AAACCTGATT-3’ 
Segment of Chr1 containing the 
phaC1 gene 
Ralstonia 
eutropha H16 
Chr1-for 5’-
CTCGGAATCGCTGACGATTCCCAG-
3’ 
 Chr1-rev 5’-
TGGCCCATGATGACTTCGCTCACCTG
-3’ 
 
Table continues below 
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 PCR product PCR Template Primer name Sequence 
1.22 kb phaC1-nkanR-phaC1 pBHR1 
 
phaC1-nkanR-for 5’-
GCAATGCCCGGAGCCGGTTCGAATAG
TGACGGCAGAGAGACAATCAAATC 
TTGTGTCTCAAAATCTCTGATGTTAC
ATTGCAC-3’ 
phaC1-nkanR-rev 5’- 
TGCAGGCCTGCCGGCGCCGTGCATGA
CGCACGCCGGCACTCATGCAAGCG 
GCCACGGTTGATGAGAGCTTTG-3’  
1.32 kb 100H.phaC1-nkanR-
100H.phaC1 
pBHR1 100H.phaC1-nkanR-for 5’-
CAAGCCGGGTCCATTCGGATAGCATC
TCCCCATGCAAAGTGCCGGCCAGGGC
AATGCCCGGAGCCGGTTCGAATAGTG
ACG-3’ 
100H.phaC1-nkanR-rev 5’-
TGACAACGTCAGTCATTGTGTAGTCC
TTTCAATGGAAACGGGAGGGAACCTG
CAGGCCTGCCGGCGCCGTG-3’ 
 
Table continues below 
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PCR product PCR Template Primer name Sequence 
50H.phaC1-kanR-50H.phaC1 zwf-kanR-zwf 50H.phaC1-kanR-for 5’-
GCAATGCCCGGAGCCGGTTCGAATAG
TGACGGCAGAGAGACAATCAAATCGG
AATTGCCAGCTGG-3’ 
50H.phaC1-kanR-rev 5’-
TGCAGGCCTGCCGGCGCCGTGCATGA
CGCACGCCGGCACTCATGCAAGCGTC
AGAAGAACTCGTCAAGAAGG-3’ 
phaC1-rckanR-phaC1 zwf-kanR-zwf 50H.phaC1-rckanR-for 5’-
GCAATGCCCGGAGCCGGTTCGAATAG
TGACGGCAGAGAGACAATCAAATCTC
AGAAGAACTCGTCAAGAAGG-3’ 
50H.phaC1-rckanR-rev 5’-
TGCAGGCCTGCCGGCGCCGTGCATGA
CGCACGCCGGCACTCATGCAAGCGGG
AATTGCCAGCTGG-3’ 
 
Table continues below 
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 PCR product PCR Template Primer name Sequence 
100H.phaC1-kanR-100H.phaC1 50H.phaC1-
kanR-
50H.phaC1 
100H.phaC1-nkanR-for 5’-
CAAGCCGGGTCCATTCGGATAGCATC
TCCCCATGCAAAGTGCCGGCCAGGGC
AATGCCCGGAGCCGGTTCGAATAGTG
ACG-3’ 
100H.phaC1-nkanR-rev 5’-
TGACAACGTCAGTCATTGTGTAGTCC
TTTCAATGGAAACGGGAGGGAACCTG
CAGGCCTGCCGGCGCCGTG-3’ 
100H.phaC1-rckanR-100H.phaC1 50H.phaC1-
rckanR-
50H.phaC1 
100H.phaC1-nkanR-for 5’-
CAAGCCGGGTCCATTCGGATAGCATC
TCCCCATGCAAAGTGCCGGCCAGGGC
AATGCCCGGAGCCGGTTCGAATAGTG
ACG-3’ 
100H.phaC1-nkanR-rev 5’-
TGACAACGTCAGTCATTGTGTAGTCC
TTTCAATGGAAACGGGAGGGAACCTG
CAGGCCTGCCGGCGCCGTG-3’ 
5'.pT.100H.phaC1-kanR-5'.pT. 
100H.phaC1 
100H.phaC1-
kanR-
100H.phaC1 
5'.pT.u.phaC1-nkanR-for 5’PTO-caagccgggtccattc-3’ 
5'.pT.u.phaC1-nkanR-rev 5’PTO-tgacaacgtcagtcattg-
3’ 
 
Table continues below 
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*Underlined nucleotides are restriction sites. Nucleotides in bold represent 50 bp homology part of the primer, which is not part of PCR DNA template.
PCR product PCR Template Primer name Sequence 
5'.pT.100H.phaC1-rckanR-5'.pT. 
100H.phaC1 
100H.phaC1-
kanR-
100H.phaC1 
5'.pT.u.phaC1-nkanR-for 5’PTO-caagccgggtccattc-3’ 
5'.pT.u.phaC1-nkanR-rev 5’PTO-tgacaacgtcagtcattg-
3’ 
5'.pT.100H.phaC1-kanR- 
100H.phaC1 
100H.phaC1-
kanR-
100H.phaC1 
5'.pT.u.phaC1-nkanR-for 5’PTO-caagccgggtccattc-3’ 
100H.phaC1-nkanR-rev 5’-tgacaacgtcagtcattg-3’ 
5'.pT.100H.phaC1-rckanR- 
100H.phaC1 
100H.phaC1-
kanR-
100H.phaC1 
5'.pT.u.phaC1-nkanR-for 5’PTO-caagccgggtccattc-3’ 
100H.phaC1-nkanR-rev 5’-tgacaacgtcagtcattg-3’ 
100H.phaC1-kanR-5'.pT. 
100H.phaC1 
100H.phaC1-
kanR-
100H.phaC1 
100H.phaC1-nkanR-for 5’-caagccgggtccattc-3’ 
5'.pT.u.phaC1-nkanR-rev 5’PTO-tgacaacgtcagtcattg-
3’ 
100H.phaC1-rckanR-5'.pT. 
100H.phaC1 
100H.phaC1-
rckanR-
100H.phaC1 
100H.phaC1-nkanR-for 5’-caagccgggtccattc-3’ 
5'.pT.u.phaC1-nkanR-rev 5’PTO-tgacaacgtcagtcattg-
3’ 
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6.2.1.1 phaC1-nkanR-phaC1 
A 1.22 kb phaC1-nkanR-phaC1 amplicon was amplified using pBHR1 plasmid template as a 
source of the Pneokan-kanR gene. Forward primer:  phaC1-nkanR-for and reverse primer 
phaC1-nkanR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to the 
5’-upstream and 5’-downstream sequences flanking the phaC1 gene in R. eutropha H16, 
respectively, Table 6.3. 
 
Table 6.3: PCR protocol for phaC1-nkanR-phaC1 
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5  
5X Q5 HF Buffer 10 1X 
dNTPs (10mM) 1 0.2 mM 
phaC1-nkanR-for (20 M) 1.25 0.5 M 
phaC1-nkanR-rev (20 M) 1.25 0.5 M 
pBHR1 0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
Table 6.4: PCR programme for phaC1-nkanR-phaC1 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
70C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 45 s 
Final Extension 72C 2 minutes 
Hold 8C  
 
 
6.2.1.2 100H.phaC1-nkanR-100H.phaC1 
A 1.32 kb 100H.phaC1-nkanR-100H.phaC1 amplicon was amplified using the 1.22 kb 
phaC1-nkanR-phaC1 amplicon as PCR template. Forward primer:  100H.phaC1.nkanR-for 
and reverse primer: 100H.phaC1.nkanR-rev possessed 50 nucleotide sequences at their 5’-
ends corresponding to the 5’-upstream and 5’-downstream sequences flanking the 50 
nucleotides flanking the phaC1 gene in R. eutropha H16, respectively, Table 6.5. 
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Table 6.5: PCR protocol for 100H.phaC1-nkanR-100H.phaC1 
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5 - 
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
100H.phaC1.nkanR-for (20 M) 1.25 0.5 M 
100H.phaC1.nkanR-rev (20 M) 1.25 0.5 M 
   phaC1-nkanR-phaC1 0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
Table 6.6: PCR programme for phaC1-nkanR-phaC1 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
70C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 45 s 
Final Extension 72C 2 minutes 
Hold  8C  
 
 
6.2.1.3 50H.phaC1-kanR-50H.phaC1  
A 1.031 kb 50H.phaC1-kanR-50H.phaC1 amplicon was amplified using zwf-kanR-zwf as a 
source of the Pneokan-kanR gene. Forward primer:  50H.phaC1-kanR-for and reverse primer 
50H.phaC1-nkanR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to 
the 5’-upstream and 5’-downstream sequences flanking the phaC1 gene in R. eutropha H16, 
respectively, (Table 6.7). 
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Table 6.7: PCR protocol for 50H.phaC1-kanR-50H.phaC1 
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5 - 
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
50H.phaC1.kanR-for (20 M) 1.25 0.5 M 
50H.phaC1.kanR-rev (20 M) 1.25 0.5 M 
  zwf-kanR-zwf 0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
Table 6.8: PCR programme for 50H.phaC1-kanR-50H.phaC1 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
65C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 35 s 
Final Extension 72C 2 minutes 
Hold  8C  
 
6.2.1.4 50H.phaC1-rckanR-50H.phaC1  
A 1.031 kb 50H.phaC1-rckanR-50H.phaC1 amplicon was amplified using zwf-kanR-zwf as a 
source of the Pneokan-kanR gene. Forward primer 50H.phaC1-rckanR-for and reverse primer 
50H.phaC1-rckanR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to 
the 5’-upstream and 5’-downstream sequences flanking the phaC1 gene in R. eutropha H16, 
respectively, (Table 6.9). 
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Table 6.9: PCR protocol for 50H.phaC1-rckanR-50H.phaC1 
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5 - 
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
50H.phaC1.rckanR-for (20 M) 1.25 0.5 M 
50H.phaC1.rckanR-rev (20 M) 1.25 0.5 M 
  zwf-kanR-zwf 0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
Table 6.10: PCR programme for 50H.phaC1-rckanR-50H.phaC1 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
61C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 35 s 
Final Extension 72C 2 minutes 
Hold  8C  
 
6.2.1.5 100H.phaC1-kanR-100H.phaC1 and 100H.phaC1-kanR-100H.phaC1 
The cassettes 100H.phaC1-kanR-100H.phaC1 and 100H.phaC1-rckanR-100H.phaC1 were 
amplified from their respective 50H.phaC1-kanR-100H.phaC1 and 50H.phaC1-rckanR-
100H.phaC1 precursors. Forward primer 100H.phaC1-kanR-for and reverse primer 
100H.phaC1-nkanR-rev possessed 50 nucleotide sequences at their 5’-ends corresponding to 
the 5’-upstream and 5’-downstream sequences flanking the 50 bp sequences upstream and 
downstream of the phaC1 gene in R. eutropha H16, respectively, Table 6.11. 
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Table 6.11: PCR protocol for 100H.phaC1-kanR-100H.phaC1 and 100H.phaC1-rckanR-
100H.phaC1  
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5 - 
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
100H.phaC1.nkanR-for (20 M) 1.25 0.5 M 
100H.phaC1.nkanR-rev (20 M) 1.25 0.5 M 
  50H.phaC1-kanR-50H.phaC1/ 
 50H.phaC1-rckanR-50H.phaC1 
0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
Table 6.12: PCR programme for 100H.phaC1-kanR-100H.phaC1 and and 100H.phaC1-
rckanR-100H.phaC1  
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
72C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 45 s 
Final Extension 72C 2 minutes 
Hold  8C  
 
6.2.1.6 Phosphorotholated variants of 100H.phaC1-kanR-100H.phaC1 and 
100H.phaC1-kanR-100H.phaC1 
 
The phosphorothiolated variants of the 100H.phaC1-kanR-100H.phaC1 and 100H.phaC1-
rckanR-100H.phaC1 were constructed using primers detailed in Table 6.13. 
  
    221 
Table 6.13: PCR protocol for phosphorothiolated cassettes 
PCR reaction component Volume [L] Final concentration 
Nuclease free Water 35.5 - 
5X Q5 HF Buffer 10 1X 
dNTPs (10 mM) 1 0.2 mM 
Forward primer (20 M) 1.25 0.5 M 
Reverse primer (20 M) 1.25 0.5 M 
  100H.phaC1-kanR-50H.phaC1/ 
  100H.phaC1-rckanR-50H.phaC1 
0.5 5 ng 
Q5 polymerase (2 U/L) 0.5 1 U/50L 
 
 
Table 6.14: PCR programme for phosphorothiolated cassettes 
Step Temperature Time 
Initial denaturation 98C 30 s 
30X 98C 
60C (Anneal) 
72C (Extend) 
8 s 
30 s 
30 s/kb i.e. 45 s 
Final Extension 72C 2 minutes 
Hold  8C  
 
6.2.2 Verification of stability of pBBR1c-RED1 and pBBR1c-RED2 in Ralstonia 
eutropha H16 
The -Red plasmids pBBR1c-RED1 and pBBR1c-RED2 were transformed into Ralstonia 
eutropha H16 thus creating strains ReRed1 and ReRed2. 5 mL of NB media in a 50 mL 
falcon tube, supplemented with chloramphenicol and gentamicin was inoculated with 
transformant colonies of each plasmid. The inoculum was cultivated for up to 30 h to create 
an overnight culture. The presence and stability of the plasmids in overnight culture was 
confirmed via colony PCR using the 1 L of the liquid culture as DNA template, Table 
6.15 and 6.16. 
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Table 6.15: Colony PCR protocol for ReRed1 and ReRed2 
Reaction component Unit volume [L] Unit concentration 
Nuclease free water 19  
10X Taq Buffer 2.5 1X 
20 mM MgSO4 1.875 1X 
10 mM dNTP 0.5 1X 
20 M Forward primer [NdeI-Gam-for] 0.5 400 nM 
20 M Reverse primer [BamHI-Exo-rev/ BamHI-Exo-
lt] 
0.5 400 nM 
Taq polymerase (5 U/L) 0.125 1.25 units/50 L 
 
 
Table 6.16: Colony PCR programme for ReRed1 and ReRed2 
Step Temperature Time 
Initial denaturation 95C 5 minutes 
30 X 95C 
57C (Anneal) 
68C (Extend) 
30 s 
1 minute 
60s/kb i.e. 2 min 15 secs 
Final Extension 68C 5 minutes 
Hold 8C  
 
6.2.3 Recombineering via -Red recombinase proteins in Ralstonia eutropha H16 
The -Red-mediated gene inactivation in Ralstonia eutropha H16 was adapted from the 
protocol used in E. coli BW25113 in Chapter 6. Fresh 5 mL of NB media in a 50 mL falcon 
tube, supplemented with chloramphenicol and gentamicin was inoculated in a 1:50 ratio 
with 100 l of overnight cultures of ReRed1 and ReRed2. Cultures meant for -Red 
recombineering were supplemented with L-arabinose (0.1%), while the control cultures 
were not. The cultures were cultivated at 30C to OD600 value 0.6-1.0 to allow transient 
expression of the -Red proteins. The cultures were then transformed via electroporation 
with appropriate linear dsDNA cassette according to the protocol already detailed in 
Chapter 2. Outgrowth culture of Ralstonia eutropha strains was cultivated for 4 h at 30C, 
250 rpm. A predefined amount of cells were plated on appropriate NB agar plates 
supplemented appropriate antibiotics. Some NB agar plates were supplemented to L-
arabinose (0.1%) to allow for continued expression for the -Red proteins as the colonies 
grew. In some cases the plates were additionally supplemented with chloramphenicol (25 
mg/L) in addition to L-arabinose (0.1%) in order to select for cells that still possessed the 
-Red plasmid. 
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6.2.4 Verification of successful recombination Ralstonia eutropha H16 
Colonies observed on test agar plates were counted and the number of colonies is compared 
to number of colonies observed on control plates from cultures without induction of protein 
expression or without the addition of dsDNA cassettes. A colony count ratio of  >10:1 was 
set as an arbitrary standard for preliminary confirmation of successful genomic integration. 
Further verification of these colonies was performed via colony PCR. Colony PCR was 
performed with OneTaq or Taq polymerase by New England Biolabs, and used according 
to the manufacturer’s instructions. 
 
6.2.5 -Red Recombineering with pBBR1c-RED2 and kanR cassettes from pBbA8k-
RFP 
A number of kanR linear dsDNA cassettes with the kanR gene in pBbA8k-RFP were used 
to target the phaC1 gene in R. eutropha. The experiment was set-up as follows, Figure 6.2: 
1. 50 mL of NB supplemented with gentamicin (10 mg/L), L-arabinose (0.1%) and 
chloramphenicol (25 mg/L) was cultivated in a 250 mL flask. The culture was 
inoculated with ReRed2 overnight culture. 
2. 5 mL of NB supplemented with gentamicin (10 mg/L), chloramphenicol (25 mg/L) 
was cultivated in a 50 mL falcon tube. The culture was inoculated with ReRed2 
overnight culture. 
3. 5 mL of NB supplemented with gentamicin (10 mg/L) in a 50 mL falcon tube. This 
was inoculated with overnight culture of Ralstonia eutropha H16 (ReH16). 
 
All inoculated cultures were cultivated to OD600 of ~1.0. 24 mL of the culture in “1” was 
aliquoted into fresh 50 mL new falcon tube. 2 mL each of the culture in “B” was inoculated 
into two fresh 2 mL microfuge tube. 2 mL each of the culture in “C” was aliquoted into 2 
fresh 2 mL microfuge tubes. All cultures were pre-treated for electroporation according to 
the protocol already detailed in Chapter 3. 200 L each of cell suspension in 0.2 M sucrose 
of each culture type from “1” was aliquoted into 11 fresh 1.5 mL microfuge tubes labeled 
A-K. 200 L each of cell suspension in 0.2 M sucrose of culture from “2” was aliquoted 
into 2 fresh 2 mL microfuge tubes labeled “L” and “M”. 200 L each of cell suspension in 
0.2 M sucrose of culture from “3” was aliquoted into 2 fresh 2 mL microfuge tubes labeled 
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“M” and “N”. 500 ng of the dsDNA linear dsDNA was added to the each cell suspension 
labeled according to Table 7.17. Cell suspensions K, L, M, N and O were used as controls 
according to Table 7.18. 
 
Table 6.17: Experimental set-up of -Red recombineering using different dsDNA cassettes 
Sample Strain Culture Linear dsDNA type added 
A ReRed2 1 50H.phaC1-kanR-50H.phaC1 
B ReRed2 1 50H.phaC1-rckanR-50H.phaC1 
C ReRed2 1 100H.phaC1-kanR-100H.phaC1 
D ReRed2 1 100H.phaC1-rckanR-100H.phaC1 
E ReRed2 1 5’-PTO-100H.phaC1-kanR-100H.phaC1 
F ReRed2 1 5’-PTO-100H.phaC1-rckanR-100H.phaC1 
G ReRed2 1 100H.phaC1-kanR-5’-PTO-100H.phaC1 
H ReRed2 1 100H.phaC1-rckanR-5’-PTO-100H.phaC1 
I ReRed2 1 5’-PTO-100H.phaC1-kanR-5’-PTO-100H.phaC1 
J ReRed2 1 5’-PTO-100H.phaC1-rckanR-5’-PTO-100H.phaC1 
K ReRed2 1 - 
L ReRed2 2 100H.phaC1-kanR-100H.phaC1 
M ReRed2 2 100H.phaC1-rckanR-100H.phaC1 
N ReH16 3 100H.phaC1-rckanR-100H.phaC1 
O ReH16 3 - 
 
Table 6.18: Negative controls for -Red recombineering 
Sample Role of control 
K A negative control to ascertain integration of dsDNA kanR cassette in A-J 
L A negative control to ascertain L-arabinose-induced and -Red-mediated 
integration of 100H.phaC1-kanR-100H.phaC1 in A-J 
M A negative control to ascertain L-arabinose-induced and -Red-mediated 
integration of 100H.phaC1-rckanR-100H.phaC1 in A-J 
N A negative control to ascertain that -Red-mediated integration of 
100H.phaC1-rckanR-100H.phaC1 is ReRed2-dependent 
O A negative control to ascertain kanamycin resistance phenotype of mutants 
with genomic integration of dsDNA kanR cassette 
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All outgrowth cultures of each transformant were cultivated for up to 5 h. All cells from 
outgrowth cultures of all cell suspensions apart from B, D, F, G, H, J from were plated on 
only NB agar plate supplemented with kanamycin (250 mg/L). Cells from outgrowth 
cultures of cell suspensions B and D were plated in equal volume on NB agar plate 
supplemented with kanamycin (250 mg/L), NB agar plate supplemented with kanamycin 
(250 mg/L) and L-arabinose (0.1%), NB agar plate supplemented with kanamycin (250 
mg/L) and L-arabinose (0.1%) and chloramphenicol (25 mg/L). All plates were incubated 
for up to 96 h. 
 
To screen for possible mutants, colonies were selected from the agar plates from the 
samples A-J, and O as the control. The selected colonies were cultivated in NB media 
supplemented with 250 mg/L in a 96-well plate to screen for kanamycin resistance colonies, 
which had possibly integrated the kanR cassettes into the genome.  
 
The liquid culture of the colonies was used as genomic template for the colony PCR-based 
screening, (Table 6.19 and 6.20). Also, the primers 100H.phaC1-nkanR-for and 
100H.phaC1-nkanR-rev, which are specific to the genomic regions 100 bp upstream and 
downstream of the phaC1 gene, were used. This meant that the primers were genomic 
primers in cases where the cassettes with 50 bp homology arms were used. It also meant 
that the primers were both genomic and cassette based primers in cases where cassettes 
with 100 bp homology arms were used. Given this choice of primers, a band of  ~ 2.0 kb 
would be indicative of unsuccessful genomic integration of dsDNA cassette. A band of 
~1.1 kb would be indicative of successful genomic integration of dsDNA cassette. 
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Figure 6.1. Schematic of experimental set-up of -Red recombineering in Ralstonia eutropha H16 
using several variants of the kanR cassette from pBbA8K-RFP and the strain ReRed2 containing the 
pBBR1c-RED2 -Red plasmid. 
A B C D E F G H I J K L M N O
§ Inoculate fresh media with overnight 
cultures in a 1:50 ratio.  
§ Cultivate all cultures to OD600 ~1.0 
thus creating Cultures 1, 2, and 3. 
§  Cools cells in ice for 5 minutes. 
§ Wash cells with transformation 
buffers prior to  electroporation.  
§ Suspend cells in 0.2 M sucrose at a 
volume one-tenth the volume of each 
culture. 
Aliquot 200 µL of cell suspension into 
2 ml microfuge tubes 
A B C D E F G H I J K
Add 500 ng of linear dsDNA kanR 
cassettes into samples A to J and L, M, 
and N 
L M N O
A B C D E F G H I J K L M N O
Electroporation of cell all cell 
suspensions in 2 mm cuvettes 
Culture 1, 
induced 
Overnight culture of strain 
ReRed2 i.e.  Ralstonia 
eutropha H16 possessing the 
pBBR1c-RED2 plasmid  
Overnight culture of 
wild type  Ralstonia 
eutropha H16 
Culture 2, 
Un-induced 
Culture 3 
A B C D E F G H I J K L M N O
Transfer cells into 1ml of NB in fresh 
microfuge tubes and cultivate for 5 h 
NB agar plate type 
NB + Kan 
NB + Kan + L-arabinose 
NB + Kan + L-arabinose + Cam 
Plate cells on indicated agar type 
depending on sample type and incubate 
for up to 96 h 
Select single colonies and grow 
in NB agar plate supplemented 
with kanamycin (250 mg/L) 
Perform colony PCR to 
check for insert 
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Table 6.19: Colony PCR protocol for screening for mutant clones 
Reaction component Unit volume [l] Unit concentration 
Nuclease free water 12.6  
Liquid culture 5.0  
5X OneTaq GC Buffer 5.0 1X 
50 mM MgSO4 0.75 1X 
10 mM dNTP 0.5 1X 
20 M Forward primer [100H.phaC1-nkanR-for] 0.5 400 nM 
20 M Reverse primer [100H.phaC1-nkanR-rev] 0.5 400 nM 
Taq polymerase (5 U/L) 0.125 1.25 units/50 L 
 
Table 6.20: Colony PCR programme for screening for mutant clones 
Step Temperature Time 
Initial denaturation 95C 5 minutes 
30 X 95C 
68C (Anneal) 
68C (Extend) 
30 s 
1 minute 
60 s/kb i.e. 2 min 15 secs 
Final Extension 68C 5 minutes 
Hold 8C  
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6.3 RESULTS AND DISCUSSION 
6.3.1 Transformation of pBBR1c-RED1 and pBBR1c-RED2 into R. eutropha H16 
Agarose gel electrophoresis of the colony PCR products of the overnight cultures of 
ReRed1 and ReRed2 indicate bands at ~ 1.9 kb and ~2.2 kb, Figure 7.2. This band sizes 
correspond to the NdeI-pKD20-BamHI and the NdeI-pKD46-BamHI inserts from the -
Red plasmids pBBR1c-RED1 and pBBR1c-RED2, respectively. This indicated that the 
plasmids were indeed stably maintained in the cells. 
 
 
Figure 6.2: Agarose gel electrophoresis of colony PCR amplicons of Ralstonia eutropha 
with pBBR1c-RED1 (ReRed1), and pBBR1c-RED2 (ReRed2) transformants using 
appropriate primers for the -Red operon.  (A) 1.905 kb band shows the NdeI-pKD20-
BamHI amplicon from pBBR1c-RED1, (B) 2.2 kb band shows the NdeI-pKD46-BamHI 
amplicon from pBBR1c-RED2. L – 1 kb DNA ladder. 
 
 
6.3.2 -Red Recombineering with pBBR1c-RED2 and kanR cassettes from pBbA8k-
RFP 
The negative control samples K, L M produced 0, 0 and 1 colonies, respectively when 
plated on NB agar plate supplemented with kanamycin (250 mg/L). This is wide contrast to 
the number of colonies from samples A-J that had between 10 and 750 total colony count, 
depending on the type of NB agar plate used. Samples B and H, which were transformed 
3.0	
2.0	
1.5	
1.0	
kb	
L	 A	 B	
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with the 50H.phaC1-kanR-50H.phaC1 and 100H.phaC1-rckanR-5’-PTO-100H.phaC1 had 
the highest number of colonies (69 and 70, respectively) when the outgrowth was plated on 
NB agar supplemented with just kanamycin (250 mg/L). Sample B also had the highest 
numbers of colonies at 420 colonies when plated on NB agar supplemented with 
kanamycin (250 mg/L) and L-arabinose (0.1%) and at 750 colonies when plated on NB 
agar supplemented with kanamycin (250 mg/L) and L-arabinose (0.1%) and 
chloramphenicol (25 mg/L). Similarly, sample D had a total of 720 colonies when plated on 
NB agar supplemented with kanamycin (250 mg/L) and L-arabinose (0.1%) and 
chloramphenicol (25 mg/L).  
 
It was observed that the total number of colonies from sample B was highest (at 750 
colonies) when cells were plated on NB agar supplemented with kanamycin (250 mg/L) 
and L-arabinose (0.1%) and chloramphenicol (25 mg/L). This was lower (at 420 colonies) 
when the cells were plated on NB agar supplemented with kanamycin (250 mg/L) and L-
arabinose (0.1%). This, in turn, is lower compared to the number of cells observed when 
the outgrowth was plated on NB agar supplemented with just kanamycin (250 mg/L), Table 
7.19. The same trend was observed with the outgrowth culture from sample D, Table 7.9. 
Overall, a ratio of >10:1 was established between the colony count from some of the test 
samples and the control samples. This suggested that the colonies observed from the test 
samples might be mutants.  
 
Upon cultivation of selected colonies from the plates, most of the colonies grew in NB 
media supplemented with kanamycin (250 mg/L). Growth of the selected colonies upon 
cultivation in 96-well plate might be attributed to native resistance of Ralstonia eutropha 
H16 to kanamycin, Table 7.22. The colonies from sample N (i.e. wild type ReH16 
transformed with 100H.phaC1-rckanR-100H.phaC1) grew to a higher OD600 of ~1.3 
compared to the selected colonies from sapmle A-J which grew to OD600 0.5 - 0.9 after 48 h 
of cultivation. The cell density of Ralstonia eutropha H16 outgrowth culture is expected to 
be higher than the ReRed2 outgrowth cultures given the fact that the latter would have a 
relatively lower cell growth rate owing to the metabolic burden from replicating the 
pBBR1c-RED plasmid. Growth of the selected colonies suggested that they might be 
mutants. However colony PCR screening was primarily requisite for confirming successful 
integration of the kanR gene/deletion of the phaC1 gene.  
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Table 6.21: Colony count for -Red recombineering in R. eutropha H16 
 Total colony count on different NB agar plate types 
Sample NB+Kan NB+Kan+L-arabinose  NB+Kan+L-arabinose+Cam 
A 20 N/A N/A 
B 69 420 750 
C 15 N/A N/A 
D 54 288 720 
E 25 N/A N/A 
F 10 20 N/A 
G 30 N/A N/A 
H 70 100 N/A 
I 20 N/A N/A 
J 20 N/A N/A 
K 0 N/A N/A 
L 0 N/A N/A 
M 1 N/A N/A 
N 10 N/A N/A 
O 8 N/A N/A 
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Table 6.22: OD600 of cells of selected colonies screened for cell growth against kanamycin selection pressure.  
 A B C D E F G H I J N 
1 0.3315i 0.2510i 0.2629i 0.2371i 0.3525i 0.3008i 0.2476 i 0.3087i 0.2278 i 0.2215 i 0.2244 i 
2 0.2928i 0.3965i 0.3711i 0.2747 i 0.3698i 0.3705i 0.2822 i 0.4497i 0.3831 i 0.2605 i 1.3332 i 
3 0.9202i 0.2748i 0.2760 i 0.4217i 0.3498i 0.2995i 0.3525 i 0.4023i 0.2947 i 0.3546 i 0.3123 i 
4 0.2983i 0.4411ii 0.2903i 0.7638ii 0.7348i 0.2931i 0.5619 i 0.4125i 0.2633 i 0.3820 i 1.3642 i 
5 0.5311i 0.2205ii 0.2584i 0.3454ii 0.3840i 0.3376ii 0.4133 i 0.4518ii 0.2795 i 0.4123 i 0.2825 i 
6 0.3259i 0.2124ii 0.3810i 0.2378ii 0.4225i 0.2999ii 0.3723 i 0.3783ii 0.4546 i 0.3943 i 0.3526 i 
7 0.2428i 0.2145iii 0.2316 i 0.2975iii 0.3753i 0.2547ii 0.3963 i 0.6680ii 0.2304 i 0.6556 i 0.2316 i 
8 0.3284i 0.2240iii 0.2135i 0.3966iii 0.3032i 0.2041ii 0.5486 i 0.2150ii 0.2609 i 0.3318 i 1.2844 i 
(i) Cells on NB+Kan plates, (ii) Cells on NB+Kan+L-arabinose plates, (iii) Cells on NB+Kan+L-arabinose+Cam plates, Red colour – OD600 above 0.500 
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The cultures that grew to optical density >0.5 were selected for colony-PCR based 
screening. These include cultures in wells A3, D4, E4, G4, H7, J7, N2 and N4, 
corresponding to cultures from samples A, D, E, G H, J, and N, Table 7.22. Colony PCR 
evaluation of all selected mutants showed bands at ~2.0 kb which is indicative of a genomic 
amplicon containing the 1.77 kb phaC1 gene flanked upstream and downstream by 100 bp 
of homology arms, (Figure 7.4). This indicated that in the colonies, the phaC1 gene 
remained undeleted and thus questions if the dsDNA kanR cassettes had not been 
integrated into the genome. This suggested that the observed colonies from both the test 
and control samples probably grew as a result of adaptation to selection pressure from 
kanamycin after a lengthy incubation period of 96 h. 
 
 
 
Figure 6.3: Agarose gel electrophoresis of colony PCR from selected colonies which grew 
above OD600 after -Red recombineering with pBBR1c-RED2 in R. eutropha H16. All 8 
screened colonies show band at ~2.0 kb showing that the phaC1 gene is undeleted and that 
the linear dsDNA cassettes are not integrated into the genome. 
 
 
kb 
6.0 
3.0 
1.0 
2.0 
kb 
6.0 
3.0 
1.0 
2.0 
1 2 3 4 5 8 7 6 L L 
 233 
6.4 CONCLUSION 
Deletion of the phaC1 gene R. eutropha H16 via -Red recombineering was not confirmed. 
This might be attributed to a number of reasons especially the non-detectable levels of 
expression of the -Red proteins Gam, Bet and Exo. Other possible reasons could 
potentially include the poor compatibility of the -Red recombineering tool with native 
recombination-enabling machineries in R. eutropha H16. 
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CHAPTER SEVEN
 235 
7 CONCLUSION  
 
7.1 Contributions of this work  
In the quest to expand molecular tools for the metabolic engineering of R. eutropha H16, 
the need for chassis-compatible expression vectors is an essential requirement that has been 
emphazised in this study. Such vectors must have predictable performance in terms of their 
transformability into R. eutropha, and must offer tunable expression pattern of the genetic 
elements (biological parts) they encode. The L-arabinose inducible PBAD promoter in the 
pBBR1c-RFP vector was used to demonstrate tunable protein expression in Ralstonia 
eutropha H16 via dose-dependent expression of RFP (Chapter 2). The inducer-response 
profile of this vector showed high expression maxima at 0.2% L-arabinose. This expression 
profile has also recently been confirmed in a recent study by Xiong et al. (2018). 
 
The Fatty Acid and Phospholipid Regulator (FapR) protein – a malonyl-CoA-responsive 
transcriptional regulator is one such biological part requiring controlled expression. To 
achieve this, the PBAD promoter in the pBBR1c-FapR vector was used to drive expression of 
the FapR repressor to show that the FapR repressor can be expressed in Ralstonia eutropha 
H16 without negatively imparting on cell viability. This reported expression of the FapR– a 
vital Gram-positive bacterium fatty acid synthesis regulator is the first ever study 
demonstrating expression of this transcriptional repressor in R. eutropha H16. 
 
In expanding the frontiers of genome editing in R. eutropha H16 as a metabolic engineering 
tool, the genome editing tool - -Red recombineering was extensively studied in order to 
explore how the method might be tailored for use in R. eutropha H16. Controlled 
expression of the -Red proteins was identified as a crucial hurdle in engineering this 
method. To this end, the L-arabinose inducible PBAD expression vectors (pBBR1c-RED1, 
pBBR1c-RED2, pBBR1k-RED) plasmids for expressing the -Red proteins in R. eutropha 
were developed. Firstly, the functionality of these vectors was verified in E. coli BW25113. 
The fact that all three proteins were successfully expressed and detected in E. coli 
BW25113 and not detected in Ralstonia eutropha H16 suggests that the proteins may have 
undergone proteolysis as a cellular mechanism to protect the cell from potential cellular 
toxicity they might initiate. Although, expression was not detected in R. eutropha H16, 
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there have been no studies till date showing successful expression or detection of 
expression of the -Red proteins in R. eutropha. 
 
Whilst the L-arabinose promoter was used to demonstrate and achieve tunable expression 
in R. eutropha H16, the comparative advantage of constitutive promoters over inducible 
promoter systems was identified. To this end, replacing the L-arabinose inducible PBAD 
promoter in the pBBR1c-RFP plasmid with a set of 42 constitutive promoters yielded a set 
of 42 constitutive expression vectors with a 137-fold activity range (Chapter 3). The 
activities of these constitutive promoters arranged in hierarchical order of promoter strength 
span and exceed the entire induction range of the L-arabinose inducible PBAD promoter.  
The unique promoter identifier assigned each promoter in accordance with promoter 
strength makes the set of promoters readily assessable for pathway optimization in 
metabolic engineering applications. In engineering this set of 42 constitutive promoters, 
several strategies to alter promoter activity by tweaking promoter architecture were utilized. 
The strategies include point mutation, promoter hybridization, promoter length alteration, 
promoter configuration alteration, and incorporating cis-acting transcriptional and 
translational units. The application of these promoter engineering strategies further shed 
light on the unique transcriptional behavior/pattern of divergent promoters in back-to-back 
orientation in Ralstonia eutropha H16, a transcriptional pattern which has not been reported 
about Ralstonia eutropha H16 in prior study. This observed transcriptional pattern and 
promoter behavior could be potentially explored in other biological systems such as 
mammalian cells where the transcription process is a lot more complex in comparison to 
prokaryotic cells. The novelty of the promoter engineering strategy “E” (back-to-back 
orientation of divergent promoters) will thus potentially prove very useful in the 
engineering of mammalian promoters. This is particularly because transcriptional 
amplification is largely mediated by upstream elements and/or transcriptional factor 
binding sites in mammalian promoters (Brown et al., 2017, Brown et al., 2014). 
 
A key knowledge gap in controlling gene expression in R. eutropha H16 is the availability 
of genetic circuits to orchestrate dynamic control over gene expression. Malonyl-CoA-
responsive genetic circuits were particularly of interest as malonyl-CoA engineering is the 
core objective of this study. Whilst already developed for microbial chassis such as E. coli 
and Saccharomyces cerevisiaie, R. eutropha H16-compatible malonyl-CoA biosensors has 
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yet to be reported, prior to the study contained herein. By applying the toolbox of 
promoters already developed in this study, a set of 6 modular single-plasmid malonyl-CoA 
biosensors, which are functional in Ralstonia eutropha H16 were designed and construction 
(Chapter 4). Essentially, the novelty in the design of the biosensors lies in the application of 
the divergent promoter configuration (strategy “E”) to achieve structural modularity and 
optimal functionality of the sensors. The functionality of the best performing biosensor (S1) 
is achieved through careful selection of the promoters with the right activity levels in order 
to achieve a desired level of expression of the metabolite-responsive transcriptional factor 
(FapR). In addition, the response (RFP expression intensities) of the sensors to cerulenin 
confirmed that cerulenin is indeed a fatty acid inhibitor and a malonyl-CoA up-regulator in 
Ralstonia eutropha H16.  
 
Lastly, the need for facile genome editing tools in consolidating heterologous pathway 
optimization and gene expression control was identified. For this requirement, the 
development of a -Red recombineering method for Ralstonia eutropha H16 was attempted. 
The expression vectors pBBR1c-RED1, pBBR1c-RED2, pBBR1k-RED, successfully 
mediated deletion of the zwf gene in E. coli BW25113 using kanamycin and 
chloramphenicol resistance cassettes bearing 50 bp long homology arms to the zwf gene. 
Recombination efficiency as high as 3.3*10-5 was achieved with chloramphenicol-resistant 
pBBR1c-RED2 vector using a kanamycin resistance cassette zwf-kanR-zwf. Unsuccessful 
recombination in Ralstonia eutropha using the kanamycin-resistance markers and the 
chloramphenicol-resistant vectors pBBR1c-RED1 and pBBR1c-RED2 could be attributed 
to the previously identified poor expression of the -Red proteins driven by the L-arabinose 
inducible PBAD promoter. Other plausible reasons are limited transformation efficiency 
and/or poor stability of the linear dsDNA resistance markers in the cell prior to possible 
recombination events. To the best of available knowledge, there has been no other report on 
successful use of -Red recombineering as method of genome editing in R. eutropha H16. 
 
7.2 Future work 
Achieving malonyl-CoA engineering in Ralstonia eutropha H16 in R. eutropha will 
continue to benefit from rapid advancement in the synergistic application of the molecular 
tools studied and developed in this study viz a toolbox of promoters, malonyl-CoA-
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responsive genetic circuits, and a facile genome editing method. There remains a vast 
promoter engineering potential for regulating gene expression in R. eutropha, particularly 
through incorporation of essential genetic elements and exploring varied promoter 
configurations. This will particularly be useful in the construction of more sophisticated 
genetic circuits to control gene expression. 
 
With regards to the constructed malonyl-CoA biosensors reported in Chapter 4, these can 
be immediately leveraged upon in selecting for high malonyl-CoA producers subsequent to 
engineering Ralstonia eutropha H16 for malonyl-CoA production. Such strains could 
potentially be engineered with the controlled expression of heterologous malonyl-CoA 
source pathway(s) and/or more promising genome editing methods. The fluorescence 
intensities produced from the sensors will be used as a read-out to rank the mutants in order 
of their malonyl-CoA-production phenotype. This will require leveraging on the dynamic 
range of response of the malonyl-CoA sensors.  
 
In engineering a heterologous malonyl-CoA source pathway, the fold-range of activity of 
the engineered set of promoters from Chapter 3 will be leveraged in tuning expression 
levels in the pathway until a high-producer strain is achieved. Possible pathways/gene 
clusters worthy of experimentation include: (1) the malonyl-CoA synthetase (matB) and 
malonate carrier protein (matC) using malonate as a substrate and, (2) the acetyl-CoA 
carboxylase (ACC) genes from Corynebacterium glutamicum (Miyahisa et al., 2005).   
 
The first point of call in re-investigating the -Red recombineering method in Ralstonia 
eutropha will be optimizing the expression of the -Red proteins to levels detectable by 
SDS-PAGE protein analysis. One way to explore this might be to leverage the set of 
constitutive promoters reported in Chapter 3 in place of the L-arabinose inducible PBAD 
promoter used in this study. It is projected that experimenting with the time profile of 
expression of these promoters and their varied strengths will afford tunable expression of 
the -Red proteins to levels that might support recombineering event. Furthermore, 
investigation of the presence of, functions and mechanism of function of native 
recombination machineries, endonuclease and exonuclease enzymes in R. eutropha H16 
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will better help to understand how a functional -Red recombineering molecular tool may 
be better engineered in this microbial host. 
 
7.3 Future perspectives  
This work reported in this has successfully expanded the molecular tools for malonyl-CoA 
engineering in R. eutropha H16, particularly in the development of expression vectors and 
a collection of constitutive promoters for controlling gene expression. Potential metabolic 
engineering applications of the toolbox of constitutive promoters are: (1) optimizing static 
control of metabolic pathway(s), (2) optimizing the functionality of other metabolite-
responsive genetic circuits, (3) tunable expression of vital genetic elements required for 
genome editing in Ralstonia eutropha H16. These engineered vectors, promoters, and 
genetic circuits will also be applicable in similar microbial chassis apart from R. eutropha 
H16. 
 
However, the failure of the -Red recombineering method in Ralstonia eutropha H16 
portends that other proven methods of genome editing would continue to be adopted in 
engineering mutant strains. These methods include the more wildly applied allelic exchange 
method using suicide vectors, retrohoming (Enyeart et al., 2014) and the more recently 
developed CRISPR-Cas toolbox for R. eutropha H16 (Xiong et al., 2018). Although the -
Red recombineering method did not work in Ralstonia eutropha H16, the fact that all the 
constructed vectors were functional in E. coli BW25113 suggests that they could 
potentially be utilized in other relevant microbial cell factories where the pKD20 and 
pKD46 are not be functional. 
 
Overall, the engineered molecular tools viz: expression vectors, constitutive promoters, and 
malonyl-CoA biosensors reported in this study have expanded the collection of molecular 
tools available for the metabolic engineering of R. eutropha H16. This invariably further 
enables its genetic tractability and enhances its use as a microbial cell factory for the 
biosynthesis of varied valuable chemicals.  
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